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Abstract 
Motile cilia are microtubule based projections that assist in the movement of fluid 
over the surface of cells, such as in the respiratory epithelium, or of cells through 
a fluid, such as in sperm. Ciliary movement is driven by axonemal dyneins (ADs), 
large molecular complexes which contain long heavy chain ATPase motor 
subunits. The stability of ADs has been shown to be dependent on multiple 
cytoplasmically localised proteins, which are involved in their assembly and 
trafficking to the cilia. The heavy chain subunits have been suggested to be 
particularly reliant on specialised chaperoning pathways in order to fold into the 
correct tertiary structure. Hereditary defects in genes encoding the proteins of the 
ADs or proteins involved in their assembly result in an incurable human disease, 
primary ciliary dyskinesia (PCD). PCD results in neonatal respiratory distress with 
lifelong respiratory complications and is also highly heterogenous with mutations 
in 40 genes associated with it so far. Despite the identification of many putative 
assembly factors, where and how they interact with AD proteins remains unknown. 
In order to investigate AD complexes, from the translation of their subunits to their 
degradation, in greater spatial and temporal detail a heavy chain outer dynein arm 
subunit (ODA), Dnah5, was tagged with the adaptable SNAP tag in mice. Dnah5 
is the largest AD heavy chain and the most commonly mutated gene in PCD. When 
developing novel therapeutics the SNAP-Dnah5 mouse could be used as a 
reporter for functional rescue in PCD mouse models which exhibit loss of these 
complexes from the cilia. The effectiveness of the therapy could then be graded 
on the restoration of SNAP-DNAH5 fluorescence in the motile cilia. As a secondary 
aim this project also sought to improve the efficiency of CRISPR/Cas9 induced 
gene correction, via a novel linkage method, to develop a genome editing therapy 
for PCD, which could be tested using SNAP-Dnah5 mice. 
Using the SNAP-Dnah5 mouse tracheal epithelial cells I have directly imaged 
DNAH5’s docking onto the motile axoneme from the distal end and have 
demonstrated that there is a very low level of ODA turnover in mature cilia. I have 
also shown that the Dnah5 transcript localises to large apical clusters in ciliated 
tracheal epithelial cells and via preliminary pulldown experiments that SNAP-
DNAH5 might interact with RNA regulatory proteins in maturing motile ciliated cells 
suggestive of translational regulation. This project demonstrates the utility of this 
mouse model for future studies.
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Lay summary 
Motile cilia are hair-like structures projecting from the surface of many of our body’s 
cells that beat or wave in order to assist in the movement of fluids, like mucus out 
of our airways, or to propel cells, in the case of sperm. When mutations in our DNA 
mean that these cilia fail to beat, it can be the result of the hereditary disease 
primary ciliary dyskinesia (PCD). PCD causes neonatal respiratory distress, 
recurrent infections of the airways as well as infertility and complex problems in 
how our organs are positioned within our bodies. Currently mutations in 40 genes 
have been shown to cause PCD. As such, diagnosing and providing therapies for 
PCD is challenging, and currently there are only therapeutic interventions available 
to treat PCD symptoms. PCD urgently requires novel treatments to intervene early 
and prevent progressive airway damage.  
Many of the affected genes in PCD make proteins which are important parts of 
large molecular motors, called axonemal dyneins (ADs), which drive the movement 
of motile cilia. These are made of very large and complex subunits which require 
specialised assembly factors to help them fold and form the correct 
macromolecular machines. These assembly factors are required for cilia motility 
and mutations in the genes that encode them cause PCD. Without these factors 
ADs fail to assemble properly and are absent from the cilia resulting in incorrect or 
no movement. One aim of this project is to use genome editing as a way to cure 
PCD, by cutting any PCD gene near the incorrect DNA sequence using molecular 
scissors called CRISPR/Cas9 and replacing it with the healthy sequence. As part 
of this aim I have been trying to improve the efficiency of this gene replacement 
using published drugs and a novel method of assembling the ‘targeted’ Cas9 
scissor complex. The second aim of this project was to study the regulation and 
assembly of the mammalian AD proteins in real time to better understand disease 
mechanisms. To do this, I have used genome editing to attach a protein tag, named 
SNAP, to the dynein subunit Dnah5 in mice (SNAP-Dnah5 mouse model). This 
versatile tag can be used for live cell imaging or biochemistry by using different 
ligands. By adding different colours of dye to cells from these mice we can visualise 
where the protein is localised in a cell, its turnover and rates of trafficking. By doing 
this I established that the newly produced DNAH5 is incorporated at the growing 
tip of the cilia. Biochemical experiments that took advantage of the SNAP tag 
identified several novel putative DNAH5 interacting proteins which are also known 
to have a role in RNA regulation. To investigate whether Dnah5 mRNA might be 
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specially regulated in order to make these motor subunits, I used a technique to 
directly visualise how many Dnah5 transcript molecules exist and where they 
localise. I have shown that, in epithelial cells of the airways, transcripts of Dnah5 
cluster together beneath the upper surface of the cell where the cilia are located. 
This suggests Dnah5 transcripts are actively transported to these clusters which 
may regulate its conversion into protein. In this study I have created and 
characterised the SNAP-Dnah5 mouse line, which can be used to study the 
fundamental biology of ADs as well as record how well novel therapies work in 
restoring ADs in motile cilia of PCD models. 
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FRT Flippase Recognition Target 
g gram 
G1 Growth phase 1 
G2 phase Growth phase 2 
G3BP1 Stress Granule Assembly Factor 1 
G3BP2 Stress Granule Assembly Factor 2 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase 
GAS8 Growth Arrest Specific 8 
GRCh38 Genome Reference Consortium Human Build 38 
GRCm38 Genome Reference Consortium Mouse Build 38 
gRNA  Guide RNA 
GSTO1 Glutathione S-Transferase Omega 1 
H2B Histone-2B 
HDR Homology Directed Repair 
HEATR Huntingtin, elongation factor 3, protein phosphatase 2A, 
TOR1 Repeat 
HEATR2 HEAT repeat 2 
HEG Hexa-Ethylene Glycol 
HEK Human Embryonic Kidney 
HEK293 Human Embryonic Kidney 293 cells 
HITI Homology Independent Targeted Integration 
HR Homologous Recombination 
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HSP70 Heat Shock Protein 70 
HSP90 Heat Shock Protein 90 
HSP90aa1 Heat Shock Protein 90 Alpha Family Class A Member 1 
HSPB11 Heat Shock Protein family B (small) member 11 
hTERT human Telomerase Reverse Transcriptase 
HYDIN Hydrocephalus-Inducing Protein Homolog 
IC1 Intermediate Chain 1 
IC138 Intermediate Chain 138 
IC140 Intermediate Chain 140 
IC2 Intermediate Chain 2 
IC3 Intermediate Chain 3 
IC4 Intermediate Chain 4 
IC5 Intermediate Chain 5 
IC69  the 69,000 M(r) intermediate chain 
IC78  the 78,000 M(r) intermediate chain 
IC97 Intermediate Chain 97 
IDA Inner Dynein Arm 
IDT Integrated DNA Technologies 
IF Immuno-Fluorescence 
IFT Intra-Flagellar Transport 
IFT88 Intra-Flagellar Transport 88 
IGMM Institute of Genetics and Molecular Medicine 
ITR Inverted Terminal Repeat 
IVT In Vitro Transcription 
kDa KiloDalton 
KOD Thermococcus kodakaraenis 
KSFM Keratinocyte Serum Free Medium 
LB Luria Broth 
LC1 Dynein light chain 1, axonemal 
LC10 Dynein light chain 10, axonemal 
LC2 Dynein light chain 2, axonemal 
LC3 Dynein light chain 3, axonemal 
LC4 Dynein light chain 4, axonemal 
LC5 Dynein light chain 5, axonemal 
LC6 Dynein light chain 6, axonemal 
LC7 Light Chain 7 
LC7 Dynein light chain 7, axonemal 
LC8 Light Chain 8 
17 
 
LC8 Dynein light chain 8, axonemal 
LC9 Dynein light chain 9, axonemal 
LIG4 DNA Ligase IV  
LOX Lysyl Oxidase 
LoxP Locus of crossing (x) over P1 
LRRC50 Leucine-rich repeat-containing protein 50 
LRRC56 Leucine Rich Repeat Containing protein 56 
LRRC6 Leucine-rich repeat-containing protein 6 
mAb monoclonal Anti-Bodies 
MARCKS Myristoylated Alanine-Rich C-Kinase Substrate 
MCIDAS Multiciliate Differentiation And DNA Synthesis Associated 
Cell Cycle Protein 




MMEJ Microhomology Mediated End Joining 
MNS1 Meiosis Specific Nuclear Structural 1 
MOPS 3-(N-morpholino)propanesulfonic acid 
Mre11 Meiotic Recombination 11 Homolog 1 
MRN complex  Mre11 Rad50 Nbs1 complex 
mRNA Messenger RNA 
ms Mass Spectrometry 
MT Microtubule 
mTEC mouse Tracheal Epithelial Cells 
mTmG MARCKS Tomato MARCKS GFP 
MYL1 Myosin Light chain 1 
MYND myeloid, Nervy, and DEAF-1 
Nbs1 Nibrin 
NDK Nucleoside Diphosphate Kinase  
N-DRC Nexin-Dynein Regulatory Complex 
NEB New England Biolabs 
ng Nanograms 
NHEJ Non-Homologous End Joining 
nl Nanolitre 
nM Nanomolar 
Nm23-H5 NME/NM23 Family Member 5 
Nm23-H7 NME/NM23 Family Member 7 
NNO Nasal Nitrous Oxide 
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nt Nucleotide 
N-terminal Amino terminal 
OCT Optimal Cutting Temperature compound 
ODA Outer Dynein Arm 
OFD1 Oral-Facial-Digital Syndrome 1 Protein 
Opti-MEM Optimal Minimum Essential Medium 
ORF Open Reading Frame 
P/S Penicillin/Streptomycin 
pAb polyclonal Anti-Bodies 
PAGE PolyAcrylamide Gel Electrophoresis 
PAM Protospacer Adjacent Motif 
PARP1 Poly(ADP-Ribose) Polymerase 1 
PAXX Paralog of XRCC4 And XLF  
P-body Processing-body 
PBS Phosphate-Buffered Saline 
PCD Primary Ciliary Dyskinesia 
PCM1 Peri-Centriolar Material 1 
PCNA Proliferating Cell Nuclear Antigen 
PCR Polymerase Chain Reaction 
Pih1 Protein interacting with Hsp90 1 
PIH1D3 PIH1 Domain Containing 3 
Pol Polymerase 
Poly A Poly-Adenosine 
R2TP Ruvb1-Ruvb2-Tah1-Pih1 
Rad50 Radiation sensitive 50 
Rad51 Radiation sensitive 51 
Rad52 Radiation sensitive 52 
Rad54 Radiation sensitive 54 
RB Royal Brompton 
ReAsH Resorufin Arsenical Helix binder 
Rep40 Replication protein 40 
Rep52 Replication protein 52 
Rep68 Replication protein 68 
Rep78 Replication protein 78 
RFP Red Fluorescent Protein 
RMI1 RecQ Mediated genome Instability 
RNA RiboNucleic Acid 
RNAP II RNA polymerase II 
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RP Retinitis Pigmentosa 
RPA Replication Protein A 
RPE-1 Retinal Pigmented Epithelial-1 
RPGR Retinitis Pigmentosa GTPase Regulator 
RPM Rotations Per Minute 
rSAP recombinant Shrimp Alkaline Phosphatase 
RSP23 Flagellar radial spoke nucleoside diphosphate kinase 
RSPH1 Radial Spoke Head Component 1 
RSPH3 Radial Spoke Head Component 3 
RSPH4A Radial Spoke Head Component 4A 
RSPH9 Radial Spoke Head Component 9 
rtPCR reverse transcription PCR 
RvB Holliday junction ATP-dependent DNA helicase 
RvBL1 RuvB like AAA ATPase 1 
RvBL2 RuvB like AAA ATPase 2 
S phase Synthesis phase 
Sae2 Sporulation in the Absence of spo Eleven 2 
SAM S-Adenosyl Methionine
SDM Site-Directed Mutagenesis
SDSA Synthesis Dependent Strand Annealing
SFTPA1 Surfactant Protein A1
SGBS2 Simpson–Golabi–Behmel syndrome type 2
sgRNA single guide RNA
SGS1 Slow Growth Suppressor 1
SiR Silicon Rhodamine
SIV Simian Immunodeficiency Virus
smRNA FISH small molecule RNA Fluorescence In-Situ Hybridisation
SPAG1 Sperm Associated Antigen 1
Sprtx-2 sperm-specific trx 2
SSA Single Strand Annealing
ssDNA Single stranded DNA
STED Stimulated Emission Depletion
SV40 Simian Virus 40
Tah1 TPR repeat-containing protein associated with Hsp90 1
TALEN Transcription Activator Like Endo-Nuclease
TBE Tris Borate EDTA
TBS Tris-Buffered Saline
TCEA1 Transcription Elongation Factor 1 A
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Tctex1 t-complex-testis expressed 1 
TCTEX1D2 Tctex1 Domain Containing 2 
Tctex2 t-complex-testis expressed 2 
TE Tris EDTA 
TEM Transmission Electron Microscope 
TEMED Tetramethylethylenediamine 
TIA1L T-cell-restricted Intracellular Antigen-1 like 
TLR Traffic Light Reporter 
TMR Tetramethylrhodamine 
Tn6677 Transposon 6677 
TOP3 Topoisomerase 3 
TPR tetratricopeptide repeat 
tracrRNA Trans activating CRISPR RNA 
T-REx Tetracycline-regulated gene expression 
TRMTS112 TRNA Methyltransferase Subunit 11-2 
tRNA Transfer RNA 
Trx Thioredoxin 
TTC25 Tetratricopeptide Repeat Domain 25 
TTC26 Tetratricopeptide Repeat Domain 26 
Txl-2  Thioredoxin-like 2 
TXNDC3 Thioredoxin Domain Containing 3 
UoD University of Dundee 
UoE University of Edinburgh 
UoT University of Tokyo 
UTR UnTranslated Region 
V Volts 
VSVG Vesicular Stomatitis Virus Glycoprotein 
WDR92 WD40 Repeat 92 
WT Wild Type 
x g Times Gravity 
XLF XRCC4-Like Factor  
XPF Xeroderma Pigmentosum, Complementation Group F 
XRCC4 X-Ray Repair Cross Complementing 4 














1.1 Cilia: microtubular organelles with diverse functions  
Cilia are a diverse group of cellular organelles that protrude from the surface of 
cells with a membrane continuous with the plasma membrane and a microtubule-
based structure at their core termed the axoneme (Ledbetter and Porter 1964). 
The microtubules are composed of α and β tubulin which form nine outer-doublets 
arranged in a cylinder (Manton 1952; Manton and Clarke 1952) with the plus ends 
at the tip furthest from the cell. The doublets themselves contain one complete 
microtubular ring, the A tubule, and a second incomplete ring attached to it, the B 
tubule, as shown in Figure 1.1 B). Cilia form as an extension of the basal body, 
which itself can either originate from a centriole or de novo, with nine microtubule 
triplets arranged in a similar pattern to the axoneme (Sorokin 1968; Sorokin 1962). 
The transition from basal body to axoneme is marked by a structure known as the 
transition zone, this has been shown to have a role as a gateway into the cilia, 
restricting the entry of proteins (Craige et al. 2010; Chih et al. 2012; Garcia-
Gonzalo et al. 2011). The basal body also extends structures known as transition 
fibres into the membrane surrounding the cilium, which are important for the 
formation of cilia and regulating transport between the cilia and the cytoplasm (Wei, 
Ling, and Hu 2015). The movement of ciliary proteins in and out of the cilia is a 
highly regulated process known as intra-flagellar transport (IFT), which relies on 
the action of kinesin motors to bring material in and a dynein motor to transport it 
back out again as well as many other adaptor proteins (Cole et al. 1998; Kozminski 
et al. 1993). IFT is essential for the formation and maintenance of cilia as well as 
for their resorption and signalling responses, as reviewed by (Pedersen and 
Rosenbaum 2008).  Once IFT trains reach the tip of the cilia, termed the distal 
region, components of the ciliary tip complex assist in remodelling of the trains for 
transport out of the cilium (Sale and Satir 1977; Dentler and Rosenbaum 1977; 
Dentler 1980; Marshall and Rosenbaum 2001; Sloboda 2005). 
There are two common types of mammalian cilia, cilia with a central pair of 
doublets that run up the middle of the axoneme and cilia which lack this central 
pair, Figure 1.1 A). Generally axonemes containing a central pair are motile, 
whereas the others are immotile. The immotile or primary cilium is found on almost 
every cell of the human body and was once thought to be vestigial having little or 
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no function. It has since become clear that the primary cilium is vital for many 
important cellular functions, such as chemosensation, signal transduction, 
mechanosensation and cell cycle control (Singla and Reiter 2006; Nachury and 
Mick 2019). Defects in primary cilia can result in several life threatening 
developmental disorders, such as Bardet-Biedl syndrome, short rib polydactyly and 
holoprosencephaly (Mitchison and Valente 2017). The motile cilia however, are 
found on only a few specialised subsets of cells, such as the respiratory epithelia 
cells or sperm cells. Mutations that effect the motility of cilia also cause human 
disease most commonly; male infertility due to defects in proteins specific to the 
sperm flagella or a more general effect on several motile cilia throughout the body 
causing primary ciliary dyskinesia (PCD). As this project focuses on motile cilia and 
PCD, the following introduction will specifically discuss how the proteins of the 
motile cilia relate to PCD and the potential for development of therapies for PCD. 
1.2 The structure and composition of the motile axoneme 
Motile cilia have been studied for 344 years, the motile cilium was the first organelle 
to be observed and studied, by Antony van Leeuwenhoek who described seeing 
the “incredibly thin feet, or tiny legs, which were moved very nimbly” of a puddle 
dwelling protist (Leeuwenhoek 1676; Peter Satir 1995). This early fascination with 
the movement of cilia led to the investigation into the cause of this movement and 
the detailed structural dissection of the cilium. Early light microscopy investigations 
of single celled flagellates, such as Chlamydomonas reinhardtii and Tetrahymena 
thermophila, and the gills of molluscs identified the presence of fibres within the 
cilia (Dellinger 1909). It was not until the development of transmission electron 
microscopes (TEMs) that the fine structure of these fibres and other parts of the 
motile cilia were visualised (Fawcett and Porter 1954). Using this knowledge of 
cilia structure, it was demonstrated that the microtubules slide and this results in 
cilia bending, producing their distinct movement (Satir, 1965), Figure 1.1 B). In 
motile cilia the microtubule doublets are surrounded by multiple accessory protein 
complexes. The central doublet pair has a large protein complex, termed the 
central pair complex, associated with it that acts as a structural link to the rest of 
the axoneme allowing for fine control of ciliary beating (Goodenough and Heuser 
1985; Smith and Yang 2004). The sliding of microtubules relative to one another is 
mediated by the axonemal dynein (AD) motors. The ADs form outer (ODAs) and 
inner dynein arms (IDAs) and are arranged along the A tubule of outer doublets at 
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96 nm intervals, this pattern is determined by a molecular ruler complex (Oda et 
al. 2014). The outer doublet pairs are connected to each other via the nexin-dynein 
regulatory complex (N-DRCs), which regulates the frequency and waveform of cilia 
beat via its connections to the IDAs (Heuser et al. 2009; Awata et al. 2015). The 
outer doublets are connected to the central pair complex via structures known as 
radial spokes, which transduce mechanical and chemical signals across the 
axoneme to regulate dynein function (Patel-King et al. 2004). The tips of motile 
cilia have a specialised tip complex. In rodents and many other vertebrates this 
consists of disc-like structures which link to an extra-cellular ciliary structure termed 
a crown (Dirksen and Satir 1972; Kuhn and Engleman 1978). It has been 
hypothesised that this crown and tip structure is a signal transducer for outside 
stimuli; pathogens can become adhered to the crown suggesting it might have an 

















Figure 1.1 The structure of a 9 + 2 mammalian motile cilium 
 
A) The TEM cross-section on the left shows a 9 + 0 primary cilium with the tubules 
highlighted by white arrows. The image on the right shows a motile 9 + 2 cilium with 
the ODAs and IDAs indicated by black and white arrows, respectively. Adapted from 
(Ishikawa, 2017). 
B) The diagram on the left shows the longitudinal structure of the axoneme with the 
basal body underneath. Kinesin-2 is shown transporting IFT into the cilium and dynein 
1b is shown directing IFT out of the cilium. The transverse view of the axoneme and 
basal body are shown on the right, highlighting the structures within. Adapted from 
(Tilley et al. 2015). 
Cytoplasm 
26 
1.2.1 Axonemal dyneins: structures and functions 
Axonemal dyneins (ADs), as described above are the motors which drive the 
movement of motile cilia via microtubule sliding and form the IDA and ODA 
complexes, which are indicated in the diagram in Figure 1.1 B). The IDAs have 
been shown to be responsible for controlling the way in which motile cilia move, 
their waveform, while the ODAs control the frequency of ciliary beating (Brokaw 
1994). The structure and composition of these complexes, generally containing 
heavy, intermediate and light chain subunits, has been determined by their 
biochemical isolation and fractionation into individual components as well as 
through electron microscopy. The ODAs seem to have less variation in their 
composition than IDAs, with bikonts such as Chlamydomonas, Tetrahymena and 
Paramecium all having three heavy chains or heads (Goodenough & Heuser, 
1984; Johnson & Wall, 1983; Travis & Nelson, 1988), while opisthokonts such as 
sea urchins, tunicates, trout, cows and pigs have two heavy chains or heads (Sale, 
Goodenough, and Heuser 1985; Padma et al. 2001; Gatti et al. 1989; Belles-Isles 
et al. 1986; Hastie et al. 1986). IDAs have been well characterised in 
Chlamydomonas by observing various immotile mutants with electron microscopy 
(Burgess, Carter, Dover, & Woolley, 1991; Goodenough & Heuser, 1985; 
Mastronarde, O’Toole, McDonald, McIntosh, & Porter, 1992; Piperno & Ramanis, 
1991) and fractionation of isolated complexes (Goodenough, Gebhart, Mermall, 
Mitchell, & Heuser, 1987), but are poorly characterised in other bikonts and in 
opisthokonts where evidence is only available for some IDAs in sea urchins 
(Ogawa and Gibbons 1976; Wada, Okuno, and Mohri 1991; Yokota and Mabuchi 
1994; Inaba, Mohri, and Mohri 2005). The generalised structures of a selection of 
these dyneins are shown in Figure 1.2. 
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Figure 1.2 structure and composition of axonemal dyneins 
A) The figure shows the hypothesised positions of the constituent proteins that make
up the Chlamydomonas ODA complex, three Dynein Heavy Chains (DHCs) are
labelled α, β, and γ and make up the stalk and head regions, the light and intermediate
chains are also labelled and positioned according to available structural data and
known interactions.
B) Diagram of an opisthokont ODA, specifically using information from studies of sea
urchin and trout. The sea urchin α-DHC is an orthologue of Chlamydomonas β-DHC
and sea urchin β-DHC is an orthologue of Chlamydomonas γ-DHC.
C) This figure shows the dimeric Chlamydomonas IDA dynein I1/f and its proteins.
The diagrams shown are adapted from (Inaba, 2018).
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1.2.1.1 Outer Dynein Arms 
Human ODAs consist of two heavy chain proteins (DHCs), two intermediate chains 
(DICs) and potentially six light chains (LICs), based on information from (King 
2018). They, like other opisthokont ODAs, lack the α-dynein heavy chain, which is 
the outermost heavy chain on the A tubule as shown in Figure 1.2 B). Studies of 
Chlamydomonas mutants that lack α-DHC were shown to have increased ATPase 
activity but reduced movement, suggesting α-DHCs have a more regulatory role 
than the β and γ DHCs, (Sakato and King 2003; Furuta et al. 2009). The β-DHC 
provides the majority of the force in Chlamydomonas and sea urchin sperm ODAs, 
however it does not form an ATP dependent bond with microtubules in vitro 
(Sakakibara et al. 1993; Moss, Gatti, and Witman 1992). The γ-DHC has also been 
shown to be important for ODA force generation and flagellar movement in a study 
where only the N terminal domain was expressed (Liu et al. 2008). γ-DHC may 
bind to the B tubule via Light Chain 1 (LC1) in Chlamydomonas, which suggests 
that it might be able to act as a brake on the movement of the ODAs (Patel-King 
and King 2009).  
The opisthokont β-DHC and γ-DHC are vital for the movement of the ODAs and 
losing one of these in humans results in the loss of the entire complex (Tan et al. 
2007). Mammals have an expanded set of ODA heavy chains with three β-DHC 
(DNAH9, DNAH11 and DNAH17) two γ-DHC (DNAH5 and DNAH8) paralogues 
identified so far. It is thought that the β-DHC gene was duplicated twice in late 
metazoan evolution leading to mammals and many other vertebrates having three 
functionally distinct genes (Kollmar 2016). DNAH11 and DNAH9 are alternative 
partners of DNAH5 in the ODAs of the respiratory axoneme; DNAH11 occupies 
the proximal part of the axoneme whilst DNAH9 occupies the distal region 
(Dougherty et al. 2016). Loss of DNAH9 protein does not cause a reduction in the 
frequency of beating of respiratory cilia but does affect the way in which they move, 
due to the absence of ODAs from the distal portion of cilia. In cells that lack DNAH9 
it was also shown that DNAH11 is confined to the proximal region of the cilia. 
However, the reverse is not true; loss of DNAH11 causes DNAH9 to mislocalise 
along the entire length of the cilia (Fassad, Shoemark, Legendre, et al., 2018; 
Loges et al., 2018). The difference in regulation and function between these 
paralogues is highlighted by evidence that mammalian DNAH11 is able to enter 
the motile cilium without DNAH5 or other essential components of the ODAs 
(Dougherty et al. 2016). DNAH17 and DNAH8 are only be expressed in the sperm 
29 
 
cells and make up the heavy chains of a distinct ODA complex in these cells 
(Whitfield et al. 2019; Samant et al. 2002). It’s likely that these are the only ODA 
DHCs used in sperm (Mali et al. 2018) as DNAH5 and DNAH9 have only been 
seen in sperm axonemes in one study (Fliegauf et al. 2005). The variation in 
mammalian ODAs is further increased by the presence of alternative splice 
isoforms. In human ciliated cells DNAH5 has an alternative first exon (Olbrich et 
al. 2002). In mouse embryos two splice isoforms of Dnah11 were identified (Supp 
et al. 1999) and in mouse sperm cells Dnah8 has multiple splice isoforms which 
localise in different regions of spermatocytes (Samant et al. 2002). Whereas in rat 
brains two isoforms of Dnah9 were discovered (Tanaka, Zhang, and Hirokawa 
1995). While it is clear that mammals have an abundance of variation within and 
between the heavy chains of the ODAs the mechanistic and functional 
consequences of these differences have yet to be determined.  
1.2.1.2 Inner Dynein Arms 
IDAs are the AD complexes that point into the centre of the axoneme and are 
responsible for regulating waveform, they are more diverse in their composition 
than the ODAs. IDAs, unlike ODAs, have not been successfully isolated from 
mammals however their structure and composition has been closely studied in 
Chlamydomonas. Biochemical purification of the IDAs and electron microscopy led 
to the initial characterisation of the IDA complexes (Piperno & Ramanis, 1991; 
Piperno, Ramanis, Smith, & Sale, 1990). Genomic comparison found there are at 
least eleven IDAs in Chlamydomonas with ten IDAs possessing one DHC and a 
single IDA, containing two DHCs, dynein I1/f (Wilkes et al. 2008; Kollmar 2016).  
The most well studied IDA is the dimeric dynein I1/f, Figure 1.2 C), which consists 
of two heavy chains (DHC1 and DHC10), three intermediate chains (IC140, IC138 
and IC97), one light intermediate chain (FAP120) and five light chains (Tctex1, 
Tctex2b, LC7a, LC7b and LC8) (Porter and Sale 2000). Chlamydomonas mutants 
that lack this dynein have a slow swimming phenotype (Kamiya, Kurimoto, and 
Muto 1991). Dynein I1/f has been shown to be a regulator of microtubule sliding 
and possibly functions as a brake (Wirschell, Hendrickson, and Sale 2007). 
Phosphorylation of the intermediate chain IC138 has been shown to disable the 
motor domain of dynein I1/f (Habermacher and Sale 1997; P. Yang and Sale 2000) 
and de-phosphorylation activates it. 
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There have been few Chlamydomonas mutants isolated that have mutations in 
components of the single-headed IDAs. ida9 is the only strain with a mutation in a 
DHC gene, DHC9. This affects a single IDA, dynein c, which results in a 
Chlamydomonas strain that swims slowly in viscous fluid compared with the wild 
type, but normally otherwise (Yagi et al. 2005). ida4 mutants swim slowly and lack 
a common light chain, p28, resulting in the loss of inner dynein arms a, c, d and 
DHC11  (Kamiya, Kurimoto, and Muto 1991). The ida5 strain has a mutation in 
actin, a component of many monomeric IDAs, these slow swimming mutants lack 
the IDAs a, c, d and e. ida6, which lacks only the IDA species e, has a mutation in 
an unknown gene and is also slow swimming (Kato et al. 1993). 
While it is clear that the IDAs have a role in Chlamydomonas flagella their function 
in the motile cilia of mammals is less clear. DNAH1, the human orthologue of the 
Chlamydomonas DHC2 gene in IDA d, has the strongest evidence to support its 
importance for motility. Mutations in the mouse Dnah1 gene, formerly mDNHC7, 
results in slow moving or immotile sperm as well as a reduction in the beat 
frequency of respiratory cilia (Neesen et al. 2001). Mutation of the orthologous 
human DNAH1 results in more dramatic sperm defects, such as shortened, curled 
or narrow flagella, as well as immobility (Khelifa et al. 2014). There has been no 
assessment of whether mutations of human DNAH1 cause a decrease in the beat 
frequency of respiratory cilia similar to that in mice. A missense mutation was 
identified in a single family that segregated with symptoms of PCD (Imtiaz et al. 
2015), however no other patients have been identified suggesting that DNAH1 is 
not commonly mutated in PCD. Similarly DNAH6, the human orthologue of 
Chlamydomonas DHC3, has been identified in one study as a potential modifier 
gene resulting in PCD in patients with heterozygous mutations in other known 
disease causing genes. The authors also showed that knocking DNAH6 down in 
ciliated human nasal biopsies and mouse airway cells resulted in fewer and 
shortened cilia as well as causing a loss of motility. They showed a defect of the 
central pair but not an absence of dynein arms both upon DNAH6 knockdown and 
in one of the patients with a mutation in this gene (Li et al. 2016). However, it is not 
clear why there would be an effect only in individuals with heterozygous mutations 
in known PCD genes when knocking down DNAH6 seems sufficient to immobilise 
cilia in culture. While there have been other studies which claim to have found 
associations with IDA heavy chains and disease in humans there is insufficient 
data to confirm the validity of these links. This leaves DNAH1 as the only IDA to so 
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far be ascribed a function in mammals.  It’s likely that each IDA has a subtle effect 
on cilia motility, which will require more detailed investigation to uncover.  
1.2.1.3 Heavy chains 
The heavy chain dynein subunits make up the bulk of the dynein complex, with 
DNAH5 being the largest of these in humans, at 529 kDa. The N-terminal domain 
is the distinguishing feature of heavy chains and contains binding sites for other 
dynein subunits (Kollmar 2016). It’s followed by the linker region, which has been 
shown to transduce dynein’s movement along microtubules either as part of a 
molecular winch (Burgess, Walker, Sakakibara, Knight, & Oiwa, 2003; Roberts et 
al., 2009)  or grappling hook (Ueno et al. 2008). The heavy chains also contain four 
sequential AAA+ Walker ATPase domains that are separated from two more AAA+ 
domains by a microtubule binding domain, which is itself sandwiched between 
coiled-coil domains. The six AAA+ domains form a hexameric ring and hydrolyse 
ATP to provide the energy which allows dynein to move, together with the linker 
region this makes up the motor domain. The C terminal domain has been shown 
to be a regulatory cap in cytoplasmic dyneins (Nicholas et al. 2015). The domains 













Figure 1.3 The arrangement of the dynein heavy chain domains 
A) This figure shows the domains of a generic dynein heavy chain. The unstructured
N-terminal tail is followed by the linker region. The AAA domains, numbered 1 to 6,
are the ATPase enzymatic domains of the protein. AAA4 is interrupted by a coiled-
coil region which has a microtubule binding domain in the middle of it.
B) This is an approximation of where these domains lie in the 3D structure of the
protein, the AAA domains form a hexameric ring structure which is linked to the
microtubule binding domain via the coiled-coil region. This structure is based on the
crystal structure of the Dictyostelium cytoplasmic dynein motor domain (Kon et al.
2012).
The majority of high resolution structural information comes from cytoplasmic 
dynein and intraflagellar transport dynein (Schmidt, Gleave, and Carter 2012; 
Schmidt et al. 2015; Kon et al. 2012; Jordan et al. 2018) because, unlike ADs, they 
do not require assembly factors to form the correct structures. While the domains 
of the heavy chains are largely conserved between dyneins the number and 
diversity of heavy chains in the ADs is different. The cytoplasmic and intraflagellar 
transport dynein have two identical heavy chains, whereas outer arm dyneins can 
have two or three different heavy chains whilst inner arm dyneins can have a single 
heavy chain. The way in which the heavy chains are arranged in ODAs, with the 
hexameric rings stacked on top of one another (Ishikawa, Sakakibara, & Oiwa, 
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2007; Nicastro et al., 2006; Oda, Hirokawa, & Kikkawa, 2007), suggests that they 
might function in a different way to the homodimeric heavy chain dyneins (Roberts 
et al. 2009). The diversity of AD heavy chains points towards different functional 
roles, this has been shown to be the case in Chlamydomonas with the IDAs. Both 
the cytoplasmic dynein and the intraflagellar dynein have been shown to have 
inactive forms (Nicastro et al. 2006; Zhang et al. 2017; Jordan et al. 2018) these 
structures have yet to be identified in the ADs.   
1.2.1.4 Intermediate Chains 
While the heavy chains are the most studied and structurally characterised 
subunits the dynein intermediate chains (DICs) are also an important component 
of dynein. The classification of dynein components originally came from their 
molecular weight as observed in protein gels. Therefore the DICs are a group of 
proteins which weigh less than the heavy chains but more than the third group, the 
light chains. This grouping is not functionally assigned and it means that the 
intermediate chains encompass a wide variety of different proteins with diverse 
functions. The largest and most conserved group of DICs is the WD-repeat 
containing core intermediate chains; all oligomeric dyneins contain two of these 
DICs which differ mainly at their N and C termini (King, 2017). They are essential 
for the assembly of the dynein complex in both Chlamydomonas and humans, as 
demonstrated by the loss of ODAs in the absence of their DICs IC1 and IC2 in 
Chlamydomonas (Mitchell & Kang, 1991; Wilkerson, King, Koutoulis, Pazour, & 
Witman, 1995) and their human equivalents, DNAI1 and DNAI2 (Pennarun et al. 
2002; Loges et al. 2008). One of the ways intermediate chains contribute to the 
assembly of dynein complexes is by acting as protein interaction partners. The WD 
repeat DICs have been shown to bind to several light chains in Chlamydomonas 
as well as to each other (Susalka et al. 2002; Hendrickson et al. 2004; King, 
Wilkerson, and Witman 1991; Mitchell and Rosenbaum 1986). Other than acting 
as linkers holding together the dyneins WD repeat DICs can also act as regulatory 
proteins, such as in the inactivation of dynein I1/f by phosphorylation of IC138 as 
mentioned in Section 1.2.1.2.  
Not all DICs contain WD repeats, one group of DICs contain thioredoxin like 
modules, the N terminal of the sea urchin β-HC associated DIC IC1 has a 
thioredoxin unit with three Nucleoside Diphosphate Kinase (NDK) catalytic units 
downstream (Bell, Fronk, and Gibbons 1979; Ogawa et al. 1996). Similar proteins 
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are conserved in humans and found associated with motile ciliated cell types. This 
includes, Sptrx-2 is expressed in sperm cells (Sadek et al. 2001) Txl-2 is highly 
expressed in the testis and the lung (Sadek et al. 2003) while mutations in the 
thioredoxin TXNDC3 have been shown to cause PCD (Duriez et al. 2007). 
Thioredoxins are a group of enzymes which catalyse reduction and oxidation 
reactions regulating the cellular protein disulphide/dithiol balance (Lu and 
Holmgren 2014). The redox environment of cells has been shown to directly 
regulate ciliary beating in Chlamydomonas  and other organisms including 
mammals (Price and Sisson 2019; Wakabayashi and King 2006). It has been 
shown that ODAs react to the redox environment, although this is not necessarily 
mediated by the intermediate chains; TXNDC3 and TXL-2 are actually orthologues 
of the Chlamydomonas light chains LC3 and LC5, respectively. The NDK modules 
are also found in components of the axoneme and are presumably important for 
the regulation of ADs via phosphorylation. For instance, the Ca2+ NDK domain 
containing protein RSP23 is located on Chlamydomonas radial spokes and is an 
orthologue of the human gene Nm23-H7 (Patel-King et al. 2004). A similar protein, 
Nm23-H5, has been found associated with the axonemes of human ciliated cells 
(Munier et al. 2003). Therefore the DICs are important regulatory proteins within 
the AD complexes. 
1.2.1.5 Light chains 
The smallest and most functionally variable group of AD proteins are the dynein 
light chains (DLCs). The only DLC which has been associated with PCD so far is 
the human DNAL1 or LC1 in Chlamydomonas (Mazor et al. 2011). This protein has 
been shown to directly interact with the ODA γ-HC and its human orthologue 
DNAH5 (Horváth et al. 2005; Benashski, Patel-King, and King 1999), where it may 
act to modulate the timing of dynein beat via tethering to the B tubule (Patel-King 
and King 2009) The other core light chains fall into three groups: DYNLL, DYNLT 
and DYNLRB. The DYNLL group in humans (or LC8 group in Chlamydomonas) 
contains three classes of light chain, based on their similarity to LC8, LC10 and 
LC6. LC8 has two human homologues, DYNLL1 and DYNLL2, these proteins have 
been found to be essential components of multiple complexes in metazoans 
including cytoplasmic dynein (King, Barbarese, et al., 1996), myosin V (Espindola 
et al. 2000) and neuronal nitric oxide synthase (Jaffrey and Snyder 1996). 
Therefore loss of these DLCs in metazoan organisms leads to a lethal phenotype 
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early on in development (Dick et al. 1996). In Chlamydomonas however losing the 
function of any of these DLCs results in the development of distinct motility defects 
(Tanner et al. 2008). While LC6 is seemingly unique to Chlamydomonas LC10 is 
related to mammalian DNAL4, a gene which has been associated with mirror 
movement disorder in human patients (Ahmed et al. 2014). Despite being an AD 
protein expressed in the cilia of the mouse apical bronchial epithelium, it is also 
highly expressed during embryogenesis in the hypothalamus (Tanner et al. 2008). 
DNAL4 has also been associated with sperm defects and infertility in pigs 
(Wiedemann et al. 2018), showing it is has some axonemal function in addition to 
other non-ciliary roles.   
DYNLT1, formerly Tctex1, is related to Tctex2 and the Chlamydomonas LC9. The 
T-complex or Tctex genes were originally identified as factors that resulted in non-
Mendelian inheritance in mice due to immotile sperm cells (Lader et al. 1989; Huw 
et al. 1995). Tctex1 was subsequently found to be part of the mouse cytoplasmic 
dynein (King et al. 1996). Four DYNLT group DLCs are found in ADs; two dimeric 
Tctex1-like proteins and two monomeric Tctex2-like DLCs are localised to an 
uncharacterised axonemal complex, while both ODA and IDA I1/f have one Tctex2 
(either LC2 or Tctex2b) and contain a dimer of Tctex1 (LC9 and Tctex1) in the 
Chlamydomonas axoneme (DiBella et al. 2001). In mammals, DYNLTs are 
associated with both cytoplasmic and axonemal dyneins with DYNLT1 and 
DYNLT3, formerly RP3, being associated with the cytoplasmic dynein and Tctex2 
being present in subsets of both cytoplasmic and axonemal dyneins (DiBella et al. 
2001). The Chlamydomonas Tctex2 orthologue LC2 is essential for the assembly 
of ODAs (Pazour et al. 1999), while Tctex2b and human version, TCTEX1D2, have 
been shown to be part of IFT dynein. Human mutations in TCTEX1D2 are 
associated with a severe developmental disorder, Jeune asphyxiating dystrophy 
(Schmidts et al. 2015), a disease caused by defects in primary cilia formation. 
Tctex2 orthologues in Salmonid and sea urchin sperm cells are activated via cAMP 
mediated phosphorylation and are essential for motility as they are in mice (Inaba, 
Kagami, and Ogawa 1999). Less is known about the exact function of the Tctex1-
like proteins, other than their importance in sperm motility in mice and in Drosophila 
(Caggese et al. 2001). They have also been shown to be important for binding to 
the DICs in cytoplasmic and axonemal dyneins (DiBella et al. 2005; Lo et al. 2007). 
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The third group of DLCs, the DYNRB or Roadblock group, has only been studied 
in the ADs of Chlamydomonas where the DYNRBs, LC7a and LC7b, were 
discovered (Bowman et al. 1999). They are also found in mammalian cytoplasmic 
dyneins, where they are present as dimers (Jikui Song et al. 2005). Loss of LC7a 
in Chlamydomonas results in a significant slowing of flagellar beating similar to that 
seen in mutants with a loss ODAs, it seems to be important for ODA assembly as 
its loss results in fewer ODAs which are weakly bound to the axoneme (DiBella et 
al. 2004). 
1.2.2 Axonemal dynein assembly 
The ADs are large complexes, ~2 MDa in the Chlamydomonas ODA, which have 
been shown to exist in large cytoplasmic pools in some organisms (Auclair and 
Siegel 1966; Hisanaga and Sakai 1983). The process of making these complexes 
and ensuring that the correct subunits assemble together requires a multitude of 
cytoplasmic proteins, so called dynein axonemal assembly factors (DNAAFs). This 
is in contrast to cytoplasmic dynein which does not require assembly factors 
(Schlager et al. 2014). The first evidence showing a requirement for these factors 
was found in Chlamydomonas mutants, oda7 and oda10, which were not able to 
assemble ADs into their flagella (Kamiya 1988; Fowkes and Mitchell 1998). Since 
then many other DNAAFs have been found with the majority being functionally 
conserved in mammals. However, despite the identification of these factors by 
association with AD assembly, their precise functions are mostly unclear.  
The first DNAAF identified, oda7 in Chlamydomonas and LRRC50/DNAAF1 in 
mammals, was shown to have a specific effect on ODAs in Chlamydomonas where 
it is essential for their formation in the cytoplasm. In the absence of oda7 a specific 
ODA HC is depleted, preventing ODA formation (Fowkes and Mitchell 1998). In 
vertebrates, however, DNAAF1 mutation also results in loss of some IDAs as well 
as ODAs and cause PCD in humans (Duquesnoy et al. 2009). This leucine-rich 
repeat protein was found to interact with Kurly in zebrafish, mammalian C21orf59, 
which itself is able to interact with another leucine-rich repeat protein LRRC6 in 
Xenopus (Jaffe et al. 2016). Both of these proteins are also essential for ODA and 
IDA assembly into the axoneme, suggesting that these three DNAAFs may be part 
of the same complex (Kott et al. 2012; Austin-Tse et al. 2013; Horani et al. 2013). 
Other studies suggests that LRRC6 might actually be responsible for AD transport 
or late  stage formation of ODAs rather than assembly based on the evidence that 
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DNAI2, DNAH9 and DNAH5 are still present in the cytoplasm in its absence. 
However, the proteins do not mislocalise to the same place:  the DHCs are 
sequestered in puncta and DNAI2 is diffuse throughout the cytoplasm, suggesting 
that the ODA precursor is not formed in the LRRC6 null cells, and therefore this is 
probably the stage at which LRRC6 is required (Inaba et al. 2016). 
The most well studied complex involved in AD assembly is the R2TP chaperoning 
complex, which also interacts with LRRC6 orthologue Seahorse in zebrafish (Zhao 
et al. 2013). The R2TP complex was first isolated in yeast and contains two 
helicases (Rvbl1 and Rvbl2) and two non-enzymatic subunits (PIH1 and TAH1). It 
mediates the assembly of many different multi-subunit complexes in conjunction 
with HSP90 (Kakihara and Houry 2012). R2TP itself is therefore not a DNAAF 
specific chaperoning complex but there are multiple DNAAFs which share 
homology to its subunits and have been shown to interact with it. In vertebrates 
PIH1D3/DNAAF6 and DNAAF2 both have domains with homology to yeast PIH1. 
DNAAF2 and PIH1D3 are both important for the formation of ODAs and IDAs and 
were shown to interact with DNAI2 and HSP70 by mouse testis co-
immunoprecipitation (Omran et al. 2008; Dong et al. 2014; Olcese et al. 2017). 
Interestingly however the known interactor of the R2TP complex, HSP90, was only 
found to interact with PIH1D3 but not DNAAF2 (Dong et al. 2014). The specific 
IDAs affected by PIH1D3 mutation were identified in human patients using EM 
tomography, showing a loss of IDAs I1/f a, I1/f b and the d and g complexes in 
some parts of the axoneme (Olcese et al. 2017), suggesting DNAAFs are at least 
partially specific for different dynein species. 
Another DNAAF with homology to a R2TP complex subunit, SPAG1, has an RPAP 
domain similar to TAH1 and can bind to HSP70 and HSP90 (Benbahouche et al. 
2014). Mutation of this gene causes PCD due to loss of ODAs and IDAs, which 
combined with its cytoplasmic localisation indicate that it is indeed a DNAAF 
(Knowles, Ostrowski, et al. 2013). It has been shown in Drosophila that SPAG1 
makes up an R2TP interaction complex with WDR92, which is itself a DNAAF (Zur 
Lage et al. 2018). SPAG1 has also been shown to co-localise with DNAAF2 and 
another DNAAF, HEATR2, early on in the differentiation of human tracheal 
epithelial cells (Horani et al. 2018). If they are in a complex at this stage then it is 
possible SPAG1 represents a link between the early and late stages of assembly, 
as it has been suggested that WDR92 is a late stage recruiter of partially 
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assembled ADs to the R2TP (Zur Lage et al. 2018). Another important addition to 
the R2TP-like DNAAFs is DNAAF4/DYX1C1, which has been shown to interact 
with DNAAF2 as well as HSP70 and HSP90 (Tarkar et al. 2013; Chen et al. 2009). 
Both DNAAF4 and LRRC6 contain a p23 like domain, p23 has been shown to bind 
HSP70 and HSP90 (Buchner and Li 2013), which may mediate their binding to 
these chaperones rather than the R2TP complex itself. It is possible that there is 
an interaction between the R2TP complex and the R2TP-like DNAAFs, although 
the stage/s at which this happens and how exactly any interaction is mediated is 
unknown.  
HEATR2 is not found to be associated with the heat shock chaperones or any other 
DNAAFs by immunoprecipitation, despite its co-localisation with SPAG1 and 
DNAAF2. It is a member of the HEAT repeat containing proteins, which makes it 
unique amongst DNAAFs, and it has been shown to be essential for AD assembly 
in flies and humans (Horani et al. 2012; Diggle et al. 2014). While it was not found 
to interact with either HSP70 or HSP90 HEATR2 was shown to interact with DNAI2, 
suggesting it may be part of a different complex to SPAG1.  
ZMYND10 is another example of an HSP90 interacting DNAAF. ZMYND10 
mutations were shown to cause the loss of IDAs and ODAs in humans and mice 
(Zariwala et al. 2013; Mali et al. 2018; Cho et al. 2018). Where ZMYND10 is 
predicted to fit into the interaction network for DNAAFs is debatable as it was 
shown to interact with LRRC6, C21orf59, DNAAF4 and RUVBL2 in pulldowns (Cho 
et al. 2018). However, in another study these interactions were not seen 
endogenously and it was shown to interact with HSP90 and an immunophilin 
protein folding factor, FKBP8 (Mali et al. 2018). It has also been shown to be 
important for DIC stability, specifically for DNAII in transient expression with 
LRRC6 in HEK 293 cells (Cho et al. 2018) as well as DHC stability (Mali et al. 
2018). It is possible that it does both and may form transient interactions with the 
identified proteins. Its effect on DHC is mirrored by other DNAAFs which seem to 
be important for the stability of these proteins, such as WDR92 (Patel-King et al. 
2019), DNAAF2 (Omran et al. 2008) and DNAAF3 (Mitchison et al. 2012). It is 
predicted that due to the size and complexity of DHCs their interaction domains 
can become entangled with incorrect binding partners. It’s also possible that due 
to the requirement for a large number of these proteins, ~900,000 ODAs in a multi-
ciliated respiratory epithelial cell, the cellular space becomes abnormally crowded 
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with sticky protein domains which need to separated (King 2016). However, it has 
been demonstrated that not all DHCs require DNAAFs, DNAH11 is able to 
assemble on the axoneme without other ODA components and DNAAFs 1 or 3 
(Dougherty et al. 2016). Vertebrates do not have pools of pre-assembled ADs and 
assemble them over a long time period (Jain et al. 2010). The existence of liquid 
like collections of assembly particles and dynein subunits in cells with growing cilia 
has been shown and could potentially aid this assembly (Huizar et al. 2018). More 
detailed observation of the temporal and spatial dynamics of this assembly will help 
to elucidate the mechanisms that underlie it. 
Figure 1.4 DNAAF interactors 
The diagram shows the DNAAFs mentioned in the main text (in teal ovals). The R2TP 
complex with PIH1, TAH1, RUVBL1 and RUVBL2 are shown in the centre of the 
diagram in orange. Chaperone proteins are also shown in orange ovals. The ODA 
intermediate chains are shown in green ovals and do interact with one another despite 
not being connected in this map. Interactions are shown by black arrows, HSP90 and 
HSP70 interact with the whole R2TP complex.   
1.2.3 Trafficking axonemal dyneins 
Intra-flagellar transport (IFT) describes the action of active transport into and out 
of the cilia along the axoneme. Transport into the axoneme, anterograde, is 
mediated by the heterotrimeric kinesin-2 motor and a group of proteins which 
makes up the IFT-B complex, which travels along the B tubules at an average 
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speed of ~2.5 µm/s (Stepanek and Pigino 2016). Similarly retrograde transport in 
the opposite direction is mediated by the IFT-A complex which binds to cytoplasmic 
dynein 2/1b, also known as IFT dynein, which travels on the A tubules at an 
average speed of ~4 µm/s (Stepanek and Pigino 2016). This mechanism was 
described in Chlamydomonas (Kozminski et al. 1993) and was shown to be 
important for formation of cilia in mice and humans by homology to IFT-B gene 
IFT88 (Pazour et al. 2000). The study of IFT has led to the discovery of 22 IFT 
proteins with the anterograde complex being further subdivided into the groups B-
1, the core anterograde IFT proteins, and B-2, the peripheral anterograde IFT 
proteins (Taschner and Lorentzen 2016). Current research into the roles of these 
proteins suggest they act as transport adapters but may have various and diverse 
functions not all of which are in the cilium, such as the Golgi localised IFT20 (Follit 
et al. 2006).  
Trafficking of ADs into the assembling and mature axoneme was demonstrated in 
early experiments that used a temperature sensitive Chlamydomonas mutant of 
kinesin-2 subunit FLA10 (Piperno, Mead, and Henderson 1996). This mutant, 
when grown at the restrictive temperature, loses the ability to transport material 
into the flagella, which eventually causes its disassembly (Huang, Rifkin, and Luck 
1977; Adams, Huang, and Luck 1982). In early experiments by Piperno et al. 
(1996), it was demonstrated that when the FLA10 mutant was mixed with wild type 
in dikaryon rescue experiments that IDAs were not assembled in the cilium at the 
restrictive temperature but ODAs were, suggesting the IDAs are trafficked by IFT 
but ODAs are not. They also demonstrated that the IDAs were transported to the 
tip of the flagella and then were docked progressively towards the base (Piperno, 
Mead, and Henderson 1996). This was supported by more recent research, which 
also suggested that Chlamydomonas gene ida3 interacts with IDA intermediate 
chain IC140 and is important for transporting I1 dynein (Viswanadha et al. 2014). 
Another IDA specific IFT adapter, TTC26/DYF13, was found to be part of the IFT-
B complex in Chlamydomonas, mammalian cells and zebrafish and is partially 
responsible for IDA  import in Chlamydomonas (Ishikawa et al. 2014). In contrast 
to the research by Piperno et al. the transport of ODAs was found to be reliant on 
an interaction with the N-terminal domain of an IFT-B protein, IFT46, and a specific 
IFT adapter, ODA16 (Ahmed and Mitchell 2005; Ahmed et al. 2008; Hou et al. 
2007; Gao et al. 2010; Taschner et al. 2017). This was also shown in recent work 
in which the trafficking of ODAs was followed using a fluorescently tagged DIC, 
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IC2. In this study the trafficking of ODAs was shown to be bidirectional and slower 
than that of IDAs, this constant stopping may explain why ODAs dock along the 
length of flagella as they are trafficked rather than at the tip like IDAs (Dai et al. 
2018). Further evidence for IFT-dependent AD transport comes from sequencing 
of known cilia related genes in the genomes of PCD patients, which identified 
mutations in CFAP300/C11orf70 as causing loss of IDAs and ODAs. Analysis of 
the orthologues of this gene in Paramecium and Chlamydomonas showed that it 
is associated with IFT-A and is trafficked into the motile cilium but is predominantly 
cytoplasmic (Fassad et al. 2018; Zietkiewicz et al. 2019). Therefore both ODAs 
and IDAs are transported into the cilium via IFT, which is to be expected as the TZ 
inhibits diffusion of any complex larger than 50 kDa (Kee et al. 2012). It is clear 
that the different types of AD are recognised by specific IFT adaptors and this may 
contribute to their different distributions within the axoneme. A potential example 
of this specificity is the mammalian LRRC56 or Chlamydomonas ODA8 protein 
which has been shown to be present in assembling flagella. It interacts with IFT88 
and its deletion results in impaired ciliary movement in humans causing laterality 
defects and pulmonary problems. However, only the distal ODAs were effected, 
with 6-9 arms missing, in a T. brucei mutation model, suggesting a very specific 
trafficking function for LRRC56 (Bonnefoy et al. 2018). 
1.2.4 Axonemal dynein docking 
The ADs are arranged in a very specific pattern in the axoneme and need to be 
tightly connected to the nexins and regulatory machinery as well as the axonemal 
microtubules. The stable docking of ODAs in 24 nm repeats has been shown to 
rely on three proteins which together make up the docking complex in 
Chlamydomonas (Wakabayashi et al. 2001; Ide et al. 2013; Owa et al. 2014). More 
recently the role of this docking complex has been further elucidated by in vitro 
reconstitution of ODAs (Oda et al. 2016), which shows that ODAs are capable of 
arranging themselves in the correct periodicity but are not tightly bound to the MTs. 
Therefore the docking complex is likely to keep ODAs bound in place rather than 
direct them to the correct position. This has been shown in vivo using a tagged 
ODA protein which can be seen to transiently bind in the absence of the docking 
complex (Dai et al. 2018). In Chlamydomonas the docking complex is made up of 
a protein with homology to calmodulin, DC3, (Casey et al. 2003) and two coiled-
coil domain proteins, DC2 and DC1, (Takada et al. 2002; Koutoulis et al. 1997). 
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DC2 is the most widely conserved of these and has two orthologues in vertebrates 
CCDC63 and CCDC114. Loss of CCDC114 has been shown to result in the 
absence of ODAs, causing ciliary immobility and PCD (Onoufriadis et al. 2013; 
Knowles, Leigh, et al. 2013). CCDC63 is highly expressed in testes and has been 
shown to cause shortened sperm flagella when mutated in mice. However ODAs 
are still visible in its absence suggesting that it may not be a docking protein or that 
it is a docking protein but not required at the base of sperm flagella (Young et al. 
2015). Another coiled-coil protein, MNS1, was found to be present in sperm and 
multi-ciliated epithelial cells, and was shown to interact with CCDC114. Mutations 
in MNS1 caused mild ODA defects in tracheal cilia with arms on MT doublets 2-4 
missing in 50% of cross-sections, as well as causing severe sperm and laterality 
defects in mice and humans, with hydrocephaly in the mice (Zhou et al. 2012; Ta-
Shma et al. 2018). Mutation in another ODA DC protein, ARMC4, was also shown 
to cause a slightly more severe loss of ODAs leading to PCD in affected individuals. 
Interestingly, DNAH5 was shown to be absent at the distal ends of ARMC4 null 
tracheal epithelial cells whilst DNAH9 was present along the entire length of the 
cilia not just at the tip. This mis-localisation of DNAH9 is also observed in the 
absence of the proximal β-DHC DNAH11, which suggests ARMC4 might be 
important for directing DNAH11 to the proximal region or for DNAH5 to the distal 
end (Loges et al. 2018). 
CCDC115, another coiled-coil containing protein is found in metazoans and has 
been shown to have homology to the Chlamydomonas assembly factor ODA10 
(Dean and Mitchell 2013). In Drosophila, it has been shown to have a role in 
assembly of IFT-dependent chordotonal neuron cilia, however not in the IFT-
independent sperm flagella (Jerber et al. 2014). Mutations in CCDC115 also cause 
PCD, with loss of ODAs as well as ARMC4 and CCDC114 in affected individuals. 
Further evidence to suggest that these proteins form a docking complex comes 
from CCDC114’s co-immunoprecipitation with CCDC115 in HEK 293 cells (Hjeij et 
al. 2014). Two more potential docking proteins that seem to be important for cilia 
motility in humans are TTC25 and CCDC103. TTC25 is widely conserved in 
opisthokonts and without it the other docking factors CCDC114, CCDC115 and 
ARMC4 fail to assemble suggesting that it is an essential part of the docking 
complex (Wallmeier et al. 2016). However, CCDC103 is predicted to not be part of 
the ODA docking complex and yet seems to be important for both IDAs and ODAs 
docking to the axoneme, where it has been shown to adhere very tightly with the 
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MT doublets at regular 12 nm intervals (Panizzi et al. 2012; King and Patel-King 
2015). This protein is potentially a more general docking factor, in contrast to some 
of the other AD docking proteins suggesting a diverse array of docking complexes 
might exist. 
1.3 PCD: a disease of motile cilia 
The first records of primary ciliary dyskinesia (PCD) were made by Siewert who 
noted the correlation of people with situs inversus and bronchiecstasis (Siewert 
1904). The coalescence of these conditions with chronic sinusitis was named 
Kartagener syndrome in 1933 by Kartagener, who also noted that it was likely to 
be heritable (Kartagener 1933). The link between this condition and motile cilia 
was not made until 1976 when Afzelius used electron microscopy, sperm motility 
and measurements of muco-ciliary clearance to show that Kartagener patients had 
defects in their motile cilia (Afzelius 1976). Afzelius initially named the disease 
immotile ciliary syndrome however when it was later discovered that some suffers 
did have some motility in their cilia it was renamed primary ciliary dyskinesia to 
reflect this.  
There are as many defects associated with ciliary dyskinesia as there are different 
types of motile cilia in humans. There are at least five types of motile ciliated cell 
found within mammals, which are detailed in Figure 1.5. The sperm cells have a 
classical (9 + 2) organisation and are the most similar in terms of their function to 
the ancestral flagella from which motile cilia evolved, shown in Figure 1.5 A). The 
flagella is divided into three regions: the connecting piece, the midpiece and the 
principal piece. The midpiece has been shown to be surrounded by outer dense 
fibres and mitochondria, which presumably provide the energy for flagella 
movement (Inaba 2011). While immotile sperm is a common symptom of PCD it is 
not always present, as sperm cells have a distinct set of axonemal DHCs (Vanaken 
et al. 2017). The most typical and defining motility defect of PCD is in the epithelial 
cells in the respiratory tract which cannot provide sufficient muco-ciliary clearance 
resulting in recurrent respiratory infections and inflammation, Figure 1.5 C). These 
cells have 200-300 cilia each 5-6 µm in length and they beat in a co-ordinated 
meta-chronal wave, whereby they propel themselves forward in a stiff, straight 
conformation to push the mucus upwards and then have a recovery stroke in which 
they pull back in a more flaccid conformation (Wong, Miller, and Yeates 1993; 
Elgeti and Gompper 2013; Sears et al. 2013). These cilia also have a sensory role 
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in the respiratory tract and are able to increase their beat frequency in the presence 
of bitter tasting compounds (Shah et al. 2009). The epithelial lining of the brain 
ventricles and spinal cord is known as the ependyma and in the lateral ventricles 
it is lined with multi-ciliated epithelial cells, Figure 1.5 D). These cells are much 
like those found on the epithelium of the respiratory tract, except there are only 2-
40 cilia per cell and they are slightly longer at ~10 µm (Lechtreck et al. 2008; 
O’Callaghan, Sikand, and Chilvers 2012). The pattern in which ependymal cells 
beat in the human brain is not known but it has been hypothesised that they move 
CSF in compartmentalised circular flow systems from studies in other organisms 
(Olstad et al. 2019). Without this fluid flow PCD patients can develop 
hydrocephalus, however it is not very penetrant when compared to mice with 
immotile ependymal cilia, suggesting that there are other determinants involved 
(Lee 2013). The epithelial lining of the fallopian tubes is also covered in motile 
ciliated cells which assist in the movement of egg cells from the ovaries to the 
uterus. The cilia of these cells are approximately 10 µm in length (Satir 1992) and 
have a similar protein composition to those of the respiratory epithelia (Raidt et al. 
2015). In female PCD patients this can be the cause of fertility problems as well as 
ectopic pregnancies (Blyth and Wellesley 2008). However, it is of variable 
penetrance with 61% of female PCD patients having fertility issues in one cohort 
(Vanaken et al. 2017); this observation suggests that ciliary movement is not the 
only method of fallopian tube transport (Raidt et al. 2015). Another classical 
symptom of Kartagener syndrome are situs defects, due to immotile cilia in the 
embryonic node. This is a specialised region of the developing embryo which is 
populated with motile mono cilia and surrounded by non-motile sensory cilia 
(McGrath et al. 2003). Unlike the epithelial motile ciliated cells these cells produce 
only a single cilium and in contrast to most motile cilia it lacks a central pair, Figure 
1.5 B). This cilium moves in a rotational motion and creates a fluid flow which is 
sensed, via an unknown mechanism, by the non-motile cilia and produces the left-
right asymmetry of the body. In PCD patients there is a 50% chance that the 
symmetry will be reversed or abnormal (Nonaka et al. 2002; McGrath et al. 2003). 
These defects in symmetry, termed heterotaxy, can result in complex 
developmental problems, commonly within the heart (Shapiro et al. 2014).  
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Figure 1.5 Mammalian motile and multi-ciliated cells 
A) Diagram of the sperm tail flagella. The green panel is a cross section of the
axoneme, showing its 9 + 2 structure microtubule structure and the motile machinery
attached to the microtubules.
B) The embryonic cilia at the organ of laterality, the nodal cilia, is shown with the
circular motion indicated by the black arrow around the cilium, the cross-section
demonstrates that the axoneme has no central pair.
C) Respiratory cilia with the taste receptors highlighted, another classical 9 + 2 cross
section.
D) Ependymal cilia, in this case there are only two which is common in the ependymal
cells that line the spinal column
E) The Kinocilium, in brown, with the villi attached to it, in grey, by the CDH3 proteins.
The cross section shows the same axonemal structure as the ependymal and
respiratory cilia.
F) The olfactory cilia on the olfactory bulb, these cilia have no motility proteins but do
have a 9 + 2 structure. These images are adapted from (Choksi et al. 2014).
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While the nodal cilium is likely the only example of a (9 + 0) motile cilium in humans 
there are examples of (9 + 2) multi-ciliated cells which are not motile, such as the 
olfactory cells and the kinocilia, shown in Figures 1.5 E) and F). The olfactory cilia 
are covered in chemo-sensors for the detection of odours, they do not contain the 
motile machinery. In contrast, the kinocilia are immotile despite having all the 
necessary components for motility. The kinocilium in humans is a temporary 
structure but is vital to allow for the development of actin-based stereo cilia in the 
inner ear. Hearing problems are a common symptom of PCD but this is often due 
to chronic infection or obstruction of the otitis media, middle ear. This is a result of 
impaired muco-ciliary clearance from the eustachian tube, an extension of the 
ciliary lining of the respiratory tract, and not defects of the kinocilia (Piatti et al. 
2017). Similarly a reduced sense of smell is sometimes associated with PCD 
however, this is often attributable to the chronic nasal infections that occur due to 
muco-ciliary clearance defects (Rimmer 2018). The nasal epithelial cilia are non-
motile but are controlled by the same transcriptional program of multiciliogenesis 
triggered by MCIDAS and CCNO. Mutations in these genes result in similar 
phenotypes to PCD but also affect the nasal cilia (Boon et al. 2014; Wallmeier et 
al. 2014; Choksi et al. 2014).  
While the above symptoms describe the main consequences of impaired ciliary 
motility there are other functions of motile cilia which have been less well 
characterised. It has been shown that CSF flow creates a gradient of signalling 
molecules in the ventricles which guides the migration of neuroblasts in the brains 
of mice (Sawamoto et al. 2006). It is possible that a similar mechanism is disrupted 
in human brains leading to abnormal brain development in PCD patients, however 
this has not been well studied. While the majority of ciliated ependymal cells in the 
brain have more than 30 cilia, the spinal cords of mice have been shown to have 
a small population of bi-ciliated cells. These cilia have a (9 + 2) organisation and 
the cells begin to proliferate in response to spinal cord injuries (Alfaro-Cervello et 
al. 2012). However, whether the motility of these cilia is important for normal spinal 
cord growth and recovery is unknown, the lack of PCD related spinal symptoms 
suggests it is unlikely. 
PCD is often quoted as affecting approximately 1 in 10,000 live births, a figure 
which comes from a study of patients by Afzelius in his native Sweden (Afzelius 
and Stenram 2006). However, the true incidence of the disease is hard to calculate, 
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it is likely to be underdiagnosed and therefore underestimated. In certain 
populations it can be a lot higher, such as in Volendam in North Holland which has 
an incidence of at least 1 in 400 (Onoufriadis et al. 2013) or in the British Asian 
(majority Pakistani) population of Bradford in England which has an incidence of 1 
in 2265 (O’Callaghan, Chetcuti, and Moya 2010).  
PCD is highly heterogeneous, as might be expected when the complexity of the 
motile cilia are considered. Currently there are 41 confirmed genes which are 
known to be loss of function causes of the disease, as shown in Figure 1.6 (Leigh 
et al. 2019; Fassad, Shoemark, le Borgne, et al. 2018; Zietkiewicz et al. 2019). The 
first of these was the ODA intermediate chain DNAI1 (Pennarun et al. 2002), since 
then many other ODA genes have been shown to be important for the correct 
function of cilia. However, it’s interesting to note that while mutations in DNAH9 
cause laterality defects and dyskinetic cilia it does not result in a severe enough 
syndrome to be classed as PCD (Loges et al. 2018; Fassad et al. 2018). Similarly 
some IDA mutations result in motility defects of the tracheal cilia as well as sperm 
defects but do not cause PCD (see Section 1.2.1.2 IDAs). Another example of this 
is the putative trafficking and assembly gene LRRC56 which causes sub-threshold 
reductions in muco-ciliary clearance as well as laterality defects (Bonnefoy et al. 
2018). Therefore it could be argued that PCD exists on a ciliopathy spectrum. 
Defects in primary cilia often cause severe developmental conditions and as the 
fundamental blueprint of motile cilia these defects also result in PCD (Mitchison 
and Valente 2017). A spectrum of disorders, named Simpson–Golabi–Behmel 
syndrome type 2 (SGBS2), is caused by mutations in the X chromosome encoded 
gene OFD1, and includes PCD at the least severe end (Hannah et al. 2019). OFD1 
encodes a protein which is important for the regulation of centriolar length and the 
creation of distal appendages, therefore it is crucial for all cilia (Singla et al. 2010), 
however in hemizygous individuals the motile cilia are more severely affected. 
Another example of X-linked inheritance of PCD and another ciliopathy is RPGR, 
which causes retinitis pigmentosa resulting in degenerative blindness (Meindl et 
al. 1996; Krawczyński, Dmeńska, and Witt 2004; A. Moore et al. 2006). RPGR has 
been shown to be a part of the connecting cilium in photo-receptors  and is found 
in the transition zone of respiratory motile cilia (Hong et al. 2003). The function of 
this gene remains unclear, both in photoreceptors and motile cilia, however it has 
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been suggested that in PCD patients with RPGR mutations the orientation of the 
cilia might be affected (Bukowy-Bieryłło et al. 2013). 
 
 
Figure 1.6 Genes associated with PCD 
 
A summary of the genes currently associated with PCD and what their functions are 
in motile ciliated cells. The CFAP300/C11orf70 protein has recently been linked to 
PCD and is hypothesised to be an adapter for axonemal dynein transport into the cilia 
(Fassad, Shoemark, le Borgne, et al. 2018; Zietkiewicz et al. 2019). Similarly PIH1D3  
has been found to be an essential DNAAF, DNAAF6, which causes x-linked PCD 
when mutated (Olcese et al. 2017; Paff et al. 2017). This figure is adapted from 




The overlapping and variable symptoms that are present in PCD make it difficult to 
diagnose. The rarity of PCD also contributes to the long wait between presentation 
and diagnosis of the disease. PCD patients suffer respiratory distress shortly after 
birth, 12-24 hours, and often require oxygen supplementation for several days 
before leaving hospital. Despite the early signs of PCD people are often not 
diagnosed until early childhood. Diagnosis is made easier if they present with situs 
inversus however persistent wet cough and recurrent respiratory infections are 
also major indicators of PCD. Initial diagnosis of PCD is made by measuring nasal 
nitrous oxide (NNO) in patients above 5 years of age.  If the NNO is low, being 
somewhere below 82 nl/minutes, then there is a high likelihood of PCD although 
other conditions may also cause low NNO, such as respiratory infection or some 
cases of Cystic Fibrosis. There may also be lung function tests and a CAT scan to 
look for organ positioning defects. The next stage of diagnosis involves referral to 
a specialist centre, there are only three of these in the UK. Either a nasal brush 
sample is sent to the centre or taken there, the nasal epithelial cells can then be 
monitored by high speed video microscopy to observe ciliary beat. TEM images 
will also be taken of the cilia to check for abnormal ciliary structure, the presence 
of motile cilia proteins can also be checked using immunofluorescence imaging. In 
addition to these tests the patient’s DNA can be checked against a panel of known 
PCD causing genes using inexpensive sequencing techniques. There is still the 
possibility that these tests will miss certain cases of PCD as some gene mutations 
do not cause obvious structural defects, such as DNAH11 or LRRC56 (see 
Sections 1.2.1.3 and 1.2.4). The mutation may also not be on the panel of tested 
genes and beat frequency /waveform defects can also be subtle (Lucas et al. 2017; 
Shoemark and Lucas 2018).  Treatment of PCD involves careful monitoring of lung 
condition, cardiovascular exercise with physiotherapy to help remove mucus and 
antibiotics to treat bacterial infections of the respiratory system. In more serious 
cases of chronic infection preventative application of antibiotics is recommended. 
The use of these interventions can help slow down the decline in lung function and 
reduce bronchiectasis however it does not treat the cause of the disease, immotile 
cilia (Shapiro et al. 2016). 
1.4 Composition and development of the respiratory epithelium 
As explained in the previous section the defining pathology of PCD is respiratory, 
with diagnosis and treatment being focused on PCD patients’ poor lung function 
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and chronic respiratory infections. This is caused by the dyskinesia of the motile 
cilia in the epithelial tissues of the airways, resulting in defective muco-ciliary 
clearance and build-up of mucus that allows pathogens to infect the epithelial cells. 
The respiratory system can be broadly divided into two parts, the proximal and the 
distal, the proximal part, including the trachea, is lined with a pseudostratified 
epithelium while the distal lung is made up of specialised gas exchange structures 
called alveoli. While defects in the motile cilia of multi-ciliated respiratory cells 
defines PCD they are just one of a number of different cell types which comprise 
the proximal airway epithelium, as discussed in a recent review (Zepp and Morrisey 
2019). The mucus itself comes from mucin proteins secreted by goblet cells, which 
are rarely found in mouse but are common in human. Other cells such as 
ionocytes, a cell type recently discovered by single cell RNA sequencing of the 
respiratory epithelium (Plasschaert et al. 2018; Montoro et al. 2018), regulate the 
production and the viscosity of mucus through ion channels such as CFTR. In 
addition to trapping particles in mucus and clearing them by ciliary action the 
respiratory epithelium has other cells and methods which help it cope with 
exposure to airborne pathogens and noxious substances. The brush cells for 
example have sensory villi on their apical surface allowing them to respond to 
allergens with inflammatory factors, similarly the secretory or club cells act to 
protect the epithelial lining by secreting various proteins and by detoxifying toxic 
substances. The epithelial cells also have a direct connection to the underlying 
mesenchymal smooth muscle cells through the pulmonary neuroendocrine cells 
which act to regulate muscle contraction and immune responses. These cells 
constitute the differentiated proximal airway epithelium. 
The cells that make up the lung are specified early on in development in the ventral 
anterior foregut endoderm, at approximately 4.5 weeks gestation in humans and 
the 9th embryonic day in mice. However, the distal part of the lung, alveoli, only 
becomes fully developed at 4-6 weeks in mice and around 10 years in humans in 
a tissue remodelling process called alveologenesis. In contrast to the epithelium of 
the distal airways the pseudostratified epithelium of the proximal airways is 
essentially developed by embryonic day 16.5 in mice, with FOXJ1 positive multi-
ciliated cells being present at this time (Rawlins et al. 2007). Epithelial cells of the 
proximal airways are replaced during normal homeostasis, albeit at a slower rate 
than other epithelia, and in response to injury. To do this the respiratory epithelium 
in mice has two types of progenitor cell which can give rise to all the other cells, 
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the basal stem cell which does not reach the airway lumen due to tight junctions 
formed above it, and the secretory or club cells. The basal stem cells are found 
only in the trachea and the large bifurcated bronchi in mice, but are present 
throughout the proximal respiratory epithelium of humans. It has been shown that 
these cells differentiate first into secretory cells and then into multi-ciliated cells 
during homeostasis, a process known as trans-differentiation, whereas in response 
to injury they can directly form either. The ability of the respiratory epithelium to 
repair itself in this way means effective therapies for diseases that affect this tissue, 
such as PCD, are more feasible as the epithelial cells can be replaced. 
1.5 Gene therapy as a potential treatment for PCD 
An ideal way to treat a genetic condition such as PCD would be to replace the 
mutated gene with a functioning version. The idea of genetically correcting a 
disease or gene therapy is not new, having been first attempted in humans in 1958 
(Friedmann and Roblin 1972).  The traditional approach to gene therapy involves 
adding a functional copy of the gene affected, termed gene replacement or gene 
augmentation (Wirth, Parker, and Ylä-Herttuala 2013). Gene therapy often requires 
viral vectors for efficient delivery of the replacement gene, which puts considerable 
constraints on its size. The most commonly used viral vectors are adenoviruses, 
adeno-associated viruses and lentiviruses, these have maximum packaging 
capacities of 8 kbp, 5 kbp and 8 kbp respectively (Thomas, Ehrhardt, and Kay 
2003). This is particularly problematic for PCD, where the most commonly mutated 
gene, DNAH5, has a cDNA length of 13872 bp (Failly et al. 2009; Hornef et al. 
2006).  For long term expression of the replacement gene many therapies take 
advantage of the natural integrative capabilities of viruses like the lentiviruses. 
However, this integration event can be ineffective if the replacement is silenced or 
detrimental if it occurs either to disrupt an endogenous gene’s expression or 
ectopically activate it, such as in oncogenes (Check 2002). The alternative to 
integration is transient expression of the therapeutic gene, however this requires 
expensive repeated delivery which increases the risk of an adverse host immune 
response. 
Both integrative and transient gene therapy have been used for PCD in ex vivo and 
in vivo settings. The first of these studies used a lentiviral vector, Simian 
Immunodeficiency Virus (SIV) coated with Vesicular Stomatitis Virus Glycoprotein 
(VSVG), to deliver DNAI1 to human airway epithelial cells ex vivo. The authors 
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were able to demonstrate that delivery of the DNAI1 was able to restore beating in 
transduced patient cells with DNAI1 mutations, with approximately 10% of the 
axonemes having nine ODAs by TEM which represents ~1/5 of the transduced 
cells (Chhin et al. 2009). The relevance of this research to the treatment of PCD in 
vivo is limited because the authors transduced cells which were grown in 
suspension, whereas the respiratory epithelium is made of a diverse collection of 
cells which form tight junctions with one another and is covered in a layer of mucus. 
Another study used a lentiviral vector, this time Equine Anemia Virus (EAV) coated 
with Avian Influenza Haemagglutinin (AIH), to deliver the Dnaic1 gene. They 
showed a similar level of rescue in a Cre-inducible Dnaic1 null mice, ~10% of cells 
showed recovery (Ostrowski et al. 2014). However, this study used an air liquid 
interface culture system which is closer to physiological conditions (You et al. 
2002). They were also able to demonstrate in vivo through inducible deletion of 
Dnai1 that only approximately 20% of wild type levels of Dnai1, which equates to 
20% of cells if Cre recombination is 100% efficient, needs to be present in the 
nasopharynx for effective muco-ciliary clearance. Despite showing that the viral 
vector was able to transduce nasal epithelial cells after intranasal delivery of an 
EGFP reporter in wild type mice, there was no detectable Dnai1 in the null mice. 
This highlights the potential difficulty of delivering therapeutics in PCD patients who 
suffer from chronic rhinosinusitis with thick layers of mucus in the respiratory tract. 
There may also be an increased number of immune cells in the respiratory 
epithelial lining in PCD patients due to chronic infection which could cause the 
viruses or infected cells to be recognised by the immune system and destroyed. 
A way to avoid immune recognition of viral vectors is to package the DNA in a 
synthetically derived vector. Recently cationic lipid based vectors mixed with 
cationic peptides to allow DNA to pass through the mucosal layer have been 
developed and tested for use in PCD (Tagalakis et al. 2008; Munye et al. 2016). 
The authors showed that in combination with a small circularised transgene the 
lipid vector was able to transfect the lungs of wild type mice and was more effective 
than a full sized plasmid. Although they did not show whether it was effective in 
diseased tissue they were able to demonstrate successful expression of DNAH5 
in immortalised human bronchial epithelial cells. The ability to package a large 
gene such as DNAH5 is a significant advantage of non-viral vectors over viral 
vectors which would not be able to do this. However, the disadvantage is that the 
therapy must be administered frequently as it was shown that 7 days after delivery 
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the level of gene expression was significantly reduced in the lungs of mice. An 
ideal approach to gene therapy is gene correction, whereby the disease causing 
mutation in the endogenous gene is corrected, as it would persist as long as the 
cell is alive. 
1.6 Genome editing therapy for PCD 
Genome editing is the process of altering the genome by using a targeted nuclease 
to make an intentional change and can be used for therapeutic gene correction. 
Genome editing provides the advantage of correcting the original mutation, leaving 
the gene to be regulated by its native promoter and preserving its splice sites. This 
has only been possible in recent years due to targeted nucleases, such as 
Meganucleases, Zinc Finger Nucleases, Transcription Activator Like Endo-
Nucleases (TALENs) and Clustered Regularly Interspaced Short Palindromic 
Repeats (CRISPR)/ CRISPR Associated protein 9 (Cas9) (Cox, Platt, and Zhang 
2015; Maeder and Gersbach 2016). These work by introducing a DNA double 
strand break (DSB) in a specified location, which is subsequently repaired by the 
cell’s DNA repair machinery via non-homologous end joining (NHEJ) or if DNA with 
homology to the targeted site is present via homology directed repair (HDR). This 
can be used for mutagenesis by taking advantage of errors introduced by NHEJ or 
can be used for gene correction if a DNA template is used, the specifics of these 
repair pathways will be discussed in more detail in Section 1.7. 
The most recent targeted nucleases to be developed are TALENS and 
CRISPR/Cas9. The TALEN system was adapted from the TALE proteins which the 
bacterial Xanthomonas species use to control the transcription of their plant hosts 
(Boch and Bonas 2010). These proteins were shown to be able to bind to specific 
base pairs of DNA via 33-35 amino acid residue repeats, with each repeat 
recognising a single base (Boch et al. 2009; Moscou and Bogdanove 2009). This 
system was later modified by the addition of the DNA nuclease FokI to the C 
terminal domain of TALE, creating TALENs (Miller et al. 2011). The single nuclease 
domain cuts one strand of DNA requiring a second TALEN to target the 
complementary strand to create a DNA DSB, as shown in Figure 1.7. This system 
was used to test the effectiveness of genome editing to treat PCD in an ex vivo 
system (Lai et al. 2016). The authors transduced patients’ nasal epithelial cells 
grown in spheroid cultures with Feline Immunodeficiency Virus (FIV) coated with 
VSVG and showed that 20-29% of the previously immobile spheroids began to 
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rotate four days post transduction. The patients had mutations in DNAH11 which 
does not result in completely immotile cilia but causes them to be stiff and have a 
significantly reduced range of motion. In order to repair this mutation the cells had 
to be transduced with three separate viruses, two to encode the TALENs and one 
for the 350 bp repair template. This highlights one of the major drawbacks of the 
TALEN system, the size of the proteins. There is also the added difficulty of 
requiring two nucleases to make a single cut and the need to re-engineer the entire 
TALE domain for each site targeted. 
Figure 1.7 The principle behind TALEN editing 
The diagram shows the TALE domains, coloured rectangles, each of which 
recognises a specific base, red for G, blue for A, green for T and yellow for C. Each 
of these domains is a 33 – 35 amino acid motif, the example for the C recognising 
motif is shown highlighted by the black line. The FOKI nuclease domains are shown 
as black ovals, which cut in a region between the two TALE arrays.  
Some of these problems are curtailed by the use of the CRISPR/Cas9 system. The 
CRISPR sequences were first recognised as enigmatic repeats in the E. coli 
genome (Ishino et al. 1987). It was another two decades before the function of 
these repeats was hypothesised and proven to be part of an adaptive immune 
system in bacteria (Makarova et al. 2006; Barrangou et al. 2007). The palindromic 
CRISPR repeats were shown to flank sequences derived from bacteriophages and 
other bacterial pathogens, the sequences next to these were termed Protospacer 
Adjacent Motifs (PAMs). It was soon demonstrated that these repeats were 
transcribed and expressed RNA, CRISPR RNA (crRNA), which was 
complementary to the genomes of invading pathogens (Brouns et al. 2008). The 
crRNA was shown to direct nucleases, termed CRISPR associated proteins (Cas) 
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to these genomes with a second trans activating crRNA (tracrRNA) (Garneau et 
al. 2010; Deltcheva et al. 2011). In certain bacteria this process was mediated by 
a single protein, Cas9, which has been shown to have two nuclease domains as 
well as helicase and nucleic acid binding activity (Makarova et al. 2006; 
Sapranauskas et al. 2011). Cas9 can be guided to DNA containing the crRNA 
sequence followed by a PAM site, in the case of the commonly used Streptococcus 
pyogenes Cas9 the PAM sequence is NGG. The tracrRNA and crRNA can be 
combined to create a single guide RNA (sgRNA) (Jinek et al. 2012), as shown in 
Figure 1.8, to reduce the size of vector necessary. This system has been adapted 
in mammalian cells for experimental genome engineering and therapeutic gene 
correction, including in utero gene correction in the lungs of mice (Alapati et al. 
2019).  
The advantages of using CRISPR/Cas9 over TALENs and other genome editing 
methods are that it is easy to design a short, ~20 nucleotide, guide RNA in 
comparison to long TALE domains and it allows for the targeting of DNA DSBs to 
a large range of sequences using only a single protein. However, it is still subject 
to the same limitations as other targeted nucleases in that it relies entirely on the 
DNA repair mechanisms of the cell to make specific changes to the genome. This 
is a major limitation of genome editing compared with gene replacement as the 
efficiency of templated repair in most cells is much lower than that of virally 
mediated integration. However, recently it has been discovered that transposition 
can be directed by CRISPR/Cas ribonucleotide protein complexes which bind to 
bacterial transposases (Klompe et al. 2019), suggesting that RNA targeted 









Figure 1.8 Overview of CRISPR/Cas9 genome editing 
A) This drawing shows the Cas9 nuclease in complex with crRNA and tracrRNA
binding to the target sequence. The black pins highlight where Cas9 cuts the DNA,
the position of the PAM is also shown.
B) The crRNA and tracrRNA can be combined by use of a linker loop, as shown.
These drawings are adapted from (Doudna et al. 2014).
1.7 DNA double strand break repair mechanisms 
Eukaryotic cells have four conserved pathways which are used to repair DNA 
double strand breaks (DSBs), NHEJ, homologous recombination (HR), single 
strand annealing (SSA) and alternative end joining (alt-EJ). The HR and NHEJ 
pathways are the main mechanisms of repair whereas SSA and alt-EJ are less 
used. These pathways are summarised in Figure 1.9, further details about the 
detailed mechanisms of these pathways can be found in recently published 
reviews   (Pannunzio, Watanabe, and Lieber 2018; Wright, Shah, and Heyer 2018; 
Sallmyr and Tomkinson 2018). 
In mammals NHEJ is the most commonly used pathway to resolve DNA DSBs 
(Beucher et al. 2009), it is also vital for V(D)J recombination and immunoglobulin 
heavy chain class switching (Lieber 2016). The initiation event for NHEJ is the 
binding of protein heterodimer Ku70/Ku80 to the free double stranded DNA ends. 
This complex preferentially binds ends of DNA at DSBs and prevents 
exonucleases from digesting the DNA, essentially creating a cap (Mimitou and 
Symington 2010). One potential reason for the strong preference for NHEJ over 
other repair pathways is that the Ku complex is highly expressed in the cell (Chang 
et al. 2017). Once Ku is bound it recruits DNA-dependent protein kinase (DNA-
PKCs) in complex with DNA nuclease Artemis. Auto-phosphorylation of DNA-
PKCs when it arrives at the DNA DSB activates Artemis, presumably by 





allows Artemis to cut any ssDNA to remove 3’ and 5’ overhangs and any 
mismatched sequence (Chang, Watanabe, and Lieber 2015; Chang and Lieber 
2016). Artemis will only resect the DNA to leave maximum overhangs of ~4 nt, 
exposing short regions of homology.  Artemis is required for repairing 20-50% of 
DSBs in cells exposed to ionising radiation (Kurosawa et al. 2008), suggesting that 
there are some types DSB which do not require resection and/or other nucleases 
exist which are able to process DSBs in NHEJ (Grundy et al. 2013). The 
complementary ssDNA ends bind each other to form a stable bond and any 
resected areas not bound are then filled in by the action of DNA polymerases. In 
NHEJ these polymerases are pol µ and pol λ, both of which are capable of template 
dependent and independent synthesis (Bebenek, Pedersen, and Kunkel 2014; 
Moon et al. 2014; Bertocci et al. 2006). The addition of non-templated nucleotides 
at the ends of DNA DSBs somewhat explains the error prone nature of NHEJ. 
Finally the DNA ends are ligated together by the action of DNA ligase IV in complex 
with XRCC4, which stimulates DNA ligase IV’s activity (Grawunder et al. 1997).    
During the S and G2 stages of the cell cycle the replication of chromosomes 
provides a template which can be used for HR. During S/G2 the CDK mediated 
phosphorylation of the CtIP protein activates the MRN nuclease complex, MRE11-
RAD50-NBS1, with SAE2 to initiate bulk resection by removing the terminal 5’ 
nucleotide at each end of the break. The ends are then chewed back 5’ to 3’ by the 
actions of EXO 1 nuclease in conjunction with nuclease DNA2 and the SGS1–
TOP3–RMI1 complex (Symington 2014). The ssDNA is then coated in RAD51 
which recruits RAD54 and other proteins that aid in the binding of this ssDNA to 
the homology template, termed strand invasion (Solinger, Kiianitsa, and Heyer 
2002). The formation of bonds between the homology repair template and the DSB 
can form one of two types of DNA structure: a double holiday junction (DHJ), where 
there are two crossovers with a dsDNA repair template; or a synthesis dependent 
strand annealing (SDSA) junction, where only a single DNA strand anneals to one 
of the resected ssDNAs. This provides a template for DNA polymerases, pol δ and 
pol η, and accessory proteins, PCNA and RPA, to synthesise DNA complementary 
to the homology repair template (Sneeden et al. 2013). The ends are then ligated 
together to repair the break, in SDSA the repaired strand is then used as a template 
for the remaining broken strand. This ligation can result in crossovers at DHJs as 
is the case in meiotic recombination.  
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Figure 1.9 Double stranded DNA break repair mechanisms 
This diagram highlights the mechanisms that eukaryotic cells use to repair DNA 
DSBs. These can essentially be split into those which use homology for repair and 
those which do not. The choice is determined by regulatory proteins 53BP1, NHEJ, 
and CtIP and MRN, homology pathways. The NHEJ pathway is shown as the major 
repair pathway in eukaryotes. The various lengths of homology used in each pathway 
are shown at the bottom of the diagram in order of ascending length from left to right. 
This diagram has been adapted from (Pannunzio, Watanabe, and Lieber 2018). 
The other DNA DSB repair pathways are less commonly utilised in mammalian 
cells and can be viewed as back up pathways. They constitute two distinct 
pathways which have different requirements for homology lengths. The SSA 
pathway requires ssDNA homology of > 25 nt and uses similar complexes to the 
HR pathway. The alt-NHEJ pathway can be split into two different methods of 
repair depending on what homology is present. If there is homology between 2 and 
20 nt then Microhomology Mediated End Joining (MMEJ) is used to repair the 
break. If the homology is < 2 nt then the ends are joined together through end 
joining (EJ), alt-EJ is usually used synonymously with MMEJ. The mechanism 
behind EJ is not known, however MMEJ is known to rely on DNA polymerase θ as 
DSB 
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well as a number of other DSB repair proteins. The alt-NHEJ pathways were 
recently reviewed (Sallmyr and Tomkinson 2018).  
The reliance of mammalian cells on NHEJ, even in G2/S where an estimated 80% 
of DSBs are repaired by NHEJ (Beucher et al. 2009), makes gene correction using 
genome editing and a homology repair template difficult. Numerous ways to 
overcome this DNA repair pathway problem have been explored and are 
summarised in Chapter 5.  
1.8 Project objectives 
Axonemal dyneins are large and complex molecular machines which play a vital 
role in human health, as demonstrated in the previous sections. The decades of 
research that have been conducted on motile cilia have uncovered a wealth of 
information about the structure, composition and regulation of these complexes. 
This work has largely taken advantage of single celled organisms with motile 
flagella, such as Chlamydomonas reinhardtii. However, data about axonemal 
dyneins in mammals is less comprehensive, especially with regards to how they 
are assembled and regulated. In order to investigate the dynamics of these 
processes with high temporal and spatial resolution it is necessary to be able to 
track proteins of interest and find their interactors at different stages of 
development. This project aimed to achieve this by: 
1. Creating a library of tagged axonemal dynein proteins in Drosophila  using
a generic tagging strategy.
2. Tagging dynein proteins in mouse which were successfully tagged in
Drosophila.
3. Using the tagged protein to pulldown interactors during assembly and at
other stages of ciliary differentiation.
4. Following turnover of axonemal dynein complexes in mammalian cilia using
dye pulse-chase imaging experiments that utilise the adaptable SNAP tag,
as explained in Chapters 3 and 4.
5. Investigating the early translational regulation of the dynein heavy chains
by observing the localisation of transcripts in motile ciliated cells.
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The other aim of this project was to use the tagged axonemal dynein protein to 
quantify the rescue of PCD mutations by CRISPR/Cas9 genome editing in mice 
and cultured primary mouse cells. The ultimate aim being to rescue the PCD-like 
phenotype in mice using CRISPR/Cas9. To do this the first step was to try and 
improve the efficiency of CRISPR/Cas9 induced Homology Directed Repair (HDR) 
by: 
1. Designing a fluorescent reporter system to quickly score the effectiveness 
of HDR. 
2. Testing the effectiveness of published methods to improve HDR efficiency. 
3. Linking the repair template to the Cas9 editing complex to boost HDR 
efficiency. 
The first two results chapters cover the work done to understand axonemal dynein 
regulation in mouse motile ciliated cells, while the final results chapter details the 











2 Materials and methods 
2.1 Sequence designs 
2.1.1 Primer sequences 
The primers used for genotyping, cloning and sequencing PCRs are shown in the 
Table A1 in Appendix 1. Throughout the document, where there is mention of a 
primer being used it will be referred to by name and number. All oligonucleotide 
sequences, unless otherwise mentioned, were ordered from Sigma-AldrichTM. 
2.1.2 Design of CRISPR guide sequences 
CRISPR guides were designed for exon 1 of the mouse Dnah5 gene 
((GRCm38.p6) ENSMUSG00000022262), exons 2, 3, 38 and 39 of human PCM1 
((GRCh38.p12) ENSG00000078674, PCM1-202), exon 1 and 2 of Drosophila 
melanogaster CG6971 and for EGFP using the online tool provided by Benchling 
(see Section 2.16.2) the guides shown below in Figure 2.1 were ordered based 
on their scores, shown in Table 2.1. Figure 2.1 shows the nucleotide and the 
amino acid residue sequences from CRISPR targeted genes. Genomic sequences 
were acquired from Ensembl genome browser (see Section 2.16.1) for 
















Figure 2.1 Positions of guide RNA sequences in their target sequences. 
A) Position of mouse Dnah5 targeting guides (indicated by the labelled arrows) on 
the 1st two exons of the gene, the direction of the arrows indicates the orientation of 
the guide 5’ to 3’. The smaller arrow immediately after the guide marks the position 
of the guide’s PAM site.
B) Position of human PCM1 targeting guide on the 2nd exon of the gene.
C) Position of human PCM1 targeting guide on the 3rd exon of the gene.
D) Position of human PCM1 targeting guide on the 38th exon of the gene.
E) Position of human PCM1 targeting guide on the 39th exon of the gene.
F) Positions of Drosophila melanogaster CG6971 targeting guides on the 1st exon.
G) Positions of Drosophila melanogaster CG6971 targeting guides on the 2nd exon.
H) Position of the EGFP targeting guides in the Flp-in recombination site of T-REx 





Table 2.1 Guide sequences 
CRISPR guide sequences (shown in Figure 2.1) as designed using Benchling against 
target sites in this study. The sequence of the PAM is also shown. The specificity 
score is calculated by using the algorithms in (Hsu et al. 2013) and the efficiency score 
is calculated using algorithims from (Doench et al. 2016).  






ATTGCTGGGATGTTTAGGAT CGG 54.03 59.76 
Dnah5 guide 
exon 1_2 
TCACCCGAGTTCTGACGgta agg 90.62 59.90 
Dnah5 guide 
exon 1_3 





TGG 38.95 61.82 
PCM1 guide 
exon 3 





TGG 53.85 54.65 
PCM1 guide 
exon 39 
ttctgtttttcagAAACGGT GGG 55.41 57.34 
CG6971 guide 
exon 1_1 










AGG 49.11 59.78 
CG6971 guide 
exon 2_2 
TTCCGTTTACTTCTTGGGTG CGG 48.85 45.30 
EGFP guide 1 gtaggtcagggtggtcacga ggg 63.56 71.76 
EGFP guide 2 gtacctcgagaagcactgca cgG 64.50 65.30 
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2.1.3 Repair sequence design 
Repair templates for CRISPR/Cas9 editing were designed using the sequences 
shown in Figure 2.1. They were designed to insert a new sequence and/or alter 
the existing sequence to destroy the PAM site and prevent further cutting 
Mouse Dnah5 was targeted at the N terminus based on the evidence that this 
region has no predicted structural domains and that fusion of GFP to the mouse 
paralogue Dnah11 gene at the N terminus was non-disruptive (McGrath et al. 
2003). Homology arms were designed to be 779 bp on the 5’ side of the insertion 
and 800 bp on the 3’ side of the insertion, as summarised in a diagram of this repair 
template, Figure 4.1. The insertion site was chosen 3 bases upstream of the 
predicted site of cutting by the CRISPR guide “Dnah5 guide exon 1_2” as shown 
in Table 2.1. The plasmid repair template was synthesised by Geneart®, Thermo 
Fisher Scientific InvitrogenTM.  
The repair template for the EGFP G68A locus to convert the GFP from non-
fluorescent to green fluorescence was made to be asymmetrical, because this was 
shown to be more efficient (Richardson et al. 2016). The sequence converts a 
single nucleotide from cytosine to guanine creating the corresponding amino acid 
change from glycine to alanine, see Figure 2.2, this also destroys the PAM of 





2.1.4  Design of plasmid for universal tagging 
The universal tagging plasmid was created by Lackner et al. (2015) to be a non-
homologous end joining based tagging system that can be used with any 
Figure 2.2 Site of EGFP G68A repair template 
The figure above shows the sequence of the EGFP G68A allele. The guide RNAs 
shown in Figure 2.1 are aligned to this sequence along with the EGFP G68A repair 
template. The template is 127 nt with an 85 nt long 5’ homology arm and a 41 nt long 
3’ homology arm. The switch of the cytosine, highlighted by the red box, to guanine 
shown in red font causes the 68th amino acid alanine to change to glycine, making 
EGFP fluorescent. This also results in the change of the PAM for EGFP guide 1 from 
CGG to CGC rendering the guide unable to cut if the locus is correctly repaired.   
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sequence. The plasmid Lackner et al. designed contains recognition sites for a 
guide RNA that targets the zebrafish gene tia1l gene which flank the insertion site 
for the tag. The plasmid also expresses the guide RNA allowing the tag to be cut 
out of the plasmid when Cas9 is present. Information about cloning strategy can 
be found in Section 2.3.6 and more information about the use of this plasmid can 
be found in Section 3.2.  
2.1.5  Design of Cas9-Rep78 fusion 
To make a Cas9 nuclease capable of binding to the AAV genome and targeting 
repair templates to the site of Cas9 editing the Streptococcus pyogenes Cas9 
protein was fused to the first 244 amino acids of the Adeno Associated Virus (AAV) 
protein Rep78 which has been shown to be sufficient to mediate binding to the ITR 
(Inverted Terminal Repeat) sequences of the AAV genome (Cathomen, Collete, 
and Weitzman 2000). The linker region was taken from the Cas9-RFP fusion 
(Mircetic et al. 2017) and was used to fuse Rep78 to the C terminus of Cas9, the 










2.1.6 mTmG reporter repair templates 
Several repair templates were used in this project which work in conjunction with 
the mTmG mouse (Muzumdar et al. 2007) to report on the DNA repair outcomes 
of genome editing, a summary of this system is shown in Figure 5.1. Figure 2.4 
A) shows a plasmid with homology arms to the mTmG locus which converts the
membrane localised EGFP to a nuclear EGFP by switching the MARCKs
sequence for an H2B sequence. Figure 2.4 B) shows a TagBFP sequence in a
minicircle with a recognition site for the CRISPR guide RNA used to target adjacent
to the Loxp sites in the mTmG locus. The third template used is the plasmid from
Figure 2.4 A) but packaged in an AAV2/2 genome, shown as a cartoon in Figure
5.6.
Figure 2.3 pX330 Cas9-Rep78 sequence 
A) The plasmid map shows the fusion of the C-terminal domain of the S.p. Cas9 
(green) with the 1st 244 amino acids of the AAV Rep78 protein (purple) separated by 
a 12 amino acid linker (orange). The positions of genotyping primers Cas9-Rep F and 
Cas9-Rep R are shown. The plasmid backbone is pX330 (Addgene catalogue number 
42230).








2.2  Cas9 editing digests 
2.2.1 Surveyor assay 
The surveyor assay detects CRISPR/Cas9 editing using the Surveyor Nuclease, a 
restriction enzyme that cleaves at mismatched sequences, supplied in a kit from 
IDTTM (catalogue no. 706025). 50 ng/µl of purified PCR product was annealed and 
digested according to the manufacturer’s instructions, except that instead of 
digesting in polymerase buffer the PCR products were purified and put into a 1x 
Surveyor buffer (Jiang, Yao, and Liu 2013), recipe in Section 2.16.1. 
Reaction mixes were made as follows for volumes 20 to 40 µl: 
Hybridised DNA  200–400 ng 
0.15 M MgCl2 Solution 1/10th volume 
10x Surveyor buffer   1/10th volume 
B) 
Figure 2.4 mTmG repair templates 
A) The plasmid map shows the H2B gene flanked by a left homology arm (878 bp) 
and right homology arm (823 bp) which targets the H2B gene (378 bp) to the N 
terminus of EGFP in the mTmG locus.
B) The plasmid map shows the H2B (orange) BFP (blue) fusion downstream of a 
EN2SA splice acceptor site (green) and upstream of a strong Poly A sequence 
(orange). The minicircle is cut at the LoxP1 recognition site (grey) by Cas9 targeted 
by the Loxp1 guide RNA, which linearises it for integration.
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Surveyor Enhancer S  1 µL  
Surveyor Nuclease S   1 µL 
Nuclease free water  To final volume 
Digests were carried out at 42 °C for 45 minutes before stop solution was added 
to stop the digestion. 
2.2.2 Cas9 in vitro digest  
In vitro digests with Cas9 nuclease were used to test the efficacy of guide RNAs. 
This was done by incubating for 1 hour at 37 °C, using the mixture below: 
10x BSA (diluted from 100x, NEBTM: B9000S) 1/10thfinal volume 
10x NEB buffer 3 (NEBTM: B7003S)   1/10th final volume 
Cas9 protein (InvitrogenTM: B25640)    150 ng 
Guide RNA      400 ng 
Target dsDNA      70 - 300 ng 
Nuclease free water     To final volume 
Once digested the reactions were heated to 95 °C for 5 minutes and then placed 
onto ice. 
2.3 Sequence synthesis and creation 
2.3.1 Synthesis of guide RNA 
Guide RNA was made using the Invitrogen GeneArt™ Precision gRNA Synthesis 
Kit (Catalogue no. A29377). This kit provides primers to amplify custom made 
oligonucleotides designed by the user to encode their guide RNA sequence, which 
is the target sequence immediately preceding the PAM, and to add a transcriptional 





These primers are used in a PCR reaction to create the DNA template for in vitro 
transcription using PfusionTM polymerase (GeneartTM). The PCR product is then 
used to synthesise the guide RNA using the Transcriptaid RNA polymerase at 37 
°C for 2-4 hours. This product is then treated with DNAseI to remove the template 
DNA and the RNA is purified using the GenejetTM RNA purification micro-columns 
provided. Detailed instructions for this protocol can be found on the Fisher 
Scientific InvitrogenTM GeneartTM website. RNA was heated to 70 °C for 2 minutes 
then placed directly into ice to denature before being analysed using the AgilentTM 
Bioanalyzer 2100 with RNA nanochip to assess the RNAs’ concentration and the 
purity. 
2.3.2 cDNA synthesis for reverse transcription PCR of EGFP Flp-In HEK 293 
T-REx cell lines 
cDNA was synthesised from 1 µg of RNA for each sample using the Transcriptor 
First Strand cDNA Synthesis Kit (catalogue no. 04379012001) from RocheTM, 
except for the reaction with control RNA which used 10 ng.  
Figure 2.5 Design of primers for GeneartTM IVT gRNA synthesis (adapted from 
Thermo Fisher ScientificTM 2016) 
The diagram shows the positions of the primers that are used to make the DNA 
template for sgRNA synthesis, the sequences that are added to the primers encoding 
the guide or target sequence itself are shown below the diagram.   
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The following master mix was set up with random hexamer primers for 10 x 13 µl 
reactions: 
Hexamers (600 µM)      20 µl 
Nuclease free water      74 µl 
This was added to 1 µg of RNA made up to a volume of 3.6 µl and 10 ng in the 
case of the control. The reaction was incubated at 65 °C for 10 minutes and then 
put straight on ice. 
The following master mix was made while the reaction above was incubating: 
Transcriptor buffer (5x)    40 µl  
dNTPs (10mM each)     20 µl  
Transcriptor reverse transcriptase    5 µl 
Nuclease free water      5 µl  
7 µl of this was then added to the other reaction mixes and the reactions were 





2.3.3 Reverse transcription PCR for EGFP G68A Flpin Cell line 
2 µl of the cDNA produced in the reaction described in Section 2.3.2 was used as 
a template for the following reactions. In addition a pool of all the RNA (1 µg each) 
was used as a negative control after being diluted 1 in 100. 10 ng of the G68A 
plasmid was used as a positive control. Incidentally the same PCR was used with 
genomic DNA as well, for genotyping. 
The following 12 x master mix was set up: 
DreamTaq green (2x)      120 µl 
primer mix (21 and 22) (10uM)     4.8 µl 
nuclease free water      91.2 µl 
18 µl of this mix was added to 2 µl of each sample. 
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The control RNA reaction was amplified using its own primers and program as 
described in the First strand cDNA synthesis protocol except that 95°C instead of 
94°C was used and DreamTaq polymerase was used instead of quick start. 
2.3.4 Site-directed mutagenesis to create EGFP G68A plasmid 
To make a null EGFP integrated into a cell line to act as a fluorescent reporter 
EGFP FRT plasmid (EGFP PCDNA5) (840 ng/µl) was targeted for site directed 
mutagenesis as shown in the plasmid sequence in Figure 2.6 the primers were 
designed to have a 20 nt overlap region and the forward primer (no. 11) had the 
insertions to introduce an XhoI site downstream of a G to C transition resulting in 
a change in the 68th amino acid from glycine to alanine. Reagents to perform this 
site-directed mutagenesis were a gift from Dr. Mark Handley and the EGFP 
PCDNA5 plasmid was a gift from Dr. Matthew Ford. 
The following reaction was set up to methylate the plasmid DNA: 
NEB buffer 2 (10x)     1.6 µl    
SAM (10x) made from 200x stock   1.6 µl    
EGFP PCDNA5 plasmid (100 ng)   0.12 µl   
Ss1 (DNA methylase)     1 µl  
Nuclease free water     11.68 µl 
This was incubated using program SDMMETHY (37°C for 1 hour then 20 minutes 
at 65 °C and held at 4 °C). 6 µl of this template was used to set up the following 
PCR reactions: 
Betaine (5 M)      30 µl 
KOD DNA polymerase buffer (10x)   15 µl 
dNTPs (5 mM)                15 µl 
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MgSo4 (25 mM)     6 µl 
Template DNA     6 µl 
Forward primer no. 11 (10 µM)   4.5 µl 
Reverse primer no. 12 (10 µM)   4.5 µl 
KOD DNA polymerase    1.5 µl 
Nuclease free water     67.5 µl 
50 µl of this was aliquoted into each of three 200 µl tubes and run on the program 







A gradient was set up from 55 to 60°C, with tube 1 at 55°C, tube 2 at 58°C and tube 








Figure 2.6 Site Directed Mutagenesis to make EGFP G68A reporter plasmid 
The figure shows the site mutagenised by the primers, shown as yellow arrows. The 
highlighted base guanine in the reference sequence and cytosine in the primer is the 
site which results in the switch from glycine to alanine. The red coloured letters are 
the bases which are different between the original plasmid and the mutagenised one. 
The area above the brown arrow is the site where the XhoI recognition sequence was 
introduced. 
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2.3.5 Cloning CRISPR guides into plasmid backbone 
The protocol used to clone CRISPR guide sequences into the Cas9 expressing 
plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9 (pX330). The plasmid map shown 
in Figure 2.7, developed by the Zhang lab (Cong and Zhang 2014), has a site for 
the insertion of CRISPR guide sequences under the control of the human U6 
promoter. The guide sequences are ordered as 5’ phosphorylated oligonucleotides 
with overhangs that are compatible with overhangs created by BbsI restriction 
digest of the plasmid, the design of these primers is shown below. 
Guide oligonucleotide design for cloning into pX330: 
 5’ – CACCGNNNNNNNNNNNNNNNNNNN           – 3’  
 3’ –           CNNNNNNNNNNNNNNNNNNNCAAA – 5’ 
The protocol followed for this cloning was identical to that described in the article 
except that instead of digesting and ligating simultaenously the steps were 
separated and the DNA was purified using the InvitrogenTM PurelinkTM PCR 
purification kit, see Section 2.7.1.5 for details, before being ligated to annealed 
oligonucleotides overnight.  
The plasmid was digested using either BpiI (Thermo ScientificTM Catalogue no. 
ER1011) or BbsI (NEBTM catalogue no. R0539S). 
Px330 digestion @ 37 °C for 1 hour: 
 BpiI 6 U/ BbsI 10 U 
 pX330 plasmid 1 µg 
 1 x Buffer G (BpiI Thermo)/ 1x Cutsmart (BbsI NEB) 
 Water to volume total 
Denature @ 65 °C for 20 minutes. 
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To be inserted into the plasmid the oligonucleotides need to be re-suspended in 
nuclease free water or pH 8 TE buffer at 100 µM then diluted to 10 µM together. 
Then they are annealed to each other using the recommended settings from Ran 













Once the digested plasmid was purified it was ligated with the annealed guide 
oligonucleotides.  
Ligation of pX330 and guide oligonucleotides at 16°C for 16 hours: 
 T4 DNA ligase buffer (NEB)     1 µl 
 Annealed oligonucleotides (1:200 dilution)   1 µl 
 pX330 plasmid digest (50 ng)    1 µl 
 T4 DNA ligase (NEB)      1 µl 
 Nuclease free water     6 µl 
 
76 
2.3.6 Cloning tags into the generic tagging plasmid 
The protocol used to clone tags into the generic tagging vector (Lackner et al. 
2015) was designed to clone the tags into the three different frames either 0, +1 or 
+2 as mentioned in the original article. The multiple cloning site for the vector is
between two guide RNA target sites from the Zebrafish tia1l gene and has BamHI
at the 5’ end and HindIII at the 3’ end of the tag insertion site. The tags were
amplified with primers to add the BamHI and HindIII restriction sites to the ends of
the tags. The primer designs for the different frame shift insertions and the plasmid
map are shown in Figure 2.8.
Figure 2.7 pX330 plasmid 
The diagram shows a plasmid of the pX330 vector which contains the S.p. wild type 
Cas9 protein under the control of the chicken beta-actin promoter as well as a BbsI 
restriction site downstream of the human U6 promoter and upstream of the sgRNA 































SNAP BAMH1 cloning F +0 ORF AAAGGATCCGGCGGAAGCGGAGACAAAGA 
SNAP HindIII cloning r +0 ORF AAAAAGCTTACCCAGCCCAGGCTTGCCCA 
SNAP BAMH1 cloning F +1 ORF AAAGGATCCGGGCGGAAGCGGAGACAAAGA 
SNAP HindIII cloning r +1 ORF AAAAAGCTTTCACCCAGCCCAGGCTTGCCCA 
SNAP BAMH1 cloning F +2 ORF AAAGGATCCGAGGCGGAAGCGGAGACAAAGA 





The PCR to add the restriction sites to the tag for insertion into pMA-tia1l, shown 
in Figure 2.8 was performed as described below. 
20 µl reactions were set up in 0.5 ml Eppendorf tubes as follows: 
Primer F (10 µM) 0.4 µl 
Primer R (10 µM) 0.4 µl 
Mixed dNTPs (10 mM) (Thermo ScientificTM: R0181)  0.4 µl 
GC buffer (10 x) (Thermo scientificTM: F519L) 0.44 µl 
Nuclease free water 13.4 µl 
Hotstart II Phusion DNA polymerase  (Thermo scientificTM: F549L) 0.2 µl 
(Thermo scientificTM: F549L)  
SNAP tag plasmid template (9.7 ng/µl)     1 µl 
These were run using the PCR program Phugrad: 
Figure 2.8 Cloning a tag into pMA-tia1l tagging vector. 
A) The design of the primer sequences to amplify tags is shown in this image. The 
example given is for the SNAP tag. 20 nt primers were designed with either the BamHI 
recognition site on the 5’ end of the forward primer or a HindIII recognition site at the 
5’ end of the reverse primer, shown in green. Triple adenosine, shown in red, was 
added to the ends of primers to allow the PCR products to be efficiently cleaved by 
the restriction enzymes.
B) To ensure that the tag is inserted in the correct frame. Extra base pairs are added 
into the primer sequences as shown in the table, these are coloured in blue, to shift 
the frame 1 base a G is added to the forward primer while a TC is added to the 
reverse, to shift the frame 2 bases GA is added to the forward while C is added to the 
reverse.
C) The whole plasmid map of pMA-tia1L is shown with the presence of the tag 
insertion site, the tia1l expression site and target sites annotated.
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Once amplified the inserts and the pMA-tia1l universal tagging vector are digested 
by BamHI-HF and HindIII-HF (NEBTM catalogue no. R3136S and R3104S, 
respectively)          in 1 x Cutsmart buffer (NEBTM catalogue no. B7204S) for 2-3 
hours at 37 °C the     enzymes were deactivated at 65 °C for 15 minutes. 
Once digested the pMA-tia1l plasmid was de-phosphorylated by having 1 unit of 
rSAP (NEBTM catalogue no. M0371L) per µg added to it with Cutsmart buffer to 
make it 1x and was incubated at 37 °C for 1 hour and heat deactivated at 65 °C for 
15 minutes. 
Inserts and plasmid digest were purified using the InvitrogenTM PurelinkTM PCR 
purification kit (catalogue no. K310001), see Section 2.7.1.5. They were then 
ligated together in a molar ratio of 1:3 (vector:insert) using the same protocol as 
described in Section 2.3.5. After ligation samples were digested with 0.8 µl of 
EcoRV-HF (NEBTM catalogue no. R3195L) and 1.2 µl of Cutsmart buffer for 1.5 
hours at 37 °C and were heat inactivated at 65 °C for 15 minutes to remove 
undigested plasmid which would contain an EcoRV restriction site between the 
BamHI and HindIII restriction sites. 
2.3.7 Cloning of Cas9-Rep78 
As described in Section 2.1.5 Cas9-Rep78 is a fusion of the N-terminal domain of 
AAV Rep78 to the C-terminal domain of S.p. Cas9 with a flexible linker of amino 
acid sequence APGSAGSAAGSG from (Mircetic et al. 2017) in between. The 
linker-Rep78 fragment was made using primers for 2 rounds of PCR firstly to 
amplify the N-terminal domain of the Rep78 gene from the cloning vector pAAV-
RC/AAV2 Rep78 plasmid (Genbank accession no. AF369963.1) while adding the 
linker sequence at the 5’ end and an EcoRI restriction site at the 3’ end, Figure 2.9 
A). The next PCR used the product of the first PCR as a template and added the 
end of the Cas9 protein and MCS from pX330 moving the FseI site to the 5’ end of 
the linker sequence and placing a stop codon at the 3’ end, as shown in Figure 
2.9 B). The inserts and the pX330 plasmid vector were then digested with EcoRI-
HF (NEBTM catalogue no. R3101L) and FseI (NEBTM catalogue no. R0588S) for 2 





















Rep78 was amplified from the AAV2 Rep78 plasmid using the following reaction: 
Template DNA (10 ng/µl)      1µl 
Phusion Hotstart II       1 µl 
HF buffer (5x) (Thermo Fisher scientificTM catalogue no. F518L)  10 µl 
Primer mix of EcoRI Rep78 R and Linker Rep78 F (10 µM)  1 µl 
dNTPs         1 µl 








Figure 2.9 Cas9-Rep78 construction 
A) The sequence shown is from the AAV2 Rep78 plasmid and has the forward 
primer Linker Rep78 F and the reverse primer EcoRI Rep78 R attached, the grey 
arrow indicates the EcoRI recognition site added and the orange bar is the linker 
sequence. 
B) This shows the end of the Cas9 sequence and the junction with Rep78, the 
primer FseI Rep78 adds the 3’ end of Cas9 which is removed by FseI EcoRI 
digestion back onto the 5’ end of the linker sequence with the FseI left intact as 
indicated by the “start” arrow, the “end” arrow indicates the part of the linker the 
primer contains. 
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This reaction was run using PCR program PhuGFP60: 
After this the samples were purified using the InvitrogenTM PurelinkTM PCR 
purification kit and a second round of PCR was performed with primers FseI Rep78 
F and Stop Rep78 R with the same conditions and amounts as the first round of 
PCR.  
Digests and ligations were performed as described for the pMA-tia1l cloning in 
Section 2.4.5. The primers mentioned are below with restriction sites coloured 
green and extra sequence in blue: 
2.4 Transformation 
DH5α (Thermo Fisher: catalogue no. 18265017) E. coli were used for cloning 
transformations according to the protocol provided and were grown with LB. For 
SDM TOPO Oneshot (Thermo Fisher ScientificTM catalogue no. C404003) E. coli 
were used instead, according to the protocol provided with them. 
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2.5 PCR conditions used for genotyping 
2.5.1 SNAP-Dnah5 genotyping 
The following conditions were used for PCRs to genotype the insertion of the SNAP 
tag into Dnah5. 
PCRs from the SNAP tag into exon 1 and the 5’ UTR was performed in 20 µl 
reaction volumes: 
DreamTaq green master mix (2x) 10 µl 
Earclip DNA/ 100 ng purified genomic DNA 1 µl 
Primer mix SNAP_r and DNAH5nterm F (10 µM)  0.4 µl 
Nuclease free water     9.6 µl 
Reaction conditions used interchangeably for this genotyping PCR: 
Expected product size of 426 bp 
PCRs to span the SNAP tag insertion site in Dnah5 were performed in 20 µl 
reaction volumes as follows: 
DreamTaq green master mix (2x)   10 µl 
Earclip DNA/ 100 ng purified genomic DNA   1 µl 
Primer DNAH5nterm F and DNAH5nterm R (10 µM) 0.4 µl 




Reaction conditions used for this genotyping PCR are below: 
  
    
 




Product size with no insertion is 328 bp and with the insertion of the SNAP tag 
the size is 874 bp. 
PCR to amplify from the SNAP tag into the 1st exon and intron of Dnah5 were 
performed in reaction volumes of 20 µl as follows: 
 DreamTaq green master mix (2x)     10 µl 
 Earclip DNA/ 100 ng purified genomic DNA    1 µl 
Primer (24) and Primer (A55) (10 µM)    0.4 µl 
Nuclease free water      9.6 µl 
 








The PCR product size for this reaction is 190 bp. 
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PCRs to amplify from the SNAP tag into the Dnah5 gene outside of the homology 
arms were performed in reaction mixes of 30 µl as follows: 
 DreamTaq green master mix (2x)     15 µl 
 Earclip DNA       2.5 µl 
Primer (A100) and primer (A101) (10 µM)    0.6 µl 
Nuclease free water       12.1 µl 








Expected product size of 980 bp. 
2.5.2 PCM1SNAP genotyping 
The following PCR conditions were used to identify and characterise the insertion 










All reactions were performed using the DreamTaq green master mix (2x) in 20 µl 
volumes with 0.2 µM final concentration of primers. The reaction conditions for all 
but the exon spanning PCR, PCM1ex3 which had an elongation time of 50 
seconds, are identical to those below except the annealing temperatures were 
altered, Table 2.2 summarises the different PCRs used. 
Table 2.2 PCR conditions for SNAP insertion into PCM1.  
The table summarises where the PCM1 PCRs are designed to amplify, the name of 
the PCR program, the name of the primers used, the annealing temperature and the 
product sizes expected with a SNAP tag insertion in the correct position. 
 
2.5.3 PCR for D. melanogaster genotyping 
The following PCRs were used to test for the insertion of the SNAP tag into the 
second exon of CG6971, all reactions were done using the DreamTaq green 
master mix (2x) in 20 µl volumes with 0.2 µM final concentration of primers. The 
reaction conditions are shown below. 
PCRs to amplify from the gene sequence into the 5’ end of the SNAP tag were 
performed in reaction mixes of 20 µl as follows: 
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 DreamTaq green master mix (2x)     10 µl 
 Embryonic DNA      1 µl 
Primer C-1F CG6971 and SNAPCR CG6971 (10 µM)  0.4 µl 
Nuclease free water      9.6 µl 
 








Expected product size of either 273 bp for guide C1 or 255 bp for guide C2. 
PCRs to amplify across the SNAP tag integration site were performed in reaction 
mixes of 20 µl as follows: 
 DreamTaq green master mix (2x)     10 µl 
 Embryonic DNA      1 µl 
Primer C-1F CG6971 and C-1R CG6971 (10 µM)   0.4 µl 
Nuclease free water      9.6 µl 










Expected product size of either 266 bp with no insertion or 851 bp with an insertion. 
2.6  Gel electrophoresis 
2.6.1 Agarose gels 
Agarose gels were made up in 1 x TBE buffer with Hi-Pure Low EEO (BiogeneTM 
catalogue no. 300-300), to either 1% W/V or 2% W/V. Either 0.00002% ethidium 
bromide or 0.0001% SYBR SAFE was added to image the DNA bands.  
2.6.2  Polyacrylamide gels 
PolyAcrylamide Gel Electrophoresis (PAGE) was used for both protein analysis as 
well as for nucleic acid analysis and purification for modified guide RNA and repair 
DNA. 
PAGE for proteins 
Beads from immunoprecipitation or protein lysate were suspended in 1X protein 
loading buffer (see Section 2.16.1) with final volumes of ~30 µl for a 10 well gel 
or ~20 µl for a 12 well gel, samples were heated to 72 °C for 10 minutes before 
loading. 
PAGE for PCM1 used the NuPage® 4-12% Bis-Tris gel system (Thermo Fisher 
ScientificTM catalogue no. NP0321BOX) with the NuPage® MOPS SDS running 
buffer (catalogue no. NP0001) diluted from 20x to 1x with distilled water. The gel 
was run at 150 V for 55 minutes. 
PAGE for DNAH5 used the NuPage 3-8% Tris-acetate gel system (Thermo Fisher 
ScientificTM catalogue no. EA0375BOX with the NuPage Tris-acetate SDS running 
buffer (catalogue no. LA0041) diluted from 20x to 1x with distilled water with 
NuPage sample reducing (10X) (catalogue no. NP0009) agent added to the top 
chamber only. The gel was run at 150 V for 65 minutes. 
PAGE for nucleic acids 
15 % polyacrylamide 8M urea gels were made with 1.0 mm thick wells for analysis 
and 1.5 mm thick wells for purification. The recipe for 15 ml of gel is below: 
TBE (1x)       9 ml 
Acrylamide (30%)     6 ml 
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Urea        6.3 g 
Urea was added to liquid and left at 65 °C for 5 minutes then mixed until clear. 
150 µl of 10% APS and 15 µl of TEMED were added and the gel was pipetted into 
a BioradTM (catalogue no. 1702982) 1.5/1.0 mm glass plate. Gels were left to set 
for ~60 minutes. 
The wells were flushed with 1x TBE running buffer to remove urea, they were then 
pre-run before the nucleic acid was loaded. 
Nucleic acids were mixed with RNA gel loading dye (2x) (Thermo Fisher 
ScientificTM catalogue no. R0641) before being loaded into the gel. Gels were run 
at between 65 and 90 V for 1 to 2 hours.  
Gels were post-stained with SYBR Gold (Thermo Fisher ScientificTM catalogue no. 
S11494) diluted 1 in 10,000 in 1 x TBE. The gel was left to soak gently rocking at 
4 °C for 30 minutes. 
2.7  Extraction and purification 
2.7.1 DNA extraction and purification 
2.7.1.1 Sodium hydroxide extraction 
Mouse earclips were submerged in 25 mM sodium hydroxide heated to 95 °C for 
20 minutes before being neutralised with an equal volume of 40 mM Tris-HCl. 
2.7.1.2 Quick lysis with proteinase K 
Single colonies of mammalian cell lines from the PCM1 SNAP tagging experiment 
were pelleted and lysed with QuickExtract™ DNA Extraction Solution 1.0 
(EpicentreTM catalogue no. QE0905T) overnight at 56 °C using the following 
volumes of reagents: 
Pelleted cells           1/10 96 well 
QuickExtractTM solution 1.0        40 µl 
Proteinase K (20 µg/µl)                                                            5 µl 
2.7.1.3 DNA extraction from fly embryos 
Injected Drosophila melanogaster embryos were picked up with forceps and 
placed on a 200 µl pipette tip before being squashed against the side of a 0.5 ml 
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Eppendorf tube. 20 µl of Smashing Buffer (Section 2.18.1) with added proteinase 
K was added to each embryo. The embryos were incubated at 37°C for 30 minutes 
then 95°C for 5 minutes. 
2.7.1.4 Qiagen DNeasy blood and tissue kit 
This kit was used as described in the manufacturer’s protocol, samples were 
always heated to 56 °C for 10 minutes and eluted in 30-50 µl of elution buffer. 
2.7.1.5 InvitrogenTM PurelinkTM PCR purification kit 
Restriction digests and PCRs were purified using the InvitrogenTM PurelinkTM PCR 
purification kit following the manufacturer’s instructions except eluting in smaller 
volumes between 10-20 µl. 
2.7.1.6 InvitrogenTM PurelinkTM Quick Plasmid Mini-prep kit 
Bacterial colonies were grown in 5 ml of LB overnight then the InvitrogenTM 
PurelinkTM miniprep kit (catalogue no. K210010) was used according to the 
protocol provided, DNA was eluted in 40 µl.  
2.7.1.7 InvitrogenTM PurelinkTM  HiPure Plasmid Filter Maxiprep kit 
100 ml of LB was inoculated with 200 µl of LB with E. coli grown for 4-6 hours at 
37 °C and shaking at 250 rpm. The 100 ml of LB was left to grow overnight with 
the same conditions. All steps of the protocol provided with the PurelinkTM HiPure 
kit (catalogue no. K210007) were followed except the following: 
• When loading the precipitated lysate into the column the column was first 
covered with gauze to prevent precipitate from potentially blocking the 
column. 
• The column was eluted into 30 ml Corex, DNA binding glass, tubes instead 
of plastic falcons. 
• The ethanol was dried first with paper and then left to evaporate. 
• The pellet was left to dissolve in pH 8 TE overnight at 4 °C to increase the 
yield of the DNA. 
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2.7.1.8 Plasmid clean-up for zygote injection 
The repair template for Dnah5 tagging was further purified by running through an 
Amicon column (Merck MilliporeTM catalogue no. UFC503096) as follows:. 
1. The plasmid was diluted to 100 ng/µl in distilled water. 
2. 50 µl of this was added to a 30 kDa centrifugal filter. 
3. The column was spun at 13,000 rpm for 5 minutes. 
4. 100 µl of wash buffer (1 mM Tris-HCl, 1 mM EDTA) was added to the 
column. 
5. The column was spun at 13,000 rpm for 5 minutes. 
6. The column was washed with 100 µl of wash buffer. 
7. The column was spun at 13,000 rpm for 10 minutes. 
8. 10 µl wash buffer was added to the column. 
9. The column was incubated at room temperature for 1 minute. 
10. The column was inverted into a clean collection tube. 
11. The column was spun at 13,000 rpm for 3 minutes. 
12. Add 40 µl Transfer buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 8). 
2.7.2 RNA extraction from Flp-In T-REx HEK 293 cells 
HEK 293 cells that had EGFP either 68G or 68A were grown in 6 well plates, 
trypsinised and 90% were pelleted, frozen on dry ice and then had their RNA 
extracted using the QiagenTM RNeasy Plus mini kit (catalogue no. 74134) as 
follows: 
1. Pelleted cells were resuspended in 600 µl of RLT plus buffer by vortexing 
for 30 seconds. 
2. The lysate was then transferred to QiaShredder columns (catalogue 




3. The lysate was transferred into gDNA Eliminator spin columns and placed 
in 2 ml collection tubes. 
4. The column was centrifuged for 30 seconds at ≥8000 x g (≥10,000 rpm). 
The column was discarded and the flow-through was saved. 600 μl of 70% 
ethanol was mixed well with the flow-through by pipetting. Do not 
centrifuge. 
5. 700 μl of the sample, including any precipitate, was transferred to an 
RNeasy spin column placed in a 2 ml collection tube, the remaining 500 µl 
was also transferred to another RNeasy spin column. The lids were closed 
and the columns were centrifuged for 15 seconds at ≥8000 x g, the flow-
through was discarded. 
6. 700 μl of Buffer RW1 was added to the RNeasy Mini spin column (in a 2 ml 
collection tube). The lids were closed and the columns were centrifuged for 
15 seconds at ≥8000 x g and the flow-through was discarded.  
7. 500 μl of buffer RPE was added to the RNeasy spin column. The lids were 
closed and the columns were centrifuged for 15 seconds at ≥8000 x g and 
the flow-through was discarded. 
8. 500 μl of buffer RPE to the RNeasy spin column. The lids were closed 
gently and the columns were centrifuged for 2 minutes at ≥8000 x g 
(≥10,000 rpm).  
9. The RNeasy spin columns were placed in new 1.5 ml Eppendorf tubes. 30 
μl of RNase-free water was added directly to the spin column surface of the 
columns with 700 µl added in step 5 and 20 µl to columns with 500ul added 
in step 5. The lids were closed and the columns were centrifuged for 1 
minutes at ≥8000 x g to elute the RNA. 
RNA content was measured using NanodropTM and the RNA concentrations were 
between 276 and 1712 ng/µl for all tubes except HEK 293-Flpin EGFPWT G6, which 
had fewer cells. 
2.7.3 Purification from polyacrylamide gels for DNA-RNA fusions 
The click chemistry reaction products were analysed in polyacrylamide gels as 
described in Section 2.6.2. Products which appeared to be of the right size were 
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extracted by first imaging the stained gels on a blue light illuminator and using a 
razor to cut the bands of the correct size out of the gel, making sure to only cut out 
the centre of the band at the brightest part. The bands can then be stored at -80 
°C for a week. 
Extraction: 
1. Excised acrylamide bands were placed in 0.5 ml Eppendorf tubes that had 
a hole made in them by using a 21 G needle, these were then placed in a 
1.5 ml Eppendorf and spun at 21,100 x g for 5 minutes.  
2. The slurry at the bottom of the big centrifuge tube was covered with 150 µl 
of TE pH 7.4.  
3. The samples were then frozen at -80 ° C for ~30 minutes 
4. Samples were thawed for 5 minutes at 55 °C before being left at 4°C 
overnight shaking at 40 rpm on a rotary shaker. 
Precipitation: 
1. The gel slices left in TE overnight were spun with elution buffer at 21,100 x 
g for 3 minutes.  
2. The liquid was then transferred to a 0.2 µm filter spin column (Co-starTM 
catalogue no. CLS8161-100EA) and spun at the same speed for 1 minute 
to remove the bits of gel.  
3. The volume of the flow-through was then measured using a pipette. In this 
example ~90 µl. 
4. 9 µl or ~1/10 the volume of the flow-through of precipitation buffer was 
added (3 M sodium acetate pH 5.19).  
5. 225 µl or 2.5 volumes of 96 % ethanol was added with 1 µl (15 ng) of 
Glycoblue Coprecipitant (Thermo Fisher ScientificTM  Catalogue no. 
AM9516). 






1. The precipitated material was then pelleted by spinning at 21,100 x g at 4 
°C for 30 minutes.  
2. The supernatant was removed and 10 µl of ice cold 96% ethanol was added 
to the pellet.  
3. The tube was spun at the same temperature and speed for an additional 
10 minutes.  
4. The ethanol was removed and the tube was spun with the lid open for 1 
minute at maximum speed to dry the pellet.  
5. The pellet was re-suspended in 10 µl of TE pH 7.4.  
6. The concentration was estimated by measuring absorbance at 260 nm and 
averaging between ssRNA and ssDNA multipliers. 
2.7.4 Protein lysis and Immunoprecipitation 
Tissues and cells were lysed for immunoprecipitation of their proteins using the 
SNAP antibody and western blot analysis as follows: 
Lysis: 
Three different samples were used for immunoprecipitation in this project (1) 
mTECs, (2) HEK 293 cells and (3) mouse tracheas. 
(1) mTECs were rinsed 2x with PBS (Dulbecco’s PBS pH 7.5) in transwells. 
(2) HEK 293 cells were pelleted before being rinsed 1x with PBS. 
(3) Mouse tracheas were dissected, placed into PBS and snap frozen in liquid 
nitrogen for storage before lysis. 
All cells and tissues were lysed in the same buffer, IP lysis buffer (see recipes 
Section 2.18.1).  
(1) mTECs had lysis buffer directly added to them and were scraped and     re-
suspended with a pipette.       
(2) Similarly HEK 293 pelleted cells were re-suspended in lysis buffer. 
94 
(3) While tracheas were put into lysis buffer and homogenised using a motorised
hand pestle for several minutes.
Lysis was carried out at 4 °C for 10 minutes with agitation. 
Measure Protein concentration: 
Protein concentrations were estimated using absorbance with a DenovixTM 
spectrophotometer. For (1) mTEC IP 1 transwell/replicate was used. 
Optional: SNAP label. 
For (2) HEK 293 PCM1SNAP cell IPs 10 µM fluorescent SNAP-cell 647 SiR (NEBTM 
catalogue no. S9102S)  was added to 1 mg protein for 30 minutes at 37 °C. 
Optional: Preclear lysate. 
1. PureProteome beads (Millipore MerckTM catalogue no. LSKMAGAG10) were
resuspended by gently rotating on roller.
2. A volume equal to the number of IPs x 30 µl of beads was transferred to a
fresh tube, placed on a magnetic rack for <2 minutes and aspirated with fine-
tip pastette.
3. Beads were pre-equilibriated by adding X µl IP lysis buffer (where X is the
amount in µl of lysate added to antibody x no. IPs) for 5 minutes and were left
to gently rotate on a roller.
4. The beads were placed on a magnet tube rack <2 minute and the buffer was
aspirated off with a fine-tip pastette.
5. Beads were re-suspended in (no. IPs X 30) µl of lysis buffer.
6. 1 µl of Benzonase (Merck MilliporeTM catalogue no. E1014) was added to 1
mg of lysate.
7. 1 mg of protein was incubated with 30 µl of beads.
Binding of antibody to target protein in cell lysates 
1. If preclearing was done then PureProteome beads were magnetically
separated from the lysate.
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2. The lysate was incubated with 10 µl or 8 µl (1) SNAP tag antibody (NEBTM 
catalogue no. P9310S)  per ~1 mg/transwell (1) of lysate. 
3. Lysates were incubated with antibody overnight at 4 °C with mild agitation 
(side-to-side, 18 rpm, setting 90).  
Immunoprecipitations of immunocomplexes using PureProteome Beads  
1. PureProteome beads were re-suspended by gently rotating on a roller. 
2. A volume of beads equal to the number of IPs x 30 µl of beads was transferred 
to a fresh tube, placed on a magnetic rack for <2 minutes and aspirated with 
fine-tip pastette. 
3. Beads were pre-equilibriated by adding X µl IP lysis buffer (where X is the 
amount in µl of lysate added to antibody x no. IPs) for 5 minutes and gently 
rotating on roller. 
4. The beads were placed on a magnet tube rack <2 minutes and the buffer was 
aspirated off with a fine-tip pastette.  
5. Beads were re-suspended in (no. IPs X 30) µl of lysis buffer. 
6. They were then incubated for 30-45 minutes (always < 1 hour) on a roller to 
concentrate immuno-globulin complexes on the beads. 
7. 8 washes in X µl of wash buffer (where X is the volume of the lysate added to 
the antibody) were performed by adding the wash buffer to the beads and 
agitating at 4 °C for 2-5 minutes before briefly centrifuging for ~5-10 seconds 
and placing in the magnetic rack to remove the liquid from the beads with a 
fine tip pastette, each time ensuring all liquid is aspirated away. The wash 
buffers used had decreasing amounts of detergent as detailed below: 
a. 2 x washes with IP wash buffer 1 (see Section 2.18.1). 
b. 2 x washes with IP wash buffer 2 (see Section 2.18.1). 
c. 4 x washes with IP wash buffer 3 (see Section 2.18.1). 
8. After the final wash before aspirating the suspended beads were transferred 
to a new tube and then the liquid was carefully removed using a fine tip 
pastette. The dried beads were stored at -80 °C for later use in Western 
blotting or mass spectrometry. 
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2.8 Western blotting 
The blots shown in this document were both to measure the effectiveness of 
immunoprecipitation of the SNAP tag from an endogenously tagged cell line and 
mouse. The details of the protocols used are below and the antibodies used for 
these experiments are listed in Table 2.3. 
Protein gels were blotted by removing the gels from their plates, washing in water 
or 20% ethanol and then transferring to nitrocellulose membranes (Thermo Fisher 
ScientificTM catalogue no. IB23001) with the iBlot 2 dry blotting system (Thermo 
Fisher Scientific catalogue no. IB21001) using the 7 minute 25 V program 0 for 
PCM1 and a custom program of 8 minutes at 20 V was used to transfer the much 
larger DNAH5 protein.  
Manual method of western blotting, used for PCM1: 
1. The transferred blot was blocked in blocking solution, which is 1x TBS with 
0.1% (w/v) Tween-20 detergent (TBST) and Marvell’s Milk Powder 5% 
(w/v) added to it, for 1 hour at 4 °C.  
2. The block was then removed and replaced with block containing primary 
antibody, anti-SNAP tag antibody diluted 1 in 250, this was left to incubate 
overnight at 4°C. 
3. The blot was washed twice to remove primary, then 3 times for 10 minutes 
each time in TBST shaking at 4°C. 
4. Secondary antibody, HRP-conjugated rabbit heavy-chain, diluted 1 in 
10,000 was added to the blot in blocking solution for 50 minutes at room 
temperature and then 2 hours at 4°C. 
5. The blot was washed three times in TBST for 12 minutes per wash.  
6. The blot was then submerged in SuperSignal™ West Femto Maximum 
Sensitivity Substrate (Thermo Fisher Scientific catalogue no. 34095) for 5 
minutes. 





iBind Western Device (Thermo Scientific catalogue no. SLF1000) used for 
DNAH5: 
1. 5 ml of 1x iBind buffer was made as follows: 
a. 1 ml of 5x FD buffer 
b. 50 µl of 100 x additive 
c. 3.95 ml of distilled water  
2. Blots were placed in water after transfer then moved into 50 ml Falcon 
tubes with 2 ml of 1x iBind buffer and were left to roll at 4 °C for 30 minutes. 
3. The iBind buffer was replaced with 2 ml of iBind buffer containing primary 
antibody, which was left rolling overnight at 4 °C. 
4. The rest of the steps are described in detail in the iBind manual, secondary 
antibody was diluted 1 in 10,000. 
5. Blots were imaged in the same way or with photographic film. 
Blots were stripped using Thermo Fisher Scientific’s Restore™ Western Blot 













Table 2.3 Primary antibodies used for western blotting 
The table above shows the polyclonal (pAb) and monoclonal (mAb) antibodies used 
to analyse the western blots of SNAP Tag IPs.  
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2.9  Mouse work 
Mice were housed in a Specific Pathogen Free environment. Experiments on these 
mice were performed following the guidelines issued by the Medical Research 
Council in ‘Responsibility in the Use of Animals in Medical Research’ (July 1993). 
Licence to do this work was granted by the Home Office under the Animals 
(Scientific Procedures) Act 1986. 
2.9.1 Injection mix preparation for SNAP-Dnah5 tagging 
S. pyogenes GeneArt™ Platinum™ Cas9 Nuclease (Thermo Fisher ScientificTM 
(catalogue no. B25640) was mixed with in vitro synthesised guide RNA Dnah5
guide exon 1_2 up to 1 hour before injection using the following reagents and
volumes in a 1.5 ml Eppendorf.
Repair Plasmid (10 ng/µl)   6 µl 
Cas9 protein (100 ng/µl)   2 µl 
sgRNA (25 ng/µl)   15 µl 
Transfer buffer   37 µl 
This mix was incubated at room temperature for 5 minutes to allow RNP complexes 
to form. This was then placed on ice. 
2.9.2   Tracheal dissection and mTEC derivation 
Mice aged between 9 days and 1 year were dissected to remove their tracheas to 
either generate primary cell cultures from their tracheal epithelial cells or for lysis 
to analyse the expression of tagged DNAH5 protein.  
Mice were culled with either CO2 asphyxiation or by using intraperitoneal injection 
of a lethal dose of anaesthetic, in order to preserve the trachea. The mice were 
then dissected, as previously described in detail (Vladar and Brody 2013). The 
protocol to make mouse tracheal epithelial cells (mTECs) is also provided by 
Vladar and Brody 2013, it was followed exactly up until the point of seeding. 
Another publication (Eenjes et al. 2018) showed it was possible to expand mTECs 
in culture for an extended period of time to increase the number of cells grown from 
each trachea. Therefore instead of being seeded into transwells directly the 
mTECs were instead grown in T75 flasks for 1 to 2 weeks before being seeded 
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into transwells, this was done by growing the cells in KSFM media, see Section 
2.18.3 for the recipe. 
The steps after this were the same as the original publication except that Life 
Technologies DMEM was substituted for advanced DMEM F12 (Catalogue no. 
12634028) instead of DMEM F12 (Catalogue no. 11330-032) and the PLUS 
proliferation media was supplemented with Y-27632 as well as the KSFM media, 
at the same concentration the recipe for PLUS and NS media can be found in 
Vladar and Brody 2013.   
2.10  Tissue culture 
2.10.1 mTEC tissue culture techniques 
2.10.1.1 Dissociating and seeding or freezing mTECs 
Dissociating 
mTECs being grown in T75 flasks were dissociated using a dissociation media 
described previously (Eenjes et al. 2018), the (recipe in Section 2.18.3), 3 ml of 
dissociation buffer was added to each T75 flask of mTECs and the flasks were left 
to incubate at 37°C 5% CO2 for 10-15 minutes. Once the cells began to detach 
from the flask the trypsin was neutralised with 300 µl of FCS. The cells were 
pipetted up and down to evenly disperse them and then they were spun in 50 ml 
Falcon tubes at 400 x g for 10 minutes. 
Seeding 
To seed mTECs, Transwells® (Corning®) were coated with collagen coating 
solution from 4 hours to overnight and the cells were then seeded on these (Vladar 
and Brody 2013). The pelleted cells from the mTEC flasks were re-suspended in 
PLUS media and were either counted using the Sceptre cell counter (Millipore 
MerckTM) to seed between 40,000 and 200,000 cells per well or the cells from a 
single T75 flask were divided equally between 5 to 15 Transwells. The tendency 
of the cells to aggregate can make counting difficult, therefore excess cells were 
often seeded, this approach did not appear to harm the ability of mTECs to grow 





Pelleted cells can be re-suspended in freezing media (Section 2.18.3) similar to 
other cell lines used in this work. mTECs were frozen in 500 µl of freezing media 
at a high density between 1/3 and 1/2 of a T75 flask per Cryo-vial (Thermo Fisher 
Scientific catalogue no. 10004220).  
2.10.1.2 Reverse seeding, differentiating and SNAP dye imaging 
Reverse seeding 
Imaging of mTECs live is made difficult due to the high auto-fluorescence on the 
membrane of the transwells and the thickness of the membrane. To overcome this 
a method to grow the mTECs on the underside of the transwell inserts was 
developed in this project, such that the cilia of the cell point down towards the lens 
of the inverted microscope. This was accomplished by putting the transwells 
upside down in a 12 well plate and then placing a short piece of plastic tubing over 
the bottom of the insert, the chamber normally named the apical chamber is now 
facing downwards. The apical chamber is filled with 200 µl of PLUS media which 
is kept in place by surface tension. Then the upwards pointing side of the 
membrane has the cells seeded onto it. These are left overnight at 37°C 5% CO2 
to adhere and then the inserts are put back into a 24 well plate, in the normal 
orientation, with 500 µl of PLUS media in each well and the temporary chamber is 
removed.  
Differentiating mTECs 
mTECs are differentiated as described (Vladar and Brody 2013), by removing the 
PLUS media and replacing only the basal chamber media with NS differentiation 
media. The stage at which mTECs are ready to be differentiated was difficult to 
ascertain and therefore proliferation time varied considerably between cultures. 
SNAP dye imaging 
mTECs derived from SNAP-Dnah5 mice had SNAP cell permeable dyes added to 
them. The most effective dyes, concentrations and protocols for staining were 
found to be as follows: 
1. Addition of 0.6 mM SNAP-Cell TMR-Star (NEBTM catalogue no. S9105S) in 
DMSO at 0.5 µM final concentration or 0.6 mM SNAP-Cell 647-SiR (NEBTM 
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catalogue no. S9102S) in DMSO at 0.3 µM final concentration to NS media 
with retinoic acid, mixed thoroughly by pipetting. 
2. 500 µl of this dye solution was added into the basal chamber of the mTECs,
which were incubated at 37°C 5% CO2 for 24 to 48 hours.
3. The dye is then washed off as follows:
a. 1st wash: media was aspirated off, replaced with new media
b. 2nd wash:  media was immediately removed and replaced with more
media.
c. 3rd wash: after 1 hour at 37 °C 5% CO2 the media was removed and
replaced with new media before incubated at 37 °C 5% CO2.
d. 4th wash: 1 hour later the media was removed and replaced with
new media.
4. DNAH5 will be stably labelled now for at least ~32 days, the longest
timepoint studied in this thesis.
2.10.2 Flp-In™ T-REx™ HEK 293 Cell Line 
2.10.2.1 Integration of EGFP G68A vector into Flp-in cells 
The Flp-In HEK 293 cells have a detailed manufacturer’s protocol that explains 
how to maintain them and how to integrate constructs, as such this will be a brief 
overview highlighting where the approach taken differs from the published 
protocols. 
2.10.2.1.1 Transfection of the Flp-In HEK 293 cell line 
Cells were grown to 70% confluence and were transfected with Lipofectamine 
2000 (Thermo Fisher ScientificTM catalogue no. 11668019) with a ratio of 1 µg to 
4.5 or 6 µl of DNA to Lipofectamine 2000 (see Section 2.10.4.1). The ratio of EGFP 
pcDNA FRT plasmid, the plasmid which is integrated, was 1 to 10 of the pOG44 
plasmid which contains the Flp recombinase. This makes multiple integrations of 
the EGFP gene less likely. This is a summary of the transfection protocol used: 
1. The following master mixes were made with Opti-MEM (Thermo Fisher
ScientificTM catalogue no. 31985070), lipofectamine 2000 and either
plasmid DNA in TE or plasmid DNA diluted in Opti-MEM.
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2. 6 µg of DNA in total was added to each of the wells in the 6 well plates. 
3. The table below summarises the different reactions, wells 1-5 are the 
experimental wells whereas wells 6-12 are the controls. 
4. The media was replaced 4 hours after transfection with antibiotic free 
media. 
5. The media was changed the next day to media containing penicillin and 
streptomycin. 
2.10.2.1.2 Hygromycin selection 
The transfected cells had their media changed to DMEM containing 100 µg/ml 
Hygromycin 2 days after transfection. They were then transferred from 6 well plates 
into 10 cm dishes, the like wells were pooled. Cells began to die within 2 days and 
were under selection for 12 days before colonies of cells could be observed to have 
grown. 
2.10.2.1.3 Transferring cell colonies from 10 cm dish 
When the colonies of Hygromycin resistant cells were visible to the naked eye they 
were drawn around with a marker pen. The circled areas had a drop of TrypLE 
express (Thermo Fisher ScientificTM catalogue no. 12605010) put onto them and 
were carefully pipetted up and down to dislodge the cells, they were then 
transferred into 24 well plates with 500 µl of DMEM with Hygromycin in each of the 
wells.  
2.10.2.1.4 Inducing EGFP expression in Flp-in T-REx HEK 293 cells 
The Flp-in locus in T-REx HEK 293 cells is under the control of the tetracycline 
repressor operon, therefore in order to have consistent expression of EGFP from 
these cells 1 µg/ml Doxycycline in the selection media was added at least 24 hours 
before analysis of the cells. 
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2.10.3 Mouse Embryonic Fibroblasts 
Mouse Embryonic Fibroblasts (MEFs) from mTmG mice, immortalised with the 
large T antigen from Simian Virus 40 (SV40), were cultured as an editing reporter 
system. In this study they have been used to test the effectiveness of putative small 
molecule enhancers of Homology Directed Repair (HDR) and Cas9-rep78 in 
improving Cas9 nuclease induced HDR.  These cells were grown in modified Opti-
MEM, the recipe for MEF Media can be found in Section 2.18.3. 
2.10.4  Transfection and transduction 
2.10.4.1 Lipofectamine 2000 
Flp-in HEK 293 cells were transfected with Lipofectamine 2000 for the creation of 
the EGFP reporter line as described in Section 2.10.2.1.1 and to tag the 
endogenous PCM1 locus with SNAP. The SNAP tagging was done in the same 
way, except with equal masses of pX330 with PCM1 guides to SNAP tagging pMA-
tia1l plasmids were added in a 24 well plate. 
2.10.4.2 Lipofectamine CRISPRMAX 
Lipofectamine CRISPRMAX (Thermo Fisher ScientificTM catalogue no.
CMAX00015) was used to transfect EGFP Flp-In T-REx HEK 293 cells with Cas9 
nuclease and EGFP guides and repair. This was done in accordance with the 
protocol. 
7.62 pmol of guide RNA and repair DNA were added to 7.62 pmol of Cas9 nuclease 
with 2 µl of Plus reagent in 50 µl of Opti-MEM and were mixed and left to incubate 
for 5 minutes at room temperature. 50 µl of Opti-MEM was mixed with 3 µl of 
lipofectamine. The RNP plus mix was added to the lipofectamine and was 
incubated at room temperature for 10 minutes. The solutions were then added to 
the Flp-In T-REx HEK 293 EGFP68A cells and were left to incubate overnight with 
the cells before removing. 
2.10.4.3 Neon transfection system 
MEFs were transfected using the Neon transfection system (Thermo Fisher 
ScientificTM) as follows: 
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1. Cells were trypsinised (Section 2.10.5.1) and were re-suspended in 1x
Dulbecco PBS before being counted using the sceptre cell counter.
2. 10% excess of cells and plasmid DNA was used to make sure there was
enough.
3. 110,000 cells were counted and re-suspended in 22 µl R buffer.
4. The plasmids, pX330 and pX330-Rep78 were mixed with R buffer, two 2.2
µg of plasmid pX330-Rep78.
5. The cells were then electroporated in two transfections with one 10 µl tip
per well.
6. The cells were electroporated with 1350 V, width 30 ms and 1 pulse.
7. Cells were then put into MEF media in a 24 well plate at 37 °C 5% CO2.
2.10.4.4 Electroporation and small molecule treatment of MEFs 
MEFs were transfected using the Neon electroporator, as described in the previous 
section, with Cas9 protein (1 µg/well), Loxp 1 guide RNA (180 ng/well), H2B GFP 
repair plasmid (500 ng/well) and H2B BFP minicircle (500 ng/well) diluted in Opti-
MEM. Each well was a technical replicate and contained 100,000 MEFs, the mixes 
were left to stand for 5 minutes at room temperature before adding to the cells and 
electroporating. This electroporation was done in two separate experiments, the 
first used three technical replicates and had only H2B GFP repair plasmid added 
(1 µg/well) while the second had five replicates and H2B BFP minicircle in addition 
to H2B GFP repair plasmid. Once electroporated, cells were pipetted into wells 
containing 2 ml of MEF media with the small molecules (dissolved in DMSO) at 
the concentrations listed in the table below:  
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2.10.4.5 AAV2 transduction of MEFs for HDR reporting 
MEFs were transduced with AAV2/2 H2B GFP repair virus after being transfected 
with the Neon system, this was done by adding virus to cells immediately after 
transfection at an MOI of 100,000.  
2.10.5  General tissue culture techniques 
2.10.5.1 Trypsinisation 
Unless otherwise stated passaging and dissociation of cells was carried out as 
follows: 
1. The media was removed from the flask or plate.
2. The cells were covered in TrypLETM express (Thermo FisherTM).
3. The cells were left to incubate at 37 °C 5% CO2 for several minutes until
cells detached.
4. The media was neutralised with an equal or greater amount of culture
media.
5. Cell suspensions were either pelleted at 1,300 x g for 3 minutes or
transferred to new culture vessels for passaging.
2.10.5.2 Freezing cells in liquid nitrogen 
Cells centrifuged at 1,300 x g for 3 minutes and re-suspended in freezing medium 
(Section 2.18.3) for long term storage in liquid nitrogen. 
To revive cells for culture they were thawed at 37 °C before being seeded into 
culture media. 
2.11  Fixed tissue experiments 
2.11.1  Para Formaldehyde fixation: for cells 
mTECs were fixed for immunofluorescence and for RNA FISH while MEFs were 
fixed for imaging. 
1. 4% paraformaldehyde (PFA) was made up fresh by diluting 16% PFA
(Sigma-AldrichTM catalogue no. 28908) with 1x PBS.
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2. Cells were washed twice with 1x PBS and then covered in 4% PFA for 
5 minutes. 
3. PFA was washed off the cells and replaced with 1x PBS. 
4. PBS was washed off and replaced with more PBS. 
5. This PBS was washed off after 5 minutes and was either replaced with 
1x PBS with 0.001% Sodium Azide added for storage of the cells or the 
cells were used immediately for immunofluorescence (Section 2.9.2). 
2.11.2 Fixation for cryosectioning  
Mouse tracheas were fixed for cryo-sectioning and smRNA FISH (Section 
2.11.4.2), all solutions were diethylpyrocarbonate (DEPC) treated and autoclaved 
to minimise RNAse contamination. 
1. The dissected tracheas were placed in 4% PFA and were left for 1 hour 
on a roller at 4 °C. 
2. The tracheas were then rinsed twice with 1x PBS. 
3. Tracheas were then placed in 20 % sucrose (w/v, made up in 1x PBS) 
overnight on a roller at 4 °C. 
4. The tracheas were then placed upright into cryo-moulds (Agar 
ScientificTM catalogue no. AGG4581) dry ice. 
5. While being held up with forceps the tracheas were submerged in OCT 
(VWRTM catalogue no. 361603E) until the compound hardened enough 
for the trachea to stand, ~2 minutes, and then another 30 minutes until 
the OCT had hardened fully. 
Tracheas were sectioned transversely using a cryostat set at -20 °C. Sections were 
cut at a width of 8 µm, then placed on microscope slides and air dried before being 
stored at -80 °C. 
2.11.3 Immunofluorescence mTEC protocol 
Fixed cells were incubated with primary antibody to visualise the localisation of 
specific proteins. The antibodies used for these experiments are shown in Table 
2.4. This was done using the following protocol: 
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1. PBS was removed from the surface of cells, for mTECs washes apply to 
both top and bottom chambers. 
2. The wells were filled with TBST (TBS with 0.1% Triton X-100) and left to 
incubate at room temperature for 5 minutes. 
3. Blocking buffer was made with TBST containing 5% donkey serum 
(Sigma-AldrichTM catalogue no. D9663). 
4. The top and bottom chambers had blocking buffer added to them and 
the cells were left to incubate with block for 30 minutes at room 
temperature. 
5. The bottom chamber had 1% donkey serum in TBST added to it while 
the top chamber had 1% donkey serum in TBST with primary antibody 
added to it. 
6. The cells were then left at 4 °C overnight to incubate with primary 
antibody. 
7. Primary antibody was washed off with TBST, three times 5 minute 
washes. 
8. 1% donkey serum in TBST was put into the bottom chambers and the 
top chambers had 1% donkey serum in TBST with secondary antibody 
added. 
9. After 1 hour at room temperature the secondary antibody was washed 
off, three times 5 minute washes. 
10. mTECs transwells were then removed from their wells and the 
membranes were cut off using a razor. Membranes were placed face up 
on microscope slides (Thermo Fisher ScientificTM catalogue no. 
10149870). Samples were covered with mounting medium ProLong-
Gold (Thermo Fisher ScientificTM catalogue no. P36930) and then a 
coverslip and allowed to cure as per the manufacturer’s protocol. 
11. Slides were usually imaged the same day or the next day and were kept 
at room temperature for up to ~2 months. 
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Table 2.4 Antibodies used in immunofluorescence 
 
2.11.4  Single molecule RNA FISH using Stellaris probes  
2.11.4.1 RNA FISH and immunofluorescence for adherent cells 
Single molecule RNA fluorescence in situ hybridization (smRNAFISH) was 
performed as described in the Stellaris® combined immunofluorescence and RNA 
FISH protocols (https://www.biosearchtech.com/support/resources/stellaris-
protocols). Custom Stellaris® FISH Probes, 48 in total, were designed against 
mouse Dnah5 (catalogue number SMF-1065-5) by utilising the Stellaris® FISH 
Probe Designer (Biosearch Technologies, Inc., Petaluma, CA) available online at 
www.biosearchtech.com/stellarisdesigner. The mTECs were hybridised with the 
Dnah5 and mouse Gapdh (catalogue number SMF-3140-1) Stellaris® FISH Probe 
set labelled with Quasar 670 dye (Biosearch Technologies, Inc.), following the 
manufacturer’s instructions for simultaneous IF and FISH. 
The following exceptions and additions to the protocol were made: 
• All steps except mounting were performed within the wells. Fixative and 
hybridisation buffer were only applied to the top chamber. 
• Cells were left to permeabilise in 70% ethanol at 4°C for 2-3 days. 
The table above shows the polyclonal (pAb) and monoclonal (mAb) antibodies used 
for immunofluorescence imaging of fixed cells and tissues with the source, catalogue 
number of each note.  
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• RNase treated cells that are fixed and permeabilised were washed with
PBS and incubated with 50 µg/ml RNase A (Thermo Fisher ScientificTM
catalogue number K2100-27) diluted in 1x PBS, for 1 to 2.5 hours at 37°C.
*note it is important to keep these RNase treated samples away from the
experimental samples*
• 10x the recommended amount of probe (10 µl or 1.25 µM concentration)
was used when hybridising with cells.
• Hybridisation was always carried out overnight in a 37°C degree oven
inside a box with wet tissue paper.
• Mounting was the same as that in the protocol for immunofluorescence.
2.11.4.2 smRNA FISH and immunofluorescence of cryosections 
The tracheal cryosections produced as described in Section 2.11.4.1 were 
processed as described in the protocol in the previous sections combined with the 
protocol for frozen tissue provided by Stellaris on their website. These samples 
had the recommended concentration of probes added. 
2.12 Microscopy and imaging analysis 
2.12.1  Confocal microscopy 
The confocal images shown were captured using the AndorTM Dragonfly Spinning 
Disc confocal with the high sensitivity Xyla camera. Images were acquired using a 
100x or 40x lens on the multimodal Imaging Platform Dragonfly (Andor 
technologies, Belfast UK) equipped with 405, 458, 488, 514, 561, 640 and 680nm 
lasers built on a NikonTM TiE microscope body with a Perfect focus system (NikonTM 
Instruments, Japan). Data were collected in Spinning Disk 40 µm pinhole mode on 
the iXon888 EMCCD camera using a Bin of 1 and frame averaging of 1 using 
Fusion v1.4 software. 
2.12.2  Widefield microscopy and automated acquisition 
Acquisition to quantify levels of HDR in edited mTmG MEFs was performed using 
a Nikon wide field microscope and NikonTM JOBs software set to acquire either 240 
or 148 images per well from the centre of each the wells at 20x magnification using 
the perfect focus system.   
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2.12.3  Stimulated Emission Depletion Microscopy 
Super resolution images were captured using the LeicaTM SP8 3X STED system 
using the pulsed 770 nm laser. All STED images were captured by Dr. Alison Dunn, 
Edinburgh Super Resolution Imaging Consortium (ESRIC), Heriot-Watt University. 
2.12.4 High-speed video microscopy and transmission electron microscopy 
High-speed video microscopy was used to assess ciliary beat patterns (speed and 
changes in shape) of Dnah5SNAP/SNAP MTEC axonemes compared to littermate 
control. These procedures were carried out by Dr. Amelia Shoemark (University of 
Dundee). Transmission electron microscopy was used to examine the 
ultrastructure of Dnah5SNAP/SNAP MTEC axonemes compared to littermate control 
performed by Dr. Farheen Daudvohra (Royal Brompton & Harefield NHS 
foundation trust) as described in (Fassad, Shoemark, le Borgne, et al. 2018). 
2.12.5 CellProfiler analysis to quantify percentage GFP positive nuclei 
Images acquired were analysed using the free open source software CellProfiler 
(https://cellprofiler.org/) (Doan et al. 2016). The pipeline was developed by Dr. 
Laura Murphy. Briefly, it identifies nuclei and then measures mean GFP intensity 
within the nucleus as compared with the area directly surrounding the nucleus. 
This ratio was then used to score nuclei as either GFP positive or not and was 
found to be the most effective way to distinguish between GFP positive nuclei and 
GFP positive membranes. 
2.12.6  Image J analysis for general image manipulation 
Image J 2.0 with 64 bit Java 8 (https://imagej.nih.gov/ij/) was used post-acquisition, 
primarily to process images and convert them to other file types (Schindelin et al. 
2012).  
2.12.7 Imaris processing and analysis of large stacks 
Imaris was used to analyse confocal images and make 3D images from large 
stacks. Imaris v 9.2, Bitplane AG software available at http://bitplane.com. 
2.13 Mass spectrometry analysis 
Mass spectrometry analysis of the immunoprecipitated samples was performed by 
the mass spectrometry facility at the IGMM, specifically by Dr. Alex von Kriegsheim 
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and Dr. Alfonso Bolado using an IP/MS workflow carried out according to 
(Turriziani et al. 2014). MaxQuant software was used to analyse mass spectra and 
obtains label-free quantification intensity values which were used to calculate 
enrichment (log2 fold change of SNAP vs WT IPs). Statistical significance was 
measured using a T-test based on these results.  
The volcano plot created was made using a pipeline designed by Dr. Jimi Wills 
using LIMMA analysis software. 
2.14 Fluorescence activated cell sorting 
MEFs were trypsinised and pelleted as described in Section 2.10.5.1. The pellets 
were then re-suspended in 200-400 µl of PBS. This cell suspension was 
transferred into 4.5ml FACS tubes (BDTM Falcon). Samples were analysed using 
the LSR Fortessa (BDTM Biosciences). Sorting gates were manually set on all 
machines. For EGFP and Tomato an excitation filter of 488/50 and 561/20 was 
used with an emission filter of 525/50 (488-525/50) and 610/20, respectively. Cell 
counts were usually between 50-100,000 cells. FACS was performed by the 
technicians at the Institute of Genetics and Molecular Medicine (IGMM), Elisabeth 
Freyer and Stacey Thomson. 
2.15 Sanger sequencing 
Sanger sequencing was performed by the IGMM technical services department on 
an Applied Biosystems 3130 (4-capillary) Genetic Analyzer or a 48-capillary 3730 
DNA Analyzer (Both Thermo FisherTM). Sequencing and the AgilentTM Bioanalyzer 
were both run by the IGMM technical service team members, Stephen Brown and 
Jeffrey Joseph.  
2.16 Genome browsers, DNA sequence design and analysis 
2.16.1 Genome browsers 
Mammalian genomic sequences were downloaded from Ensembl genome 
browser 90, 2017 (https://www.ensembl.org/index.html) (Kersey et al. 2018).  
Drosophila DNA sequences were downloaded from Flybase (https://flybase.org) 
FB2016_03, Dmel Release 6.11 (Thurmond et al. 2019). 
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2.16.2 DNA sequence design and analysis 
DNA sequences were deposited and re-designed in the online biology software 
tool Benchling (https://benchling.com 2016-2019) to create genomic reference 
sequences for tagging as well as for plasmid Chromatic DNA traces and 
sequences from Sanger sequencing were aligned to these sequences. Benchling 
was also used to design the CRISPR guide RNA sequences used in this project. 
All pictures of DNA sequences, alignments and plasmid maps are from Benchling.  
2.17 Miscellaneous software used 
2.17.1 Primer design 
Primers were designed using the online primer design software Primer3 
(Koressaar and Remm 2007; Untergasser et al. 2012). 
2.17.2 Statistical analysis and graphing 
All statistical analysis and graphs shown were generated using GraphPad 
Prism version 8.2.0 for Windows, GraphPad Software, La Jolla California 
USA, www.graphpad.com. 
2.17.3 Figures and illustrations 
All figures and illustrations were made with Adobe Illustrator 2019, Adobe 
Indesign 2019 and Adobe Reader DC 2019. Some images were created 
using www.Biorender.com 
2.18 Recipes 
2.18.1  Buffers 
20x TBE (1000ml): 
Tris base    216.0 g  
Boric Acid   110.0 g  
0.5 M EDTA, pH 8.5  80 mL  
Add deionised water to 1000ml 
1x PBS (1000ml): 
Deionised water 800 ml  
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NaCl    8.00 g  
KCl    0.20 g  
Na2HPO   41.44 g  
KH2PO4   0.24 g  
Adjust pH to 7.4 with HCl 
Add deionised water to 1000 ml 
 
10x Surveyor Buffer (10 ml): 
100 mM HEPES buffer 10 ml 
KCL    100 mM  
MgSO4   100 mM  
BSA    20 µg  
Triton-x-100   0.02% 
HEPES was made to pH 7.5 and all other ingredients were added to make a 
solution. This was stored at 4 °C and 3 ml was kept at -20°C. 
Protein Loading Buffer (1x) 
NuPageTM LDS sample buffer (4x)  
(Thermo Fisher ScientificTM catalogue no. NP0007)  1/4 total volume 
NuPageTM sample reducing buffer (10x)  
(Thermo Fisher ScientificTM catalogue no. NP0004) 1/10  total volume  
Deionised water to total volume  
Ip lysis buffer 
Tris-HCl pH 7.5  50 mM (from 1 M solution) 
NaCl                  100 mM (from 5 M solution) 
Glycerol             10%     (from 100%) 
EDTA                 0.5 mM (from 500 mM solution) 
IGEPAL              0.5%    (from 10% stock) 
Add HALT protease inhibitor (1/100) fresh to lysis buffer. 
IP wash buffer 1 
Tris-HCl pH 7.5  50 mM (from 1 M solution) 
NaCl                  100 mM (from 5 M solution) 
Glycerol             10%     (from 100%) 
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EDTA  0.5 mM (from 500 mM solution) 
IGEPAL  0.5%   (from 10% stock) 
IP wash buffer 2 
Tris-HCl pH 7.5 50 mM (from 1 M solution) 
NaCl      100 mM (from 5 M solution) 
Glycerol       10%     (from 100%) 
EDTA      0.5 mM (from 500 mM solution) 
IGEPAL       0.2%    (from 10% stock) 
IP wash buffer 
Tris-HCl pH 7.5 50 mM (from 1 M solution) 
NaCl      100 mM (from 5 M solution) 
Glycerol       10%     (from 100%) 
EDTA      0.5 mM (from 500 mM solution) 
Smashing buffer (1x) 
Tris-HCl (pH 8.2)  10 mM 
NaCl   25 mM 
EDTA   1 mM 
Triton x100 0.2% (v/v) 
Just before use, dilute Proteinase K into buffer at 200 ug/mL 
2.18.2 Bacterial solutions 
Luria-Bertani Broth (LB) (1000 ml): 
Tryptone 10.00 g 
Yeast Extract 5.00 g 
NaCl 10.00 g 
Glucose 1.00 g 
Add deionised water to 1000 ml 
Add Ampicillin (100 μg/ml) or Kanamycin (50 μg/ml) 
Freezing Media: 




LB-Agar (1000 ml): 
Tryptone 10g 
Yeast Extract 5 g 
NaCl 10 g 
Glucose 1 g 
Agar 15 g 
Add deionised water to 1000 ml 
Add Ampicillin (100 μg/ml) or Kanamycin (50 μg/ml) as required 
2.18.3  Tissue culture solutions 
MEF Growth Media (500ml): 
Opti-MEM (Thermo FisherTM catalogue no.31985070)  445 ml 
FCS            50 ml 
P/S              5 ml 
KSFM mTEC proliferation media (500 ml): 
KSFM (GibcoTM catalogue no. 17005034)        491 ml 
P/S            5 ml 
EGF (PeprotechTM catalogue no. 315-09)                      2.5 ml  
BPE (GibcoTM catalogue no. 13028014)        1 ml 
Isoproterenol (SigmaTM catalogue no. I-6504)       500 µl 
Add fresh to aliquots when used: 
Y-27632 1 in 1000 dilution (Cayman ChemicalTM catalogue no. 10005583) 
DAPT 1 in 1000 dilution (Sigma AldrichTM catalogue no. D5942) 
mTEC dissociation buffer (50 ml): 
EDTA 0.5 M          270 µl 
Trypsin           125 mg 
Non-enzymatic 1x (Sigma) to make 50 ml                    49.73 ml 
Filter sterilise with 0.22 um filter. 
Final concentrations: 0.25% Trypsin and 2.7 mM EDTA 
Store at 4 °C 
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Freezing media (1000 ml): 
Ham’s F10 (Thermo Fisher ScientificTM catalogue no. 31550)           480 ml 
Tryptose Phosphate Broth (Sigma-AldrichTM catalogue no.  T8159)  400 ml 


























3 The design and testing of a high throughput endogenous 
axonemal dynein tagging strategy for in vivo analysis 
3.1 Introduction 
3.1.1 Axonemal dynein assembly, regulation and challenges to study 
Axonemal dyneins (ADs), as introduced in Section 1.2.1, are large molecular 
complexes responsible for the movement of motile cilia and flagella. While a lot is 
understood about how these molecular machines function from work in model 
organisms (reviewed (Dutcher 1995; Luck 1984)) and by studying people with 
diseases of motile cilia (Afzelius and Stenram 2006) there are still many 
unanswered questions. ADs are assembled in the cytoplasm with the help of 
several assembly factors (Fowkes and Mitchell 1998), which recruit chaperoning 
proteins to sites of dynein assembly (Diggle et al. 2014; Dong et al. 2014). To date, 
most studies on AD assembly and function rely on antibody detection in fixed 
samples, and while these are able to provide a snapshot of AD localisation in motile 
ciliated cells, they do not convey the temporal information that is important for 
understanding how ADs are regulated. Therefore, being able to follow AD 
localisation over time, for example during motile ciliogenesis, is of great value in 
helping to understand how these molecular machines are made, regulated and 
turned over. Transiently expressing cDNAs with functional protein tags has been 
the standard method used to study many biological processes, including AD 
assembly (Mali et al. 2018; Kobayashi et al. 2017). However, the ADs are only 
expressed in a few motile ciliated cell types which are not easily transfected or 
cultured. Therefore endogenous tagging in vivo is necessary to investigate AD 
localisation in a dynamic and relevant system. While fluorescently tagged ADs do 
exist, expressed both endogenously (McGrath et al. 2003) and from ectopic 
genomic sites (Diggle et al. 2014), there are many more genes which remain 
untagged. The recent emergence of precise genome editing tools mean it is now 
much easier to tag genes endogenously, opening up a path to a better 
understanding of complex biological processes in their physiological contexts. 
3.1.2 Endogenous tagging strategies 
In order to investigate the dynamics and regulation of AD proteins endogenous 
tagging was employed. The ability to integrate protein tags into a locus of choice 
has been greatly aided by the recent development of easy-to-use genome editing 
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tools, such as CRISPR/Cas9.  Many different strategies to endogenously tag 
genes of interest using CRISPR/Cas9 have been developed utilising different 
endogenous DNA repair pathways. The traditional method of genetic engineering 
requires the tag to be flanked by long stretches of sequence homologous to the 
targeted locus. Both single stranded and double stranded templates (Mali et al. 
2013) have been used for this type of homology directed repair (HDR) to introduce 
changes in mammalian genomes. Although recent work has shown that long single 
stranded DNA is an effective template for endogenous tagging with larger 
insertions in mouse embryos (Quadros et al. 2017), in general, single stranded 
repair templates tend to be more suitable for shorter tags such as HA or V5 due to 
the difficulty and expense of synthesising long single stranded DNA.  
While HDR is a well proven method for the insertion of a tag into the genomes of 
whole organisms and cells it either requires lengthy generation of double stranded 
homology arms or costly synthesis of single stranded DNA. Therefore methods of 
endogenous tagging have been developed that utilise the homology independent 
DNA repair pathways, non-homologous end joining (NHEJ) (Auer et al. 2014) and 
micro-homology mediated end joining (MMEJ) (Nakade et al. 2014). The main 
advantages of these approaches are the aforementioned savings on time and cost 
and the fact that mammals suppress homologous recombination in the G1 phase 
of the cell cycle (Orthwein et al. 2015). Without the constraints of homology arms 
a single tagging vector can be used to tag any gene within the genome and in any 
place where a guide sequence is present, significantly reducing the amount of time 
and resources needed to create a library of tagged genes. For these reasons the 
generic NHEJ tagging system (Lackner et al. 2015) is the strategy employed in this 
project for the tagging of AD proteins in Drosophila melanogaster, see Section 
3.2.1 and Figure 3.1.  
3.1.3 Adaptable protein tags 
In order to study AD assembly and regulation in detail, high temporal and spatial 
resolution of the underlying processes is required. Ideally it would be possible to 
follow the known components of ADs over time in a live cell and uncover their 
localisation, their turnover rate and what they are interacting with from their 
synthesis to their degradation. A first step to achieving this goal is to directly label 
the proteins of interest. While fluorescent protein tags such as GFP provide a way 
to visualise the protein of interest in live cells and have been used for a long time, 
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they do not offer flexibility of function. In recent years modular tagging systems 
have been developed, in which the protein tag binds covalently to substrates linked 
to a variety of moieties including fluorescent dyes, magnetic beads and biotin. 
Examples include the HALO-tag (Los et al. 2008), SNAP tag (Keppler et al. 2003) 
and CLIP tag (Gautier et al. 2008). A slightly different modular tagging system 
involves the use of  activatable biarsenical fluorescent dyes, such as FlASH 
(Griffin, Adams, and Tsien 1998), CrASH (Cao et al. 2006), CHoXAsH, ReASH 
(Adams et al. 2002) and AsCy3 (Cao et al. 2007), which fluoresce when bound to 
a tetracysteine tag sequence. The SNAP tag was chosen for this project because 
of its small size, 19.4 kDa, making it less likely to be disruptive and reducing the 
size of the tagging vector. It has also been used extensively for various purposes, 
particularly imaging at high resolution, reviewed in (Kolberg et al. 2013), and can 
be used alongside the CLIP tag with very similar reagents for imaging experiments 
involving two tagged proteins. The SNAP tag is a modified human O6-alkylguanine-
DNA alkyltransferase (AGT) which irreversibly binds to O6-benzylguanine (Keppler 
et al. 2003). The O6-benzylguanine group is easily synthesised and can be 
attached to a multitude of fluorescent dyes, creating a greatly expanded repertoire 
of potential fluorescent labels for in vivo use. The O6-benzylguanine group can also 
be attached to a variety of other substrates including biotin and magnetic beads 
allowing the SNAP tag to be the ‘Swiss Army knife’ of protein tags, see the diagram 
in Figure 3.1 A). The ability to sequentially add dyes of different colours makes it 
possible to observe the dynamics of protein turnover and localisation over a wide 
range of time periods, Figure 3.1 B). With a library of SNAP tagged ADs it would 
be possible to study AD assembly in the cytoplasm, visualise exactly when the ADs 
enter the cilium during differentiation and determine turnover rates at the motile 
axoneme. 
3.2 A generic tagging strategy to produce a library of SNAP tagged 
axonemal dynein proteins 
In order to generate a library of AD proteins and assembly factors, of which there 
are 18 genes and 7 genes in humans, respectively, a high-throughput method 
needs to be considered. To circumvent the challenges presented by the large size 
of the ADs and the need to study primary motile ciliated cells, we pursued a 
strategy of endogenous tagging (Lackner et al. 2015). The generic tagging 
strategy, Figure 3.1 C), consists of a plasmid encoding sgRNA targeting the 
zebrafish gene tia1l under the control of the human U6 promoter and the tag 
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flanked by recognition sites for the tia1l sgRNA upstream of a PAM site. This 
plasmid is co-transfected into cells with a plasmid expressing Cas9 nuclease and 
a sgRNA recognising the target site within the cell’s genome. Upon Cas9 
expression, the tagging plasmid is cut, releasing the tag sequence and cutting the 
genome at the desired site, resulting in simultaneous double stranded DNA breaks 
and allowing the tagged sequence to be integrated into the genome via NHEJ. The 
lack of homology means that the tag can be integrated in either orientation and that 
the genomic cut site must be in a coding region to work. This necessitates the 
creation of plasmids in different reading frames and careful screening to ensure 
functional tagging. However, the tagging vector can be used for any gene and due 
to the facile nature of the cloning protocol it’s possible to generate many plasmids 
with different tags relatively quickly.  
The aim of endogenously tagging multiple ADs for in vivo study requires the use 
of many animals, and while the main focus of this project is in understanding AD 
regulation in the context of mammalian biology and human disease, mammalian 
animal models are slow to generate and expensive to maintain. It is more 
economical and practical to perform initial pilot experiments in non-mammalian 
animal models, such as Drosophila melanogaster, which breed more quickly and 
are relatively cheap to maintain. Drosophila and humans have many orthologous 
AD and motile cilia genes, despite Drosophila only having two motile ciliated cell 
types, making them good models for motile cilia biology and well suited to PCD 
candidate gene screening (zur Lage, Newton, and Jarman 2019). The initial 
tagging screen, conducted in collaboration with Prof. Andrew Jarman and outlined 
in Figure 3.1 D), aimed to tag multiple Drosophila AD proteins at different locations 
with SNAP. These could be quickly screened for tag functionality by imaging with 
fluorescent SNAP dyes. Non-disruptive tagging can be confirmed in homozygous 
flies by a gravitaxis assay, a test of chordotonal neuron function which is disrupted 
by defects in the motile ciliary machinery. Once established as a viable fusion 
protein in the Drosophila model the orthologous gene in mice would be targeted 
and tagged at the same end with SNAP for further analysis. This approach would 
create multiple SNAP AD fusion lines in flies, which could be used for biochemical 
and imaging studies to address AD localisation and stability, as well as detection 
of novel interacting partners. Importantly, they would also provide valuable 
information about which genes, and where in the gene, would be the best targets 
for SNAP tagging and analysis in mice.  




Figure 3.1 Universal SNAP tagging strategy
A) The SNAP tag (pie shape) covalently binds to benzyl-guanine (black triangle),
which can itself be linked to fluorescent dyes, biotin adapters or magnetic beads.
B) The SNAP tag can be used to identify newly translated protein by adding a dye in
one colour, washing it out and adding a dye in another colour. The second dye will
label only those proteins produced after the 1st dye was washed out.
C) The generic tagging strategy utilises two plasmids, the one shown encodes a guide
RNA which cleaves the tag from the plasmid when it is co-transfected with another
plasmid expressing Cas9 (scissors) and a guide targeting the gene of interest. This
results in the tag being released from the plasmid at the same time that the gene is
cut, allowing the tag to integrate at the DSB with NHEJ.
D) The aim is to use this generic strategy to tag multiple dynein genes with SNAP in
flies. This would serve to build up a library of tagged genes in Drosophila and also
to screen for functional SNAP-dynein fusion proteins, which would indicate which 
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3.3 Testing the feasibility of creating a library of SNAP-tagged axonemal 
dyneins in Drosophila 
The SNAP tag was cloned into the generic tagging vector with a flexible N-terminal 
linker and used to tag Pericentriolar Material 1 (PCM1) in Flp-In T-REx HEK 293 
cells. This was to test the SNAP tag with equipment and reagents previously 
validated in the lab and to check that the generic tagging strategy would work for 
the purposes of endogenous insertion of SNAP. PCM1 is the core structural 
component of centriolar satellites, protein rich particles that surround the centrioles 
(Kubo et al. 1999). It was chosen as the test case because it was already known 
that PCM1 was able to tolerate a SNAP tag in mice and the cell line would be useful 
for experiments being conducted by others. HEK 293 cells were chosen because 
they were readily available and easy to transfect with plasmid DNA.  
Guide RNA sequences were designed that targeted exons 2, 3, 38 and 39 and 
these were then cloned into an S. p. Cas9 expressing vector, pX330. The cells 
were transfected with the guide plasmids and the SNAP tag in the generic tagging 
vector in either a +1 frame or a +2 frame depending on where the predicted cut 
site was. After transfection the cells were screened for insertion of the SNAP tag 
using PCR, Figure 3.2 A). The cells from the exon 2 transfection did not yield 
enough DNA for PCR, however of the 3 tested populations it appeared that the 
SNAP tag had been inserted at a detectable level into PCM1 in exons 3 and 39, 
with exon 3 having the stronger band. Therefore this population was then diluted 
and seeded into wells such that each well contained 1-3 cells. This was to increase 
the number of SNAP positive cells to make imaging easier to optimise. These 
colonies of SNAP-PCM1 cells were screened with PCR to find the clonal 
population with the correct insertion. A quick lysis method was used to extract DNA 
from the colonies, which were then screened by PCRs (data not shown). The 
colonies which returned positive bands for the SNAP insertion were then grown on 
and DNA was extracted from them for further characterisation. The cells were 
screened by PCRs that amplified from SNAP upstream, from SNAP downstream 
and across the insertion site, shown in Figure 3.2 B). Doing this showed that only 
one colony seemed to have PCR products of the correct size, colony 52, although 
other bands were observed. This is likely due to concatemers of SNAP being 
inserted at other alleles in the same cell or in other cells, similarly smaller bands 
could be the result of deletions 
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These cells were then further characterised by immunoprecipitation with the anti-
SNAP antibody and blotting with anti-PCM1, Figure 3.3 A). The band for PCM1, 
around 260 kDa, in the sample immune-precipitated with anti-SNAP from colony 
52 cells was stronger than that in the wild type immunoprecipitation, indicating that 
endogenous SNAP-PCM1 is expressed in these cells. SNAP dye was also added 
to the lysate before incubating with anti-SNAP, however no fluorescent band could 
be seen (data not shown), this suggests that either the lysis denatured the protein 
or that the fluorescence was too weak to be detected, see Section 4.5 for 
discussion.  
The cells were also imaged using the cell permeable SNAP dye SNAP-cell SiR-
647, Figure 3.3 B). This initially did not work in the pool of cells, however with 
optimisation of the protocol clusters of PCM1 could be observed in the cytoplasm 
of colony 52. The staining is consistent with centriolar satellite localisation, as 
published for PCM1 (Kubo et al. 1999). This demonstrates that the generic tagging 
system is suitable for the integration of SNAP into endogenous loci and that SNAP 
can be used for live cell imaging. 
A)
C)
Figure 3.2 PCR screening for SNAP insertion into PCM1
A) Schematic showing the exon structure of PCM1 and where the guide RNA targets 
are. The PCRs used to screen for SNAP insertion are also shown, PCR 1 amplifies 
from PCM1 into the 5’ end of SNAP, PCR 2 amplifies from the 3’ end of SNAP to 
PCM1 and PCR 3 spans the insertion site, the same SNAP primer (R) was used 
for PCRs of all three exons, expected product sizes with insertion are indicated.
B) The gel shows PCRs of DNA from transfected HEK293 cells, PCR 1 was 
used for all exons the expected sizes are 329, 341 and 435 bp for exons 3, 38 
and 39, respectively. There was no DNA from the exon 2 targeted transfection.
C) These gels show PCRs 1, 2 and 3 of exon 3 from single, double and triple cell col-
onies, the numbers denote the colony. SNAP to PCM1 PCR 2 gives an expected band 
size of 198 bp. Spanning PCR 3 gives an expected band size of 785 bp with SNAP, 
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Figure 3.3 Integrating the SNAP tag into PCM1 
A) Lysed HEK 293 cells from SNAP PCR positive and negative colonies with either
SNAP-cell 647-SiR added or not were pulled down with the anti-SNAP antibody and
were blotted with anti-PCM1 antibody on western blots.The band corresponding to
PCM1 is indicated by the black arrow.
B) HEK 293 cells were incubated with SNAP-Cell 647-SiR (magenta) and Hoescht
(blue) for imaging. The images show the accumulation of tagged PCM1 in large punc-
ta near the nucleus, which is consistent with centriolar satellite localisation. Not every
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After establishing the effectiveness of the generic tagging vector and the cell 
permeable SNAP dyes in mammalian cells, further proof of principle studies were 
conducted in Drosophila. CG6971, an orthologue of the human Dynein Axonemal 
Light Intermediate chain 1 (DNALI1), was targeted for SNAP tagging at the C 
terminus because it was already known to be functional with a C terminal mVenus 
fusion (Diggle et al. 2014). Additionally an endogenously expressed SNAP 
CG6971 or Dnali1 in mouse would be a useful tool for the study of AD regulation 
and assembly. Two guides were designed to target the C terminus of CG6971, to 
optimise the chance of a successfully tagged gene. The guides were tested against 
PCRs from the C terminus of CG6971 by in vitro digestion, this showed that both 
guides were very active in their ability to cut at the required sites with guide C2 
being slightly more efficient, shown in Figure 3.4 A).  Injections into fly embryos 
were attempted with guides expressed from plasmids and with RNA and Cas9 
protein mixed with the SNAP tagging plasmids. Embryos were allowed to gestate 
for 24 hours and then were screened for insertion of SNAP by PCR, Figure 3.4 B), 
injections and screening were conducted in collaboration with Dr. Petra zur Lage 
(Dr. A. Jarman lab University of Edinburgh). Despite PCRs spanning the tagging 
site producing a product of the correct size for SNAP insertion subsequent PCRs 
for the tag and sequencing showed the tagging to be unsuccessful, suggesting that 
the large product produced could have been the result of aberrant amplification. 
No editing could be detected when a selection of injected embryos were screened 
using PCR to amplify over the edited region and were digested with the Surveyor 
nuclease to detect mismatched bases introduced by Cas9 editing, Figure 3.4 C). 
This suggests the CRISPR/Cas9 activity at the targeted region was inefficient in 




Figure 3.4 Testing guides for endogenous tagging in the fly
A) The gel shows that digestion of a PCR product from the C terminus of the CG6971
gene is possible with either guide C1 or C2, however C2 would appear to be more
efficient. The expected sizes of the digest are 224 bp and 42 bp for guide C1 and 206
bp and 60 bp for guide C2. The control lanes contain either the PCR DNA with no
guide or the guides without the DNA.
B) DNA extracted from injected embryos was used for PCR to amplify over the inser-
tion site, all embryos injected with guide C1 are labelled with C1 and those injected
with C2 are labelled with C2. E3 is an uninjected embryo control and H2O had water
added as a template as a negative control. The expected band sizes are 266 bp with-
out the SNAP insertion and 854 bp with.
C) Surveyor digest of 3 fly embryos either injected with guide C1 (C1-9) or guide C2
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By creating an extensive library of tagged AD proteins it was hoped that the 
fundamental biology of their assembly and regulation could be teased apart in the 
fly model and that successful tagging candidates would be prioritised for more 
detailed analysis in mice. However, despite successfully demonstrating that the 
strategy would work well within a human cell line it appears to be incompatible or 
at least much more difficult to implement in the intended Drosophila model. There 
are many reasons why a CRISPR/Cas9 based tagging strategy designed for 
immortalised human cell lines may not work in another organism. 
First and most fundamentally the two species are separated by 782.7 million years 
of evolution, when their most recent common ancestor existed, and humans have 
homologues to only 14.9% of Drosophila genes (Shih, Hodge, and Andrade-
Navarro 2015; Hedges, Dudley, and Kumar 2006). These differences likely 
contributed to the failure of SNAP tagging in the targeted genes, potentially due to 
the promoters used being sub-optimal for expression in flies. The guide RNAs used 
were expressed under the control of the human U6 promoter. The U6 promoter is 
responsible for controlling the expression of Small Nuclear RNA U6, an important 
structural component of the U6 small nuclear ribonucleoprotein splicing complex 
which is conserved amongst most eukaryotes (Brow and Guthrie 1988). There is 
evidence of expression of small inhibitory RNA from human U6 and Drosophila U6 
at equal levels in Trichoplusia ni insect cells (Kim et al. 2012), suggesting that there 
might be enough conservation between the two promoters to allow for expression 
in the distantly related D. melanogaster. Despite this, there is no published record 
for the use of the human U6 promoter in Drosophila, with most studies preferring 
to use one of the three Drosophila encoded U6 promoters. Even within these 
promoters there appears to be wide variation in the levels of guide RNA expression 
(Port et al. 2014). Therefore the guide RNA is unlikely to be expressed at as high 
a level with human U6 promoter as if it were under the control of one of the 
Drosophila U6 promoters. The levels of guide RNA expression and Cas9 editing 
could be enhanced by using a system which has been optimised for use in flies. 
Another way to avoid sub-optimal expression of guides and Cas9 nuclease is to 
add the editing complexes as ribonucleoproteins, obviating the need for promoters. 
This was attempted with C2 guide RNA and tia1l guide RNA for SNAP tagging, 
however again no tag insertion was detected (data not available). This could be 
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due to cleavage of the tagging plasmid before injection into the embryo resulting 
in linearised DNA being injected with the editing complexes targeted to the gene. 
Linear DNA was shown to be unable to integrate in the original publication of the 
generic tagging system (Lackner et al. 2015).  
It is also a possibility that the DNA repair mechanisms in Drosophila do not allow 
for the incorporation of exogenous DNA by NHEJ, potentially another consequence 
of divergence between humans and flies. However, the lack of editing observed 
with the Surveyor nuclease assay points towards poor expression of the editing 
complexes as the cause of the failure to tag CG6971. To improve this a Drosophila 
line which constitutively expresses Cas9 could be used as well as the endogenous 
U6:3 promoter for guide expression, both of which have been shown to boost 
editing to up to 100% (Port et al. 2014). The addition of an easily identifiable 
selection marker, such as the mini-white gene (Roseman, Pirrotta, and Geyer 
1993), would also vastly decrease the time taken to screen for the rare insertion of 
SNAP. Given these technical hurdles it was decided that the initial tagging of AD 
genes in flies would be bypassed and that instead the mouse genes would be 
targeted directly. 
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4 Generation and validation of a novel SNAP-Dnah5 mouse 
line to study of mammalian axonemal dynein regulation. 
4.1 Introduction 
4.1.1 Axonemal dynein heavy chains: subtle variations between giants. 
Axonemal dyneins (ADs) are large and molecularly complex motors up to 2 
megadaltons in size, with a variety of subunits that can be incorporated. The largest 
of these subunits are the heavy chains, which contain six AAA ATPase domains 
and in humans are as long as 4624 residues, as introduced in Section 1.2.1.3. 
There are seventeen classes of dynein heavy chain proteins across all phyla and 
ten in humans; despite this diversity they have high structural conservation 
(Kollmar 2016). Yet differences exist in which cell types as well as in what part of 
the axoneme the various AD heavy chains can be found, suggesting that each 
heavy chain has a distinct function.  For example, it has been shown that the β 
Outer Arm Dynein (OAD) heavy chains DNAH11 and DNAH9 have distinct 
proximal and distal, respectively, localisations along the motile axonemes of multi-
ciliated respiratory cells, and cannot functionally substitute for one another as 
shown in dyskinetic cilia from patients with pathogenic mutations in either gene 
(Dougherty et al. 2016; Loges et al. 2018; Fassad, Shoemark, Legendre, et al. 
2018). In contrast, DNAH5, their partner heavy chain in the ODA, is localised along 
the entire axoneme (Oltean et al. 2018; Dougherty et al. 2016). How these 
molecularly defined boundaries are established is not clear and moreover may vary 
between cell types. For example, DNAH11 is expressed along the full length of the 
axoneme of embryonic node monocilia (McGrath et al. 2003). Clear tissue specific 
paralogues also exist; mammalian DNAH9 and DNAH11 are not expressed in 
sperm (Mali et al. 2018) whilst DNAH17 is, causing male infertility when mutated 
(Whitfield et al 2019). Given the variety of ways in which different types of cilia 
move across these cell types, it is likely that these different heavy chains are 
responsible for altering the frequency, direction and/or the waveform of the beating 
cilia in mammals as they do in single celled flagellates (Brokaw and Kamiya 1987; 
Edwards et al. 2018). This suggests that the cell is able to alter the movement of 
cilia by docking different dynein arms in a modular fashion.  
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4.1.2 Axonemal dynein docking. 
Although this process is clearly regulated, very little is known about what 
determines which AD is docked where in the cilium and how this is controlled. It 
has been shown that ADs dock at the assembling ciliary tip in Chlamydomonas 
reinhardtii (Viswanadha et al. 2014) and in Trypanosoma brucei (Georgikou et al. 
2017) and that in Trypanosoma  there is very little turnover of these proteins. It has 
also been heavily implied that this mechanism of AD docking is highly conserved 
and active in mammals (Oltean et al. 2018). While most axonemal proteins dock 
at the growing tip Inner Dynein Arm (IDA) complexes I2 and I3 were shown to be 
proximally localised and to dock only in the final stage of ciliary growth in 
Chlamydomonas (Piperno and Ramanis 1991). This demonstrates that the spatial 
separation of different AD complexes is not restricted to mammals. 
Chlamydomonas have also been used to show that there are differences in how 
ODAs and IDAs dock in dikaryon rescue experiments, with ODAs seemingly 
docking along the entire length of the axoneme and IDAs docking from only the tip 
of the axoneme (Piperno, Mead, and Henderson 1996; Dai et al. 2018; 
Viswanadha et al. 2014). While this type of rescue experiment may not be 
physiologically relevant it does indicate that mature axonemes can still 
accommodate new ADs. It has also been shown that the ADs are replaced in the 
mature axonemes of Chlamydomonas (Dai et al. 2018) and sea urchin embryos 
(Stephens 1997), although not in T. brucei (Georgikou et al. 2017). 
The study of axonemal docking lags behind in mammals, where there has been no 
direct observation of AD docking at the ciliary tip or any investigation into AD 
turnover in the mature cilium. This is mainly due to the lack of genetic tools, such 
as temperature sensitive mutants and inducible fluorescently tagged AD genes. 
This was the reasoning behind the creation of the SNAP-Dnah5 mouse line, which 
would allow AD complexes to be tracked over time and space giving valuable 
insights into how they are regulated, in healthy and diseased cell types. 
4.1.3 Cytoplasmic axonemal dynein assembly. 
Individual AD subunits are assembled to form their quaternary complexes in the 
cytoplasm (Fok et al. 1994) and it is assumed that there are shared regulatory 
pathways to enable this (Desai, Dean, and Mitchell 2017). However, there is also 
evidence that there might be a specialised assembly pathway for some of the AD 
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components, especially the heavy chains. It has been shown that several dynein 
axonemal assembly factors are important for the stability of heavy chains in 
particular (Omran et al. 2008; Moore et al. 2013; Mitchison et al. 2012; Patel-King 
et al. 2019). The increased number of heavy chain specific co-chaperones could 
be due to the length and complexity of these proteins in comparison to the smaller 
intermediate and light chains. It has been shown that longer proteins often require 
more chaperones (Gong et al. 2009). They also take longer to translate making 
them more prone to misfolding, therefore they often require co-translational folding 
and assembly. It’s been shown that co-translational folding and assembly is a 
process common to large or complex molecular assemblies (Kamenova et al. 
2019). It’s possible that ADs, large molecular complexes themselves, are also co-
translationally assembled and this happens in assembly factories. The presence 
of high concentrations of chaperones and assembly factors in phase separated 
particles with intermediate and intermediate light chain AD proteins suggests that 
these factories may exist to aid in the assembly of large macromolecular 
complexes (Huizar et al. 2018). However, it has not been shown whether the heavy 
chains also localise to these so-called dynein assembly particles (DynAPs) and 
whether there is translational regulation of any of the AD subunits. Interestingly, 
the closely related cytoplasmic dynein heavy chain protein DYNC1H1 is found in 
moving translational factories (Pichon et al. 2016), which suggests that AD heavy 
chains could also undergo localised translation. The DynAPs also contain dynein 
assembly factors ZMYND10 and HEATR2, which have been shown to be important 
for the stability of heavy chain AD proteins, suggesting that the heavy chain 
dyneins also localise to these assembly particles (Mali et al. 2018, Huizar et al. 
2018). To determine whether the heavy chains are translated at these particles 
requires tracking where the heavy chain AD proteins are translated and what the 
candidate heavy chain mRNA is interacting with. 
4.2 Creation and characterisation of the SNAP-Dnah5 mouse line. 
As explained in Chapter 3 the decision was taken to bypass the creation of a library 
of tagged ADs in Drosophila and to instead focus on targeting a mouse AD directly, 
obviating the need for a high throughput tagging method. Dynein Axonemal Heavy 
Chain 5 (Dnah5) was chosen as the target for fusion with the SNAP tag. Dnah5 is 
the largest of the mammalian AD heavy chains and is a class 3 (γ OAD in 
Chlamydomonas) ODA component (Kollmar 2016). It is also the most commonly 
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mutated gene in PCD, resulting in ODA defects and loss of ciliary motility (Hornef 
et al. 2006; Davis et al. 2019). It was chosen because it is widely expressed in 
motile ciliated tissues, aside from sperm flagella, (Olbrich et al. 2002, Mali et al. 
2018) and along the entire length of the axoneme (Oltean et al. 2018; Dougherty 
et al. 2016), making it useful as a fluorescent reporter of rescue in development of 
therapeutics for PCD, including genome editing. It is also a powerful tool to study 
fundamental mechanisms of AD biology like turnover and proteostasis.  
Guide sequences were designed to target the N-terminus of Dnah5, because the 
N-terminal tail is unstructured (Kollmar 2016) and the N terminus of the closely 
related mouse Dnah11 has already been functionally tagged with GFP (McGrath 
et al. 2003). Three guide sequences were designed that targeted downstream of 
the start codon in the 1st exon of Dnah5, these were tested in vitro against a PCR 
amplified region of Dnah5 containing exon 1, see Figure 4.1 A) and B). The guide 
named Dnah5 N2 was the most efficient and was used to design a repair template 
to insert the SNAP tag into the 1st exon of Dnah5. The repair template consisted of 
a plasmid with ~800 bp of homology up and down stream of the SNAP tag insertion 
site between the last two codons of exon 1, as shown in Figure 4.1 B). This was 
injected, by Margaret Keighren (Dr. P. Mill Lab University of Edinburgh), as plasmid 
DNA into mouse embryos with guide Dnah5 N2 and Cas9 nuclease protein, as 
diagrammed in Figure 4.1 C). After three rounds of injections, 23 mice were born 
and screened by PCRs, which flanked the site of the SNAP insertion, two of these 
mice had the tag inserted. However, only one mouse, shown in the gel in Figure 
4.1 D), was taken forward for further experiments because the other mouse had 
multiple bands from the PCR, suggesting potential mosaicism (data not shown).  
While the mouse chosen appeared to produce a slightly larger PCR product than 
the plasmid control it was of the expected size for an insertion of SNAP at the locus. 
The smaller bands produced by some of the founders could be due to homozygous 
deletions in Dnah5, but as multiple mutant alleles in Dnah5 in mice have already 
been reported to result in a PCD-like phenotype (Tan et al. 2007), these animals 
were not kept for breeding.  
The founder mouse, 1394, was sequenced outside the homology arms and 
analysis focused on the SNAP tag insertion site. Unexpectedly, the animal had 
altered sequence around both N- and C-termini junctions of the tag with exon 1, as 
shown in Figure 4.2 A) and B). The changes in sequence resulted in the deletion 
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of one and the substitution of four amino acids from either end of the SNAP tag 
exon 1 fusion. While this was not expected or ideal, the alterations were not 
predicted to be detrimental to the activity or stability of the tagged protein, as 
determined by their positions in the protein (Mollwitz et al. 2012). Meanwhile, the 
founder had already been bred with wild type females to produce heterozygous 
offspring. To show that the SNAP-DNAH5 protein was stably expressed tracheal 
lysates were isolated from these offspring and treated with SNAP-cell SiR-647 
fluorescent dye before being immunoprecipitated with an anti-SNAP antibody. The 
lysates were then run in a denaturing polyacrylamide gel and imaged for 
fluorescence, however no fluorescence could be detected. The gels were then 
blotted with anti-SNAP antibody, samples corresponding to the mice with the 
SNAP tag insertion showed a correctly sized high molecular weight band whereas 
the wild type littermates did not. The blots were also analysed using anti-DNAH5 
(gift from Dr. H. Takeda, University of Tokyo) antibody and an enrichment in the 
SNAP-Dnah5 mouse IP was seen but not in the wild type mice, Figure 4.2 C). 
Given the high molecular weights of both native DNAH5 (529 kDa) and SNAP-
DNAH5 (547 kDa), it was not possible to discern size differences in heterozygous 
samples. Together, this showed that the SNAP-DNAH5 protein is stably expressed 
















Figure 4.1 Mouse injection and founder PCRs
A) In vitro digest of a PCR product from the 1st exon of mouse Dnah5 shows that
while all three guide RNAs were capable of cutting N1 and N2 seemed to be the more
efficient. Therefore guide N2 was selected as the Dnah5 targeting guide to be used
for tagging.
B) Cartoon 1 shows the cut site for guide N2 at the start of intron 1, underneath is
the repair template (2) with the length of the homology arms. The position of SNAP in
exon 1 of Dnah5  is shown (3) with the lengths of the exon and intron included.
C) The schematic shows how the SNAP-DNAH5 mouse was generated by injection
of a repair plasmid (2). This was injected into mouse zygotes with Cas9 nuclease and
Dnah5 N2 RNA in a complex. The zygotes were implanted into mice and the resultant
offspring were the F0 founder generation. This was done by M. Keighren (P. Mill lab
UoE).
D) These F0 mice were genotyped using a PCR that spanned the cut site and pro-
duced a band of 842 bp if the tag was present and a band of 249 bp if it was absent.
The plasmid lane is the positive control, which seems to migrate lower than the ex-
pected size (blue line). The results show that founder 1394 is likely to have the SNAP
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Blotted with anti-SNAP tag Blotted with anti-Dnah5
~550 kDa-
Figure 4.2 Sequence alignment and immunoblotting of Dnah5 Snap/+ mice.
A) Sequencing of the 5’ junction of the SNAP tag inserted into Dnah5, red boxed
region of the diagram above, showed that there was a deletion of 1 amino acid and
changes to 4 others. The alignment shows the correct sequence at the top and the ac-
tual sequence underneath, the pink bar is the SNAP tag coding region and the orange
bar is the coding region of exon 1. Altered bases are highlighted in red.
B) Sequencing of the 3’ end of the SNAP tag junction, red boxed area, showed that
there was a loss of 1 amino acid and 5 amino acid changes.
C) Using the anti-SNAP tag antibody for immunoprecipitation from Dnah5 SNAP/+ trache-
al lysates shows that they have a protein (boxed area) recognised by the anti-SNAP
tag antibody which the Dnah5 +/+ do not. The band corresponds to one created by
blotting the immunoblot with anti-DNAH5 antibody. This band is not present in the IP
lane of Dnah5 +/+  mice. Input is 10% of the total lysate used for pulldown.
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SNAP tag
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After establishing that the SNAP-Dnah5 mice expressed SNAP tagged DNAH5 in 
the correct organ they were bred to homozygosity to test the functionality of SNAP-
DNAH5. The primary reason for using the SNAP tag is for imaging DNAH5 
dynamics, as such it was important to verify that the SNAP tag bound to the 
fluorescent dyes and that the fluorescence localised to the axoneme of motile 
ciliated cells. To test whether this was the case, mouse tracheal epithelial cells 
(mTECs) were cultured from the SNAP-Dnah5 mice. These were then incubated 
with SNAP-cell SiR-647 cell permeable dye before being fixed and stained with 
antibodies for DNAI2 and the SNAP tag. The images shown in Figure 4.3 A) 
demonstrate that the SNAP tag antibody co-localises with the SNAP dye and with 
DNAI2 but only in the SNAP-Dnah5 cells. This demonstrates that the tag is 
functional and that the fusion protein is localising to the motile cilia in the tracheal 
epithelia of these mice. In order to further prove that the SNAP tagged DNAH5 is 
fully functional and able to generate full movement in the cilia, the homozygously 
tagged DNAH5 and control mTECs were imaged with high speed video 
microscopy. Selected stills from some of these videos are shown in Figure 4.3 B), 
these videos were then used to calculate the frequency of ciliary beat in these cells. 
By taking ten separate areas of motile ciliated cells and counting the number of 
beats per second in each it was established that the mean beat frequency was not 
statistically significant between the mTECs from the SNAP-Dnah5 mice and wild 
type mice, as shown in the graph in Figure 4.3 C). The axoneme structure of 
homozygous and wild type mTECs was also compared with transmission electron 
microscopy (TEM) of transverse sections as shown in Figure 4.3 D). Analysis of 
multiple sections from three homozygous and three wild type transwells showed 
that there was no significant difference between the number of AD arms between 
the two genotypes, Figure 4.3 D). Furthermore, mice homozygous for SNAP-
Dnah5 do not exhibit PCD-like symptoms, such as hydrocephaly, and are viable. 
This shows that the SNAP-DNAH5 fusion protein retains its ability to drive the 
functional beating of cilia in these mice. 
A)
Dnah5 +/+ Dnah5 SNAP/SNAP
B)
Figure 4.3 Showing SNAP-DNAH5 fusion functionality
A) The images show immunofluorescence of mTECs. The top left panel for each
genotype shows a merge of channels with the anti-DNAI2 antibody (red), anti-SNAP
antibody (green) and SNAP-Cell 647-SiR (magenta).
B) Still images from highspeed brightfield video microscopy of cilia beat in mTECs
from SNAP tagged and wildtype mice (obtained by A. Shoemark UoD).
C) The graph shows that there was no significant diference in the freqeuncy of ciliary
beat between the two genotypes. Unpaired t test (two-tailed) P = 0.5883, error bars =
SD, n = 10 images.
D) TEM of transverse sections through mTEC axonemes, the arrowheads indicate
the ODAs (made and analysed by Dr. A. Shoemark and Dr. F. Daudvohra. R.B.).
E) The graph shows that there was no significant difference in the percentage of cilia
that retained the normal number of IDAs and ODAs between the two genotypes. Un-













4.3 Uncovering the dynamics of mammalian axonemal dynein docking using 
the SNAP-Dnah5 mouse. 
After confirming the non-disruptive and functional tagging of the SNAP-Dnah5 
mouse line, it was used for pulse-chase imaging to investigate the turnover and 
docking of ADs. Although SNAP has been used to look at protein dynamics and 
turnover for many years (Torné et al. 2018; Jansen et al. 2007; Stenoien et al. 
2007), it does not appear that SNAP pulse-chase imaging has been attempted with 
an endogenous tag in primary cells. The main advantage of studying endogenously 
tagged protein dynamics as opposed to overexpression is that the studied protein 
is more likely to have the same rates of turnover and trafficking when expressed 
at the physiologically relevant level. It’s also necessary to have a tag integrated 
into the genome when the protein is expressed in a restricted subset of cells that 
cannot easily be transfected, as is the case for Dnah5. Therefore, the SNAP-
Dnah5 mouse is ideally suited to study AD turnover and protein dynamics in 
mammals. The pulse chase experiment was designed to try and observe whether 
there was turnover of the dynein protein complexes in the motile axoneme, using 
the mTEC system which had previously been optimised for imaging with the cell 
permeable SNAP dyes, Figure 4.3 A). The mTECs were incubated first with 
SNAP-cell SiR-647 for 2 days, the extended incubation time and reduced 
concentration was found to be beneficial for reducing background, then the dye 
was washed off and replaced with SNAP-Cell TMR-Star 7 days later. The long 
chase period is because of the expectation that there would be almost no turnover 
of the AD complexes (Georgikou et al. 2017), therefore to maximise the chances 
of recording turnover a period of a week was left before adding the second dye, 
this procedure is diagrammed in Figure 4.4 A). The potential outcomes for where 
the newly translated AD might dock are also shown in Figure 4.4 A), it’s likely that 
turnover would happen all along the axoneme in mature cilia and that in the 
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Figure 4.4 Tracking DNAH5 over time using SNAP dye pulse imaging
A) The diagram shows the protocol undertaken to investigate protein turnover in cil-
iated mTECs, these cells are proliferated before being airlifted to differentiate them.
The first dye added is SNAP-Cell SiR-647 (magenta) 28 days after airlift and is left
for 2 days before being washed out and is replaced 7 days later with SNAP-Cell
TMR (orange) which is washed off after 2 days. The potential outcomes for where
the newly translated protein is localised are shown, described from left to right these
are; no turnover (no incorporation of new dye), newly translated protein is incorpo-
rated at the tip of the cilia, newly translated protein is incorporated at the base of the
axoneme newly translated protein is incorporated all along the axoneme.
B) Images of mTECs 28 days post airlift, acetylated tubulin stains the axoneme
(green), the 1st dye is SNAP-cell SiR-647 (magenta), 2nd dye is SNAP-cell TMR
(orange). mTECs from Dnah5 +/+ mice shown on the left have no SNAP dye staining
whereas Dnah5 SNAP/SNAP cells are stained mostly with the 1st dye and have variable
incorporation of the 2nd dye. Scale bars are 7 µm.
SNAP-Cell SiR-647 SNAP-Cell SiR-647
SNAP-Cell TMR SNAP-Cell TMR
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The mTECs were 28 days post airlift, a point at which all cells should be fully 
differentiated (You, Richer, Huang 2002; Kubo et al. 2008; Vladar and Brody 2013), 
however it is possible due to culture conditions that the mTECs were not all entirely 
differentiated. This may explain why the images of the pulse-chase mTECs show 
that, while the majority of cilia have very little TMR staining a few cells seem to 
have cilia predominately stained with TMR, Figure 4.4 B). This suggests the cells 
brightly stained with TMR may have still been assembling their mature cilia when 
the first dye was washed out resulting in a small amount of SiR SNAP incorporation 
in the DNAH5 present. However, DNAH5 synthesised after SiR SNAP was washed 
out would be stained with TMR as shown in Figure 4.4 B). As suggested by 
previous studies (Oltean et al. 2018), the newly synthesised ADs appear to dock 
towards the tip of the cilia in mouse tracheal epithelial cells. It also suggests that 
the time taken for a mature cilia to form is longer than expected, as it can be seen 
that the cilia with the TMR stained DNAH5 appear to be shorter than those of the 
neighbouring cell with DNAH5 stained only with the first dye, SiR-647, suggesting 
it is still not fully matured even at the end point of the experiment, as shown in 
Figure 4.5 A).  
Further examination of these images shows that DNAH5 stained with the first dye 
is localised at the bottom of the cilia while the top is predominately stained with the 
second dye, Figure 4.5 A). The total length of the axoneme populated by the newly 
translated DNAH5 was measured for each of the cilia in two cells which had 
predominately TMR stained DNAH5. This was then divided by the total time taken 
between washing out the first dye and washing out the second dye. Doing this 
gives a rough approximation of the speed at which docking is occurring in the 
motile axoneme, which was calculated to be ~17 nm/hour, as shown in Figure 4.5 
B). This is considerably faster than the rate calculated from previous experiments 
in Chlamydomonas (Viswanadha et al. 2014) which put the rate of docking at 
approximately 5.4 nm/hour. However, this is a very preliminary result and the 
measurement was taken over a long time period. The most effective way to 
measure the rate of AD docking would be to take multiple measurements with 






Figure 4.5 Pulse chase imaging showing ODA docking towards the ciliary tip
A) Oblique slices of mTECs stained with acetylated tubulin (green), SNAP-cell SiR-
647 (magenta) and SNAP-cell TMR (orange). Clockwise from top left; merge of all
channels, acetylated tubulin, SNAP-cell SiR-647 dye, SNAP-cell TMR. The images
demonstrate that in the cilia of the left hand cell, indicated by white arrow, the newly
translated SNAP-cell TMR stained DNAH5 is localised at the top of the cilia while
the older SNAP-cell SiR-647 stained DNAH5 is localised towards the base.This is in
contrast to the neighbouring cell which has no SNAP-cell TMR stained DNAH5 and
slightly longer cilia (yellow arrowheads), suggesting the cilia are more mature.
B) Measuring the length of the DNAH5 stained with SNAP-cell TMR indicates the
amount of docked axonemal dynein along the axonemes of the cell. When this is
divided by the total amount of time since 1st dye was washed out it indicates the
minimum rate at which axonemal dyneins dock along the axoneme. This was done
for 10 cilia in 2 different cells and a student’s two tailed t-test indicated no significant





In order to examine the turnover of DNAH5 in the tracheal epithelial cilia, SNAP-
Dnah5 mTECs were cultured for longer in an air-liquid interface (ALI), 42 days, 
before adding the first dye, SNAP-cell SiR-647. The cells were then left for up to 
32 days before adding the second dye (SNAP-cell TMR star), fixing and staining 
with a marker of mature cilia, SENTAN (Kubo et al. 2008). The cilia in transwells 4 
days post airlift were all SENTAN positive, as shown in Figure 4.6 A), suggesting 
the cells were mature. Surprisingly, SNAP-cell SiR 647 was brightest in the 
transwells which had been incubated for 32 days at 37 °C with the dye. These cells 
demonstrated weak TMR staining of the cilia, suggesting low levels of DNAH5 
turnover on the axoneme after 32 days. In contrast to the staining seen in the 
growing axonemes in Figure 4.5 the TMR dye was not localised towards the ciliary 
tip but was distributed along the entire length, indicating DNAH5 is being replaced 
equally across the axoneme instead of being deposited in newly assembled areas. 
While some turnover was observed the chase period after the initial pulse would 
need to be extended for longer to determine whether there would be a complete 
replacement of the older SNAP SiR-647 labelled DNAH5.  
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Figure 4.6 Pulse chase imaging to observe DNAH5 turnover in mature cilia
A) An image showing 42 day post airlift Dnah5+/+ mTECs, 4 days after pulsing with
SNAP-cell SiR 647 dye (magenta). Imaged transwells were densely packed with
mature cilia, as indicated by SENTAN staining at their tips (green). Only the green
channel is shown.
B) These images are of mTECs differentiated at the same time as those shown in
the image above but chased 32 days after the initial dye pulse with SNAP-cell TMR
dye (orange). The Dnah5+/+  mTECs do not have cilia stained with the SNAP dyes
whereas the Dnah5SNAP/SNAP mTECs do, the cilia are marked with SENTAN as in A).
C) Oblique slices of the Dnah5SNAP/SNAP mTECs shown in B) demonstrate that there
may be limited turnover of DNAH5 at this stage, as indicated by TMR staining in the
axonemes of some cells (white arrow). However, the majority of axonemes are still
brightly stained with the 1st dye suggesting very slow turnover.
C)
1 µm





4.4 Defining the SNAP-DNAH5 interactome: novel potential regulators of 
heavy chain axonemal dynein transcripts. 
In addition to using the SNAP tag for quantitative imaging, SNAP affinity 
purification was used to identify novel interactors during dynein heavy chain 
translation, folding and cytoplasmic pre-assembly as well as trafficking. Importantly 
as the SNAP tag is at the N-terminus it will fold first, before DNAH5, allowing for 
the identification of the earliest interactors during heavy chain translation and 
folding. 
While the main transcriptional regulators of the motile ciliary machinery are known, 
reviewed as part of (Reiter and Leroux 2017), it is less well known whether there 
is a post-transcriptional or translational regulatory pathway involved. However, due 
to the length of the Dnah5 transcript, 268,300 bp, a single RNA polymerase takes 
approximately 45 minutes to transcribe it (Jonkers and Lis 2015). When the time 
taken for splicing and export is considered then it’s likely that in order to make the 
required ~900,000 ODAs the multi motile ciliated cells would maximise the 
translation of the mRNA as much as possible to save time spent on transcription. 
Cells have adapted to overcome these kinds of transcriptional challenges by 
regulating transcripts, either through storage in P-bodies and stress granules 
(Standart and Weil 2018), or by changing how and where they are translated 
(Béthune et al. 2019; Fujii et al. 2017) or via altering transcript stability (Zhao, 
Roundtree, and He 2016; Hafezqorani et al. 2016). 
Some preliminary evidence to support the post-transcriptional regulation of Dnah5 
has come from the use of the SNAP-Dnah5 mouse to find DNAH5 interactors. 
mTECs were cultured from SNAP-Dnah5 and wild type littermates before being 
lysed and immunoprecipitated using the anti-SNAP tag antibody. These samples 
were sent for mass spectrometry analysis, which was performed by Dr. Alex von 
Kriegsheim and Dr. Alfonso Bolado (Proteomics Core, University of Edinburgh). 
The results from three transwells, 28 days post airlift, of each genotype are shown 
in Figure 4.7. The volcano plot shows that DNAH5 is the most enriched protein 
from the pulldown in the SNAP tagged animals, suggesting that the SNAP antibody 
has specifically enriched for DNAH5 and its interactors. There were also known 
AD interactors found in the pulldown, including the assembly factor SPAG1 
(Knowles, Ostrowski, et al. 2013) and the heat shock chaperone HSP90aa1 (Hartill 
et al. 2018; Mali et al. 2018) as well as novel interactors. Several of these 
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interactors are RNA binding and transcriptional or translational regulators, lending 
support to the hypothesis that there may be some co-localisation of the Dnah5 
transcript and its protein. These interactors were; Transcription Elongation Factor 
1 A (TCEA1) which helps RNA polymerase II transcribe difficult sequences (Yang 
et al. 2018), Eukaryotic Translation Initiation Factor 2 Subunit 3 structural gene Y-
linked (EIF2S3Y) which is a Y chromosome encoded translation initiation factor 
essential for spermatogenesis (Matsubara et al. 2015), TRNA Methyltransferase 
Subunit 11-2 (TRMTS112) which methylates rRNA and tRNA as well as proteins 
(Gu et al. 2012) and AlkB Homolog 5 (ALKBH5) which demethylates mRNA (Zheng 
et al. 2013).  
The association with ALKBH5, which has been shown to be important for the 
removal of the most abundant mRNA modification, m6A, is of particular interest 
(reviewed in (Zhao, Roundtree, and He 2016). ALKBH5 is essential for 
spermatogenesis in mice and is highly expressed in both the testes and lungs 
(Zheng et al. 2013), both organs that express AD genes. Furthermore, ALKBH5 
has been found to be important for the correct splicing and expression of longer 
transcripts (Tang et al. 2018), although there is no evidence that it is directly 
responsible for regulating the heavy chain AD mRNA.  
While it is interesting to find RNA regulatory proteins being pulled down with 
DNAH5, it is also perplexing how this might occur especially for nuclear localised 
factors. The presence of SPAG1 and HSP90 are good indicators that these cells 
are still assembling ADs at the late stages of differentiation as was suggested by 
the pulse-chase imaging shown in Figure 4.5 A). However, there were many other 
expected parts of the outer dynein complex which were not significantly enriched, 
such as DNAI1 which was just below the threshold, casting doubt on the validity of 
these results. These issues will be discussed further in Section 4.5, however as a 
preliminary result the identification of assembly factors with a translation initiation 
factor and mRNA regulators lends further weight to the suggestion that there might 
be a co-localisation of the Dnah5 transcript and protein in assembly factories. 
  
Figure 4.7 Mass spectrometry analysis of SNAP-DNAH5 co-immunoprecipitation from mTECs.
The graph shows the Log2 fold change in the intensity of interactors immunoprecipitated with anti-SNAP 
antibody in Dnah5 +/+ over Dnah5 SNAP/SNAP mTECs from 3 replicates on the x axis and the -log10 p-value 
plotted on the y axis. A significance threshold of 1.3 and a fold change threshold of 1.5 was set. Interactors 
which are significantly enriched over these thresholds are indicated by a red dot with the ones enriched in the 
Dnah5 SNAP/SNAP sample on the right of the midline and Dnah5 +/+ on the left. This analysis was done by Dr. A. 
von Kriegshiem and Dr. A. Bolado at the University of Edinburgh. Full peptide sequence and coverage is 
shown in Appendix 2.



























































To investigate whether there is specific subcellular localisation of Dnah5 transcripts 
and if they co-localise with DNAH5 protein, mTECs were analysed using single 
molecule RNA fluorescent in situ hybridisation (smRNA FISH). They were also co-
stained with the anti-DNAH5 antibody, however no DNAH5-like staining could be 
detected and no difference between secondary only controls and experimental 
samples was observed, in mTECs. Although early experiments demonstrated 
potential co-localisation of Dnah5 transcript and protein in tracheal cryo-sections, 
Figure 4.8 G), this result could not be replicated. This suggests the protocol needs 
to be optimised in order to preserve epitope antigenicity, which appears to be 
compromised under the in situ protocol conditions. Moreover, very bright 
autofluorescence was detectable in all channels at cytoplasmic granular structures 
which did not degrade with treatment of RNAse A whereas the probe signal did, 
Figure 4.8 A) - D). Therefore puncta which fluoresced in all channels were 
discounted and only those which were solely positive for Dnah5 were regarded as 
real. Dnah5 RNA was detected in few but large (~0.55 µm3) clusters in the 
cytoplasm and nucleus of mTECs early on in the ciliogenesis program, 4 days post 
airlift, Figure 4.8 A). Imaging also demonstrated that very few of the cells at this 
stage seemed to have detectable expression of Dnah5. This localisation is in 
contrast to the control probe, Gapdh, which seems to be highly expressed in all 
cells in small (0.12 µm3) puncta and ubiquitously cytoplasmic in localisation Figure 
4.8 C).  
In order to better determine the structure of these clusters and to give an indication 
of how many transcripts there might be in them the cells were imaged with super 
resolution stimulated emission depletion (STED) microscopy, Figure 4.8 E) – F), 
with Dr. Alison Dunn (ESRIC Heriot-Watt University). This showed that the clusters 
were made up of multiple transcripts and were of variable shape and size, however 
the density and shape of the transcripts made it hard to quantify their number 
accurately. Due to the difficulties of using immunofluorescence in conjunction with 
FISH to determine the localisation of DNAH5 mRNA and protein, the SNAP-Dnah5 
mouse was used with cell permeable SNAP dye to image DNAH5 protein in the 
cytoplasm. Unfortunately, in spite of the SNAP dye working via covalent enzymatic 
coupling to the target protein, obviating the requirement for the preservation of 
antigenicity, cytoplasmic DNAH5 was not distinguishable, although some cilia were 
very faintly stained in a few cells. Fortunately, this proved to be a useful landmark 
of the apical surface, such that on imaging the cells transversely the large clusters 
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of Dnah5 transcript could be seen to be localised nearer the apical side of the cell, 
Figure 4.8 H). While this preliminary data will need further verification it is 
reminiscent of the observed localisation of DynAPs (Huizar et al. 2018) and 
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Figure 4.8 Localisation of Dnah5 transcripts to large apically localised clusters
A) mTECs stained with probes against Dnah5 in red, anti-DNAH5 antibody in green 
and DAPI in blue. The majority of the green and red spots are autofluorescence, in-
dicated by the white arrow. Clusters of transcript are indicated by white arrowheads.
B) Dnah5 staining disappears in mTECs that have been treated with Rnase A. 
C) mTECs stained with probes against Gapdh in red.
D) Rnase A treatment removes Gapdh signal. 
E) STED super resolution of Dnah5 transcript clusters in magenta.
F) STED super resolution of Gapdh transcript in magenta. STED by A. Dunn (HW).
G) A tracheal cryosection stained with DNAH5 antibody (green), Dnah5 probe (red) 
and DAPI (blue). Nuclear Dnah5 is indicated by a green arrow, the cilia are indicated 
by a white arrow and potential sites of co-localised DNAH5 protein and transcript are 
indicated by the white arrowheads.
H) Transverse view of a SNAP-Dnah5 mTEC transwell stained with cell permeable 
SNAP dye TMR-Star (red), with Dnah5 probe (magenta) and DAPI (blue). The cilia 
are highlighted by white arrows and the Dnah5 transcripts by a green arrow.
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These results taken together show that the SNAP-Dnah5 mouse exhibits normal 
AD and SNAP tag function. This makes it the second endogenously tagged heavy 
chain dynein in mice, the first being GFP tagged Dnah11 as mentioned earlier 
(Mcgrath et al. 2003). However, the advantage of the SNAP tag is that it can be 
used for more than just fluorescent imaging, such as pulse-chase imaging to 
observe protein turnover and AD docking as demonstrated. Additionally, now there 
are two tagged AD heavy chains, these mice can be inter-crossed to allow 
comparisons to be made in terms of endogenous localisation, dynamics and 
interaction partners. This is of particular interest for Dnah11 which has been shown 
to not require assembly factors DNAAF1 and DNAAF3 (Dougherty et al. 2016) 
suggesting it might have a different assembly pathway to Dnah5 which is affected 
by the loss of these assembly factors. Close examination of the individual proteins 
that make up the diverse array of large and complex ADs will illuminate the 
pathways involved in their regulation and assembly.  
Using the SNAP-Dnah5 mouse to calculate the docking rate of the ADs along the 
axoneme requires more experiments in order to make a more accurate 
measurement. As previously mentioned, measuring the length of newly docked 
dyneins along the axoneme at regular intervals over a shorter time period would 
give a more accurate reading of the rate of docking. Another possible method to 
do this would be to follow in the footsteps of previous work on Chlamydomonas 
where cells with a temperature sensitive kinesin-2 motor were mixed with I1 dynein 
deficient cells at permissive and restrictive temperatures (Viswanadha et al. 2014). 
This showed that the dynein was carried to the tip by IFT where they are released 
and diffuse through the axonemal shaft filling up docking sites closest to the tip 
first, in already assembled cilia.  This may also reflect the situation in mature 
ciliated cells if genome editing were to correct any defects in the assembly 
machinery, as in PCD the ODAs are often absent. While there are no temperature 
sensitive mutants in mice it is possible to reversibly inhibit dynein assembly using 
the FKBP8 inhibitor DM-CHX (Mali et al. 2018) which would allow the axoneme to 
assemble without the dyneins. Taking measurements at regular timepoints from 
the moment of drug washout would allow the rate of docking in assembled cilia to 
be accurately calculated and compared to the assembling axoneme.  
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It remains an important and open question as to whether there is AD turnover in 
mammalian ciliated cells, which this mouse model will be a powerful tool to 
analyse. Currently SNAP-Dnah5 mTECs are being cultured to repeat the 
experiment shown in Figure 4.6 leaving a longer time between the addition of dyes. 
It is expected that eventually the older DNAH5, bound to the 1st dye will be replaced 
by new DNAH5, bound to the 2nd dye. Although it’s possible that the rate of turnover 
is so slow that the cells will die before this happens to enough ODAs for it to be 
perceptible.  
Besides the ability to image AD docking and turnover the SNAP-Dnah5 mouse has 
also been shown to be useful for finding protein interaction partners via mass 
spectrometry. While it is possible to use the activity of the SNAP tag to covalently 
bind to beads for pulldown of interacting proteins it requires the tag to be 
enzymatically active after cell lysis. Attempts to use the benzylguanine modified 
beads to pull SNAP-DNAH5 down from cell lysates resulted in no enrichment of 
DNAH5 suggesting that the lysis conditions were either not harsh enough to extract 
the protein or inhibited the enzymatic activity of the SNAP tag. Therefore the 
SNAP-DNAH5 fusion was pulled down using the SNAP tag antibody, which did 
result in enrichment of DNAH5 however as previously discussed did not enrich for 
AD proteins and other known axonemal interactors. Nevertheless some of the 
proteins pulled down were known interactors and one of the novel interactors, 
ALKBH5, has been shown to be important in spermatogenesis and highly 
expressed in lungs. However, as previously discussed there was no detection of 
AD transcripts amongst the genes that were differentially expressed (Zheng et al. 
2013; Tang et al. 2018), although that could be due to the heavy chain axonemal 
dyneins having a low number of transcripts, as suggested by the smRNA FISH 
results and published single cell RNA sequencing data (Plasschaert et al. 2018; 
Montoro et al. 2018). It is possible that these genes were affected in both the lungs 
and testes, where ALKBH5 expression is the highest, as levels of total m6A 
methylation were shown to be increased in both these organs. The potential that 
ALKBH5 may regulate heavy chain transcription is supported by the fact that it has 
been shown to be important for maintaining accurate splicing of long transcripts as 
well as preventing nuclear export. However, ALKBH5 as an mRNA demethylase 
has been shown to function in the nucleus whereas DNAH5 is localised to the 
cytoplasm and cilia. Maintaining efficient splicing activity of very long transcripts 
with multiple exons, such as Dnah5 which has 79 exons, is likely to be crucial for 
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their stability and efficient translation. Alternately, it has recently been shown that 
ALKBH5 interacts with the DEAD-box RNA helicase DDX3 (Shah et al. 2017) 
which shuttles between the nucleus and the cytoplasm, and is a component of the 
cytoplasmic granules such as stress granules and P-bodies (Hilliker et al. 2011; 
Kanai, Dohmae, and Hirokawa 2004; Lai, Lee, and Tarn 2008). However, it has 
not been established where this interaction occurs and it could be purely nuclear. 
This interaction needs to be confirmed with further pulldowns, either using the 
antibody or potentially with benzylguanine modified biotin and streptavidin to 
bypass the need for this gentle lysis and the anti-SNAP tag antibody.  
The potential for post-transcriptional regulation of the AD subunits in P-bodies, 
stress granules or a similar phase separated organelle is supported by the 
discovery of DynAPs, which contain AD subunits and their assembly factors 
(Huizar et al. 2018). These particles were shown to contain some of the 
components found in similar types of foci. Whilst the RNA content of these particles 
was not investigated, it is possible the transcripts for AD components are also 
located here. As the RNA FISH in Figure 4.8 shows Dnah5 transcripts cluster in 
foci not entirely dissimilar in their localisation to the DynAPs however without being 
able to find out what proteins they are co-localised with it is not possible to 
speculate as to their nature. Nevertheless, post-transcriptional regulation and 
localised translation could be ways for the motile ciliated cell to cope with the heavy 
transcriptional toll of creating nearly a million axonemal dynein proteins. It has been 
shown previously that sperm cells store their transcripts for translation in order to 
complete spermatogenesis (Schäfer et al. 1995), while this is due to the genomic 
changes in the cell it is an example of how post-transcriptional control can aid in a 
cell’s differentiation. Therefore, finding out the localisation of DNAH5 as well as 
other proteins is of paramount importance in establishing the function of these 
transcript clusters. The SNAP-Dnah5 mouse will help to accomplish this and will 




5 Improving the efficiency of specific genomic editing with 
CRISPR/Cas9 
5.1 Introduction 
5.1.1   Reporters of DNA repair pathway 
The mammalian cell has many different ways to repair DNA damage; for the 
purposes of genome editing these can be simplified into two main types: those that 
use a homologous sequence of DNA to repair the damaged strand or strands 
known as Homology Directed Repair (HDR), and those that do not referred to as 
Non-Homologous End Joining (NHEJ). The details of these repair systems have 
been reviewed previously in Section 1.7; the focus of this short introduction will be 
on the fluorescent reporter systems which have been developed to differentiate 
between these pathways.  
Fluorescent reporters of genome editing repair outcomes began with the Traffic 
Light Reporter (TLR) system, which was initially developed using the SceI 
meganuclease (Certo et al. 2011) and has been adapted for use with other editing 
nucleases including Cas9 (Chu et al. 2015). It uses two out of frame fluorescent 
proteins in the same coding sequence, the upstream EGFP (+1) is separated from 
the downstream mCherry (+3) by a T2A peptide cleavage sequence. When 
supplied with a repair template with homology for EGFP that shifts it to the correct 
frame, the cells express EGFP whereas when there is no template, errors 
introduced by NHEJ can shift mCherry into frame. This kind of reporter requires a 
large repair template and is similar to the mTmG CRISPR reporter system 
developed in this lab, Figure 5.1 A), as well as another recently published reporter 
that also uses the mTmG mouse (Alapati et al. 2019).  
Another strategy relies on the ability to alter the fluorescence spectra of fluorescent 
proteins by changing single amino acid sequences. The most commonly used 
reporter utilises EGFP and the closely related blue fluorescent protein (BFP) which 
can be interchanged by introducing a single nucleotide polymorphism with a 
homology repair template (Richardson et al. 2016; Glaser, McColl, and Vadolas 
2016). If there is error prone DNA repair as a result of NHEJ it can result in the loss 
of fluorescence of EGFP or BFP, depending on which fluorophore is being 
converted to which. The advantage of this type of system over the TLR type is that 
it only requires a short exogenous piece of DNA to convert the fluorescence of the 
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reporter protein, which allows for the use of cheap and easily synthesised single 
stranded DNA repair templates. 
5.1.2   Attempts to improve CRISPR/Cas9 induced HDR 
One of the main uses for the reporter systems mentioned in Section 5.1.1 is testing 
the effectiveness of various approaches to improve the efficiency of HDR in 
genome editing. Mammalian cells have relatively low levels of homology directed 
repair, preferentially using the error-prone NHEJ pathway (Orthwein et al. 2015), 
making gene correction or replacement harder. Therefore, research to aid in the 
incorporation of exogenous DNA sequences into targeted regions of the genome 
is key to the success of gene therapy. With the development of the RNA guided 
editing system CRISPR/Cas9 for use in mammals the targeting of the genomic site 
has become easier, however repairing to the wild type sequence is still a challenge. 
The use of small molecules to alter the bias of the endogenous repair pathways 
towards HDR has shown that inhibitors of the NHEJ pathway can increase the 
levels of HDR (Maruyama et al. 2015; Srivastava et al. 2012; Robert et al. 2015; 
Leahy et al. 2004) and similarly activators of HDR can also increase HDR efficiency 
(Pinder, Salsman, and Dellaire 2015; Jayathilaka et al. 2008; Jun Song et al. 2016). 
This was predicted from genetic inhibition (Chu et al. 2015; Certo et al. 2011) and 
overexpression of proteins suspected to be important for DNA repair (Pinder, 
Salsman, and Dellaire 2015). Blind screens using a library of drugs have also 
uncovered drugs which seem to increase HDR through unknown mechanisms (Yu 
et al. 2015). Additional methods to increase HDR include changing the length, 
symmetry and chemistry of the repair template (Richardson et al. 2018; Paix et al. 
2017; Liang et al. 2017), controlling the stage of the cell cycle at which editing 
occurs (Lin et al. 2014; Yang et al. 2016; Gutschner et al. 2016) and fusing Cas9 
to proteins important for HDR (Rees, Yeh, and Liu 2019), amongst other 
approaches. 
Another method which has been used to improve HDR of targeted double stranded 
DNA breaks has been to directly attach the DNA repair template to the editing 
complex. This has been shown to increase the efficiency of HDR in yeast cells (32 
fold) and human  cells (16 fold), edited with the meganuclease SceI and repair 
guided by a DNA repair template that binds to SceI with an aptamer (Ruff et al. 
2014). Further experiments using CRISPR/Cas9 with a guide RNA that is 
covalently attached to the repair template have been conducted (Lee et al. 2017), 
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slightly increasing the efficiency of HDR. A study where a benzylguanine modified 
repair template was tethered to Cas9 by the SNAP tag concluded this was mainly 
due to the repair template being transported to the nucleus by the Cas9 nuclease, 
(Savic et al. 2018). Similar types of Cas9-fusions have been developed which bind 
to biotinylated DNA (Gu, Posfai, and Rossant 2018; Carlson-Stevermer et al. 
2017) or covalently attach to single stranded DNA via a viral replication protein 
(Aird et al. 2018). Some of these strategies to improve the efficiency of specific 
repair of CRISPR induced double stranded DNA breaks were tested in order to 
develop a genome editing therapy for PCD.  
5.2 Developing fluorescent reporters of genome editing outcomes. 
In order to develop a gene editing therapy for PCD, attempts to improve the 
efficiency of specific repair pathways were trialled in an in vivo reporter of DNA 
repair. The mTmG system was developed to act as a Cre-mediated lineage tracer 
(Muzumdar et al. 2007). This has been adapted to be used as a fluorescent 
reporter of genome editing outcome by the Mill lab, Figure 5.1 A). By directing an 
RNA targeted nuclease, such as Cas9, to the two identical LoxP containing regions 
that flank the mTomato gene, one can distinguish non-edited (membrane Tomato) 
from edited cells (other). If the ends of both cut sites are repaired by NHEJ, this 
can cause the downstream mEGFP to be expressed, or throw the mTomato gene 
out of frame causing loss of fluorescence. By including a repair template that 
changes localisation signal on EGFP from the MARCKS membrane tag to a H2B 
nuclear signal, one can distinguish NHEJ (membrane EGFP) from HDR (nuclear 
EGFP).  Furthermore, by addition of a plasmid or mini circle encoding a nuclear 
localised BFP flanked by target sites for the mTmG LoxP guides, one can report 
the efficiency of Homology Independent Targeted Integration (HITI), a method that 
uses NHEJ to integrate DNA into a targeted site and has been used for gene 
editing therapy in mice (Suzuki et al. 2016). When the guides are expressed with 
the nuclease then the BFP gene is linearised and can be inserted in the place of 
mTomato by NHEJ, Figure 5.1 A).  
Figure 5.1 mTmG editing reporter system
A) This diagram shows the mTmG reporter sytem, which consists of a gene cassette 
with a red fluorescent protein dimer (Tomato) gene upstream of a green fluorescent 
protein gene under the control of a promoter (right angled arrow). Both fluorescent 
proteins have a MARCKs tag, M in yellow box, which localises them to the plasma 
membrane. The cells do not express GFP unless the tomato sequence with its strong 
stop is removed by the action of Cas9 targeted to flanking Loxp site containing se-
quences. If there is no repair template NHEJ will likely result in green membrane 
fluorescence or no fluorescence if errors are introduced, if a repair template with 
homology is added then the fluorescence will be nuclear GFP, if DNA with nuclear 
localised BFP is added and integrated via NHEJ then there will be nuclear BFP.
B) FACS plots showing the different editing outcomes, negative and double positive 
cells are the result of error prone repair and genomic instability.
C) Images of edited mTmG MEFs stained with blue nuclear stain. Images left to right, 


























This mTmG reporter system was used to test various conditions with immortalised 
mouse embryonic fibroblasts heterozygous for mTmG (referred to as mTmG 
MEFs). The changes in fluorescence can be measured using FACS, Figure 5.1 
B), while the change in localisation is analysed using imaging, Figure 5.1 C). The 
FACS plots show that some of the cells express both EGFP and Tomato, as the 
mice are heterozygous for mTmG, this is likely due to genomic instability in the 
immortalised cells resulting in polyploidy and multiple copies of the mTmG locus. 
One limitation of the mTmG reporter system is the relatively large repair template 
needed, due to the double cut sites and large deletions required to see changes in 
fluorescence.  This is not an accurate representation of gene therapy in patients, 
which will usually be repairing a small mutation, therefore a second reporter system 
was developed, which relies on much shorter repair templates. This fluorescent 
reporter switches from non-fluorescent EGFP to fluorescent EGFP by repairing a 
single amino acid (68A>G), Figure 5.2 A). The single nucleotide change was made 
using site directed mutagenesis, which converts a cytosine to a guanine, removing 
a PAM site and changing the 68th amino acid from glycine to alanine as indicated, 
Figure 5.2 B). Glycine 68 is an essential part of the EGFP chromophore, therefore 
when altered it causes EGFP to lose fluorescence (Heim, Prasher, and Tsien 
1994). The non-fluorescent EGFP68A and the control fluorescent EGFPWT 
constructs were integrated into the Flp-In™ HEK 293 T-REx cell line (HEK 293), 
using the Flp recombinase and Hygromycin selection, allowing integration of a 
single copy into a defined genetic locus to control expression levels, Figure 5.2 C). 
After selection, clonal populations were isolated and screened by PCR for 
integration and the positive colonies were then checked for expression using 
reverse transcription PCR, demonstrating expression of either non-fluorescent 
EGFP68A or fluorescent EGFPWT in seven out of eight cell lines, Figure 5.2 D). The 
fluorescent EGFPWT cell lines were used as positive controls for the FACS 
experiments. Guide RNA and single stranded repair DNA was designed that would 
target the EGFP68A reporter. The FACS plots of the positive and negative controls 
are shown in Figure 5.2 E), the gates shown in these plots were used to identify 
which cells had undergone HDR. This shows that the single amino acid change is 
















Figure 5.2 EGFP alanine 68 reporter system generation
A) The principle of the EGFP alanine 68 reporter system is to measure HDR by editing 
the non-fluorescent EGFP allele, shown as a blank box with A, in HEK293 cells using 
Cas9 and EGFP targeting guides with a single stranded repair template that converts 
alanine 68 to glycine 68, green box with G, making the cells EGFP fluorescent. 
B) EGFP was mutagenised using site directed mutagenesis, with primers SDM F and 
R to create an EGFP with alanine at position 68 (EGFP68A), rendering it non-fluores-
cent.
C) Both the 68G and 68A eGFP (pcDNA5) plasmids were then integrated into Flp-In 
T-rex 293 cells using Flp recombinase. Colonies of cells were then selected using the 
Hygromycin resistance marker.
D) Reverse transcription PCR was performed after inducing expression with Doxy-
cyline. The plasmid used for integration was used as a positive control, A1-5 refer to 
EGFP68A cells and G1-6 to EGFPWT cells, all but one of the colonies seem to express 
EGFP.
E) EGFP fluorescence was measured with FACS, the plots shown acted as positive 
and negative controls for editing experiments. Green fluorescence is measured on the 
X axis and blue is on the Y (for cell viability). Each dot is a cell and the green gated 
population (P3) represents the GFP positive cells, 93% of the viable cells in EGFPWT.

































5.3 Testing putative small molecule modulators of genome editing using the 
mTmG reporter system. 
The mTmG system was used to test small molecules which had previously been 
shown in published work to improve the efficiency of HDR. Two of the small 
molecules used were inhibitors of NHEJ, Scr7 an inhibitor of DNA Ligase IV 
(Srivastava et al. 2012) and Nu7441 an inhibitor of DNA dependent protein kinase 
(Leahy et al. 2004). A blind screen of compounds to find chemicals to increase 
HDR efficiency identified two other molecules (Yu et al. 2015), Brefeldin-A (Brf-A), 
an inhibitor of ADP-ribosylation factor 1 (Benabdi et al. 2017), and L755,501, an 
agonist of the β3 adrenergic receptor (Parmee et al. 1998). RS-1, an activator of 
the homologous recombination pathway protein Rad51 (Jayathilaka et al. 2008), 
was also tested using the mTmG system. Despite previous reports suggesting the 
molecules increased the efficiency of HDR (Maruyama et al. 2015; Robert et al. 
2015; Jun Song et al. 2016; Pinder, Salsman, and Dellaire 2015; Yu et al. 2015), 
analysis of the levels of HDR in control and drug treated mTmG MEFs showed no 
significant differences, Figure 5.3 A). The experiment was repeated to include 
more replicates in order to gain statistical power, the HITI repair construct was also 
included to measure the effect of small molecules on the efficiency of HITI.  
Repeating the small molecule treatments with five replicates failed to produce 
results for HDR due to an issue which resulted in detachment of the MEFs from 
the plate prior to imaging. However, there were differences in the percentages of 
different types of fluorescence between the cells treated with certain small 
molecules measured by FACS. The DNA dependent protein kinase inhibitor 
(DNAPKcs) Nu7441 seemed to have the most effect on the editing outcomes in 
MEFs, which were measured as a percentage of total editing (non-red cells). It 
increased the percentage of GFP positive cells from 27% in the DMSO control to 
31%, Figure 5.3 B), while decreasing BFP positive cells from 9% to 6%,  Figure 
5.3 C). It also seemed to increase the proportion of negative cells from 41% to 
44%, Figure 5.3 D) and decrease the number of double positive cells from 25% to 
18%, Figure 5.3 E). This led to an overall increase in total visible editing in the 
Nu7441 cells from 39% to 50%, Figure 5.3 F). The increase in the number of GFP 
positive cells suggests that Nu7441 might be increasing the number of GFP 
positive nuclei through the HDR pathway however it could also be the result of 
NHEJ and expression of the membrane localised GFP. Similarly the decrease in 
BFP positive cells is to be expected, given that HITI relies on NHEJ. The effects 
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on the negative and yellow cells is harder to explain. While Nu7441 had the 
clearest effect, Brf-A seemed to have an opposite effect decreasing total editing 
from 39% to 35% as well as the proportion of negative cells from 40% to 32%, 
Figures 5.3 F) and D). It also increased the percentage of yellow cells from 25 to 
33, again the opposite effect to Nu7441 as shown in Figure 5.3 E). However, Brf-
A did not significantly decrease the percentage of GFP positive cells and had a 
similar effect on the proportion of BFP positive cells, decreasing them from 9% to 
7%. Overall, the changes in the efficiency of HDR caused by these small molecules 
suggest that they are not likely to be useful for genome editing therapy. However, 
their effectiveness is likely to be cell type dependent and the efficiency may be 
different in the target tissue. The effects of the small molecules on the choice of 
DNA repair pathway will be discussed further in Section 5.6. 
  
Figure 5.3 The effect of published small molecules on editing outcomes
A) The bar chart shows the percentage of green nuclei as a percentage of total non-
red fluorescent cells, as measured by imaging, no significant differences were noted. 
The individual points represent technical replicates, significant diferences between 
the DMSO vehicle control and the treated cells are highlighted by black lines. Signifi-
cance was tested using one way ANOVA and Dunnett’s multiple comparisons, 0.0021 
< P < 0.05 = *, 0.0002 < P < 0.0021 = **, 0.0001 < P < 0.0002 = ***, P < 0.0001 = ****. 
n= 3
B) Nu7741 increases the percentage of green (GFP+) cells as a percentage of all 
non-red fluorescent cells as measured by FACS. n =5
C)  Brf-A increases and Nu7441 decreases the percentage of Blue cells (BFP+) cells 
as a percentage of all non-red fluorescent cells as measured by FACS. n =5
D) Nu7441 increases and Brf-A decreases the percentage of non-fluorescent cells as 
a percentage of  all non-red fluorescent cells as measured by FACS.  n= 5
E)  Brf-A increases and Nu7441 decreases the percentage of yellow cells (GFP+ 
RFP+) as a percentage of all non-red fluorescent cells as measured by FACS. n =5
F) Nu7441 increases the percentage of all non-red fluorescent cells as measured by 
























5.4 Testing the effect of linked guide RNA on HDR efficiency. 
Directly attaching the DNA repair template to the editing complex has been shown 
to increase the efficiency of HDR (Ruff et al. 2014; Lee et al. 2017). For this 
method, a short repair template is required, which is not possible in the mTmG 
system, so here we used the EGFP68A reporter system described in Section 5.2 to 
assess genome editing efficiency improvements. 
The idea to link the repair template DNA to the guide RNA to improve HDR 
efficiency was trialled initially using a method based on sequence complementarity 
between the 3’ end of the single guide RNA and the 5’ end of the ssDNA repair 
template, however this proved unsuccessful (data not shown). The approach was 
changed to use Click chemistry to link the nucleic acids when it was published in 
2017 (Lee et al. 2017), however instead of linkage at the 5’ end of the guide RNA 
DNA was attached at the 3’ end of the sgRNA. This is predicted to be closer to the 
editing site and would be in the correct orientation to allow for complementary 
binding to the target region (Nishimasu et al. 2014).  
As shown in Figure 5.4 A) the 5’ end of the DNA repair template was modified with 
a DBCO molecule and the 3’ end of the guide RNA was modified with an azide 
group. The same groups were used previously to attach guide RNA and repair 
DNA using Click chemistry (Lee et al. 2017). The Click reaction is designed to be 
a very thermodynamically favourable one, which can be conducted with simple 
reaction conditions (Agard, Prescher, and Bertozzi 2004), however in order to get 
a good yield these conditions were optimised. One way to improve the ligation of 
two nucleic acids is to use a short piece of DNA complementary to both sequences, 
known as a splint, which binds them both and brings the ends closer together. 
Three different splints were designed each was complementary to the 3’ end of the 
guide RNA and to the 5’ end of the repair DNA. The lengths of the homology arms 
were either 16 nucleotides in the case of splint number 1 or 20 nucleotides in the 
case of splint numbers 2 and 3. Splint 3, shown in Figure 5.4 A) had a flexible 
hexa-ethylene glycol (HEG) linker between the homology arms which helps to 
avoid steric hindrance of the splint in the Click reaction. The different types of 
splints and concentrations of nucleic acids used to optimise the reaction are shown 
in Table 5.1. The reactions were heated and cooled to allow for annealing and 
were left at 25 °C overnight, the resulting products were then analysed on a 
polyacrylamide gel with the reaction reagents, shown in Figure 5.4 B). The yield 
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of the various conditions was calculated using gel densitometry to measure the 
intensity of the RNA and DNA bands by themselves and then dividing the intensity 
of the product band by this. These measurements showed that condition 4 had the 






Reaction sgRNA (µM) Repair DNA (µM) Splint Splint (µM) 
1 10 30    
2 10 30 1 30 
3 10 30 2 30 
4 10 30 3 30 
5 10 10    
6 10 10 1 10 
7 10 10 2 10 
8 10 10 3 10 
9 10 20    
10 10 20 1 20 
11 10 20 2 20 
12 10 20 3 20 
13 30 10    
14 30 10 1 30 
15 30 10 2 30 
16 30 10 3 30 
Table 5.1 Click reactions to link guide RNA and repair DNA 
The table shows the 16 different reaction conditions, numbered 1-16, used to 
optimise the Click chemistry mediated linkage of the modified guide RNA and repair 
DNA. The concentrations for each reagent added are given in micromolar. Splints 
are numbered 1 – 3 with splint 1 having 16 nucleotide homology arms and no HEG 
linker, splint 2 having 20 nucleotide homology arms and no HEG linker and splint 3 
having 20 nucleotide homology arms and a HEG linker. 
A)
Figure 5.4 Click chemistry to make linked RNA-DNA
A) The diagram demonstrates the reagents that were used to make the combined 
guide RNA and repair template complex used. Single stranded repair template DNA 
with a 5’ DBCO modification was added to single stranded guide RNA with a 3’ azide 
modification, this is combined with a single stranded DNA oligonucleotide that has 20 
bp homology arms that are complementary to the ends of the RNA and DNA to be 
joined. The homology arms are seperated by the addition of Hexa-Ethylene-Glycol 
(HEG). These then form a covalent bond and become joined.
B) These gels show the results of optimisation for the click reaction with different con-
centrations of DNA and RNA and different splints as detailed in Table 5.1. The 
black arrow indicates the product produced after the reaction, this is the linked RNA-
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To verify the ability of EGFP68A to report on genome editing induced HDR, cells 
were transfected with the Cas9 guide RNP complex with repair template DNA. 
These had significantly more EGFP positive cells than the controls, 0.08% 
compared with 0.03% for the untransfected cells, Figures 5.5 A) and C).  This 
shows that the EGFP alanine 68 reporter system is able to measure the level of 
HDR in transfected cells. To test whether linkage of the guide and repair could 
improve the efficiency of HDR, EGFP68A cells were transfected with gel purified 
covalently linked guide RNA and repair DNA, unpurified linked RNA and repair 
DNA and unreacted RNA and DNA. The cells were also transfected with purified 
linked RNA and repair DNA mixed with complementary single stranded DNA that 
extended the 3’ end of the repair template. However, the percentage of HDR was 
negligible in all samples, as shown in Figure 5.5 D). This suggests that the linkage 
of the guide RNA and repair DNA template does not improve the efficiency of HDR. 
However, the overall levels of HDR appear to be very low when compared to the 
mTmG reporter system for example (~1.5%), suggesting that the reporter system 
















Figure 5.5 Testing the effect of covalently linked guide and repair template on HDR
A) This FACS plot shows EGFP68A cells which have been transfected with Cas9, guide 
RNA and ssODN repair template, green fluorescence is measured on the X axis and 
blue is on the Y (for cell viability). Each dot is a cell and the green gated population 
(P3) represents the GFP positive cells, in this sample 0.08% of the living single cells 
are GFP positive.
B) The plot shows the EGFP68A cells which have been transfected with Cas9 and 
covalently linked guide RNA and repair DNA, the percentage of green cells is lower 
at 0.03%.
C) This graph shows the results of control transfections of EGFP68A cells, including 
the one analysed in the FACS plot in A). The cells transfected with guide RNA, Cas9 
protein and single stranded DNA repair template had significantly more green cells as 
a percentage of the total than the cells transfected with each component separately, 
according to one way ANOVA and Dunnett’s multiple comparisons.
D)No significant increase in the percentage of GFP positive cells was observed when 
comparing linked RNA-DNA complexes to the unlinked complexes, according to one 
way ANOVA and Dunnett’s multiple comparisons.
Unmodified guide and repair Linked guide and repair 
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5.5 An AAV based approach to increase the efficiency of HDR by tethering 
of the repair template to Cas9. 
Adeno-associated virus (AAV) is a common vector used for delivery of DNA in vivo. 
It consists of a viral capsid and single stranded DNA genome that expresses two 
genes Cap, which encodes the capsid subunits VP1 to VP3 and Rep, encoding the 
4 replication proteins Rep78, Rep68, Rep52 and Rep40. The genome is enclosed 
by T shaped inverted terminal repeats (ITRs) which are recognised by the cell’s 
DNA synthesis machinery and used as primers to synthesise complementary DNA, 
reviewed in (Wang, Tai, and Gao 2019). It was shown that Rep78’s N terminal 244 
amino acids is sufficient to bind to the ITRs of the AAV genome and is what 
mediates its integration into the AAVS1 site in the human genome (Cathomen, 
Collete, and Weitzman 2000). It was also shown that the fusion of this protein 
domain to transposases increased the efficiency of transposition into the AAVS1 
site up to 15 fold (Ammar et al. 2012).  
Given that AAV is one of the most commonly used vectors for gene therapy and is 
targeted to the nucleus it is likely to be a good method for the delivery of repair 
template DNA for genome editing. If the Cas9 nuclease fused to Rep78’s N-
terminal domain could bind and deliver the repair template to the target site it might 
increase the efficiency of specific repair. This fusion protein is shown binding to the 
ITRs of an AAV genome containing the Histone 2B GFP repair template in Figure 
5.6 A). The linker which attaches the Rep78 N terminal domain to the C terminus 
of the Cas9 protein was used previously to make a Cas9-RFP fusion (Mircetic et 
al. 2017).mTmG MEFs were transfected with the Cas9-Rep78 fusion and wild type 
Cas9, then transduced with the Histone 2B repair template in an AAV2/2 vector. 
The results show that fusion of Cas9 to Rep78 increases the efficiency of HDR 
with an AAV based repair template by approximately 30% but not enough to be 
statistically significant, Figure 5.6 B). Indicating that this increase is most likely due 
to random variation than Cas9-Rep78. The potential reasons for Cas9-Rep78 














Figure 5.6 Testing the effect of Cas9-rep78 on AAV mediated repair
A) The diagram shows Cas9 S.p. (green) fused to the N terminal 244 amino acids of 
the AAV2/2 Rep78 protein (blue) via a linker sequence (red). The Rep78 protein is 
then shown binding to the AAV genome (black), specifically to the ITRs which flank 
the homologous repair sequence. 
B) The bar chart compares HDR, measured as green nuclei by imaging, as a per-
centage of the total of non-red fluorescent cells (as measured by FACS) between 
cells transfected with unmodified Cas9 (Cas9-px330) and Cas9-Rep78. No signif-
icant difference is found when testing with a two-tailed student’s T test. n = 5 repli-




In this chapter, two methods of linking the Cas9 nuclease editing complex to the 
DNA repair template were used to try to improve the efficiency of HDR. The first 
method trialled, the covalent linkage of the guide RNA with the repair DNA, did not 
improve the efficiency of HDR. However, it’s possible that the fluorescent reporter 
system developed to test this was not functioning correctly when this was tested. 
This is evidenced by the much reduced percentage of GFP positive cells in 
samples transfected with the unmodified guide repair DNA than those transfected 
with modified DNA and RNA. This could have been due to the effect of the 
modifications on the function of the guide RNA or on the DNA repair template, 
however this is unlikely to be the case given that there seemed to be no adverse 
effect of these modifications in the original publication (Lee et al. 2017). The azide 
group was attached at the 3’ end of the tracrRNA portion of the single guide RNA 
here, differing from previously published work which tethered at the 5’ end of 
crRNA, however this would not be expected to make a difference as altering the 3’ 
tail of the tracrRNA or sgRNA does not seem to effect its ability to mediate Cas9 
cleavage (Cheng et al. 2016).  
The baseline level of editing in the EGFP alanine 68 reporter system was also a 
potential source of failure to report change as the level of editing was not consistent 
between experiments. It was also much lower than other reporter systems in HEK 
293 cells, such as the BFP to EGFP reporter system which showed 
approximately 17% conversion of BFP to EGFP (Lee et al. 2017) compared to 
less than 0.1% in the EGFP alanine 68 reporter system. This suggests that the 
locus was not very amenable to editing or HDR.  
While no change in HDR could be demonstrated using these methods it was 
encouraging that the efficiency of the Click reaction could be increased by using 
splinting to bring the nucleic acids together. Using this optimised method the yield 
of the final RNA-DNA product was increased from 60% to 81% which is over double 
that reported in previous publications (Lee et al. 2017). As suggested earlier 
covalent linkage of the guide RNA and DNA may have increased the efficiency of 
HDR but it was undetectable using the reporter system developed, Figure 5.2. The 
same experiment was tried with the BFP to EGFP reporter system, however the 
linkage of sgRNA and repair DNA for the BFP to EGFP (data not shown) 
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sequences could not be achieved. It’s unclear why it was not possible to link the 
nucleic acids, it’s possible it could be due to errors in synthesis of the constituents. 
The second method to attach the Cas9 editing complex to the repair template DNA 
by fusion of Cas9 to Rep78 is a novel approach. However, it did not seem to result 
in any increase to the efficiency of HDR. This could be because the AAV replication 
proteins act as a hetero tetramer and as such Rep78 requires the other three 
subunits. Indeed, making the Rep78 N-terminal domain tetrameric was suggested 
to improve its ability to bind to the ITRs of the AAV genome (Cathomen, Collete, 
and Weitzman 2000). A new Cas9-Rep78 with a tetramerization domain is 
currently being made and tested for its ability to improve HDR efficiency with AAV 
mediated repair. If successful this method is directly applicable to genome editing 
therapy and only requires modification of the Cas9 nuclease and use of an AAV 
vector, which is already widely used for gene editing repair.  
The effect of small molecules on the CRISPR mediated editing observed in 
Section 5.3 did not recapitulate the increase in HDR efficiency shown in the 
published literature. Some publications agree with these findings: Scr7 does not 
increase HDR in certain cell types (Yang et al. 2016; Song et al. 2016; Zhang et 
al. 2017) and similarly one study showed L755,501 and RS-1 do not affect the 
efficiency of HDR (Zhang et al. 2017). While there was no effect on the HDR 
efficiency as observed in the experiment with three replicates, there was an effect 
on the DNA repair pathways of transfected cells when using Nu7441 and Brf-A. 
The increase in GFP positive cells observed with the treatment of Nu7441 points 
towards a potential increase in GFP positive nuclei. However, the increase in 
percentage of GFP positive cells in FACS measurements (4%) cannot be 
explained by what was observed in the previous experiment for the increase in 
HDR seen with Nu7441, only a ~0.3% increase. There was also a large increase 
in the number of non-fluorescent cells suggesting that Nu7441 may have promoted 
large deletions or insertions causing loss of fluorescence. If the NHEJ pathway was 
inhibited by Nu7441, as is predicted by its mechanism of action and by the 
decrease in HITI induced BFP positive cells, then its possible alternative DSB DNA 
repair pathways could have been employed. Blocking NHEJ using the DNA-PKCs 
inhibitor Wortmannin was shown to increase the levels of Microhomology Mediated 
End Joining (MMEJ) (Sharma et al. 2015). It’s unclear why this would result in the 
increased loss of fluorescence or gain of GFP expression, it’s possible that the 
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homology present in the HDR template resulted in it being ligated directly to the 5’ 
of Tomato which would destroy the guide site and push the Tomato gene out of 
frame. However, without deep sequencing of the treated cells the exact editing 
outcomes cannot be determined. As for the increase in the double positive and 
decrease in all other populations in the Brf-A treated cells it’s possible that Brf-A 
sensitised the cells to DSBs, as there was an increase in cell death in these cells 
after transfection. Potentially the more transformed polyploid cells were better able 
to survive this sensitisation and could escape DNA damage induced death, 
however without knowing Brf-A’s mechanism of action on DNA repair it is hard to 
conclude the reason for these results. It is likely that the failure to increase HDR 
efficiency using these small molecules lies in the differences between the cell types 
and reporter systems used. To investigate this more fully it would be necessary to 
try different cell types from the mTmG reporter and compare the effects, however 

















6 Conclusions and future directions 
6.1 SNAP-Dnah5 mice as part of a new motile ciliated toolset 
The research described in Chapter 4 demonstrates the effectiveness of 
endogenous gene tagging with an adaptable protein tag. The techniques employed 
to accomplish this result are particularly important for use with dynein heavy 
chains, which are often too large to for transient gene expression and transgenesis. 
As such, most tagging studies have focused on the much more manageably sized 
intermediate chains, which are often essential for the assembly of axonemal dynein 
(AD) complexes. However, it is the heavy chains which seem to require the most 
assistance for assembly and function (King 2016). Therefore, using fusion tags to 
pull down these massive proteins will help identify many of the components 
involved in assembly of the ADs. Isolated AD complexes could also be used for 
structural analysis using high resolution cryogenic electron microscopy, providing 
details about different dynein complexes during their trafficking, pre-assembly and 
axoneme docked forms.  
While it was not possible to conclusively identify DNAH5 interactors in the 
immunoprecipitation reactions shown in Chapter 4 (Figure 4.7), further 
optimisation continues to help to identify more interactors. As discussed in Section 
4.5, a potential way to improve these pulldowns would be to add benzylguanine-
modified biotin to the cells, thereby covalently labelling the SNAP-DNAH5 protein 
with biotin. This approach has been used before to pulldown SNAP-tagged 
proteins in cell lines (Siwek et al. 2018) and will remove any non-specific interactors 
of the SNAP antibodies which may be hindering the current experiments. 
Biotinylation of SNAP-tagged flagella proteins has also been used for Cryo-EM to 
study the structure of nexin dynein regulatory complexes in situ in the axoneme 
(Song et al. 2015). Preliminary results from streptavidin pulldown of biotin labelled 
SNAP-DNAH5 suggest this approach does work. However, results from these 
pulldowns need further analysis by mass spectrometry to assess whether 
streptavidin biotin pulldowns give a better enrichment for DNAH5 and may confirm 
the interactors in Figure 4.7.  
While using the SNAP tag to pulldown SNAP-DNAH5 was at least partially 
successful and will be improved through optimisation, this was not the case for live 
imaging of SNAP-DNAH5. Despite SNAP-DNAH5 being labelled in live cultured 
cells with cell permeable fluorescent dyes which could be imaged after fixation, no 
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fluorescence could be seen in the SNAP-Dnah5 live cells. This is in contrast to live 
imaging of PCM1SNAP cells, suggesting it is not the chemistry or dyes themselves 
that are precluding the imaging. It is more likely to be something specific to the 
MTECs and/or how they are cultured. For example, it could be due to the rapid 
movement of the cilia in live culture, reducing the time that each position is exposed 
to the imaging laser. Additionally, imaging SNAP-DNAH5 in the cytoplasm of 
mTEC cultures was particularly challenging, as the membrane they grow on is 
highly auto-fluorescent which makes cytoplasmically localised DNAH5 hard to 
detect. These problems are mainly due to the brightness of the fluorescent dyes, 
or low ‘signal-to-noise’ when used live. It is possible that with further optimisation 
of the imaging and staining protocols these issues could be overcome. An 
alternative solution would be to use primary cells from the GFP-Dnah11 mouse to 
optimise live imaging of tagged ADs (McGrath et al. 2003). The advantage of using 
GFP-Dnah11 is that it does not rely on the addition of dyes for fluorescence and 
therefore reduces the number of variables that need to be optimised for live cell 
imaging. If it is possible to image GFP-DNAH11 in live cells, then the same 
conditions could be used for SNAP-DNAH5 imaging, allowing the concentration 
and incubation time of the fluorescent dye to be optimised independently of other 
variables.  
The advantage of being able to track the movement of AD components live in 
motile ciliated cells was demonstrated by recent research which used fluorescently 
tagged DNAAFs and dynein intermediate chains to show that these factors are 
concentrated in cytoplasmic phase separated dynein assembly particles (DynAPs) 
(Huizar et al. 2018). The limitation of this study was that these genes were 
overexpressed which may result in erroneous interactions and force the proteins 
to phase separate. However, if these results could be recapitulated with 
endogenously tagged proteins it would reinforce their findings. It would also be 
interesting to compare the localisation of two different heavy chains which are both 
part of the same complex yet have different requirements for DNAAFs (Dougherty 
et al. 2016). It might be that DNAH11 is recruited to the axoneme independently of 
DNAH5 as part of another complex, being able to identify the interactors of both 
proteins via pulldown and mass spectrometry would help to identify these 
complexes. The combination of the existing GFP-Dnah11 mouse and the newly 
created SNAP-Dnah5 line will help to define how mammalian cells are able to 
recognise a diverse array of dynein heavy chains, where they are assembled into 
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dynein arms and how they are trafficked into distinct regions of the axoneme. It is 
likely that each β-DHC of the ODA has its own adaptor for transport or docking, 
these could be identified using the methods described with not only DNAH5 and 
DNAH11 (proximal) but also DNAH9 (distal). 
Therefore further endogenous tagging of the AD components will help to uncover 
the complex mechanisms underlying the assembly and regulation of these 
molecular machines. 
6.2 Learning from failure: a potential application for high throughput 
endogenous tagging in immortalised cell lines 
It is clear that the initial objective to create a library of endogenously tagged genes 
in different fly lines did not succeed, however the methodology was shown to work 
in immortalised mammalian cell lines, see Chapter 3. As such a similar approach 
for the primary cilia and centriolar proteome might prove useful in primary ciliated 
cells. Fluorescently tagged centriolar proteins have already given the field valuable 
insights into how centriole length is maintained in fly embryos (Aydogan et al. 
2018). Similarly a transgenic tricistronic fluorescent Arl13b and the Fucci system 
(Sakaue-Sawano et al. 2008) have provided a way to link dynamic processes such 
as ciliogenesis and the cell cycle (Ford et al. 2018). Therefore tagged proteins are 
a valuable tool to investigate the fundamental mechanisms involved in the 
formation and function of primary cilia and centrioles.  
The PCM1SNAP HEK 293 cell line could be used for similar purposes as the SNAP-
Dnah5 mouse cells, namely to isolate centriolar satellites and identify interactors, 
although this was recently done (Gheiratmand et al. 2019; Quarantotti et al. 2019). 
The turnover of these proteins could also be measured in the same ‘pulse-chase’ 
manner as described in Chapter 4. This would demonstrate whether PCM1 really 
is the stable scaffold of centriolar satellites or if it has a more transitory role. This 
could also be used to investigate whether distinct populations of centriolar satellites 
with differing stability exist. However, although HEK 293 cells are a robust cell line 
and are amenable to genetic manipulation they have an abnormal karyotype 
(Stepanenko and Dmitrenko 2015). Therefore tagging PCM1 in a more 
physiologically relevant cell line, such as h-TERT immortalised RPE-1 cells 
(Bodnar et al. 1998), would provide more relevant information. Similarly live cell 
imaging could be more easily achieved in cells using a bright fluorescent tag, which 
with the generic tagging strategy is easy to change (Lackner et al. 2015). An 
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interesting possibility would be to observe the movement of PCM1 in relation to 
ciliogenesis as it has been suggested that the centriolar satellites are important for 
this process (Hori and Toda 2016). This could be achieved via endogenous tagging 
of PCM1 in the already established Arl13b Fucci cells. While PCM1 is an important 
part of centriolar satellites it would also be useful to be able to track the movement 
of other proteins in the cell as well. Tagging centriole and cilia associated proteins 
would further help delineate when and where satellites interact with these 
structures.  
High throughput endogenous tagging could also be applied to the various IFT 
complex proteins to help define what their interactors are as well as to observe 
where they are localised and when they are expressed. Although much of this has 
already been achieved with overexpression studies the use of endogenous tagging 
reduces the level of background interactions.  
While the high throughput strategy employed proved ineffective for tagging fly 
embryos, it may yet be applicable for studying cilia related processes in 
immortalised cell lines by creating a library of tagged genes.  
6.3 The role of translation in regulating the axonemal dyneins 
As previously discussed in Chapter 4, translational regulation of large heavy chain 
dyneins is a way in which motile ciliated cells might control how many ADs they 
produce. It is clear from the results shown in Chapter 4 that the AD heavy chains 
are still being produced at least 28 days after the initiation of differentiation in 
mTECs, indicating that translation happens over a long period of time. This is in 
contrast to the levels of the transcript which appear to remain relatively low 
(Plasschaert et al. 2018; Montoro et al. 2018), Figure 4.8. The low number of 
Dnah5 transcripts could be a result of their unusual length, 268,300 bp, which 
would take approximately ~45 minutes to transcribe at the fastest estimated 
transcription speed of a single RNA polymerase II (RNAP II) (Jonkers and Lis 
2015). Splicing at the 79 exons present and nuclear export would also contribute 
to the time taken to produce the Dnah5 mRNA. Therefore it’s possible that the cell 
makes a few transcripts which are then highly translated in the cytoplasm by 
polysomes. The storage of mRNA for later translation is conducted by liquid-liquid 
phase separated organelles such as stress granules and processing bodies (P-
bodies). Stress granules are a molecular response to sudden stresses such as 
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heat-shock, they consist of stalled pre-initiation complexes and a variety of RNA 
binding proteins. In contrast, the P-bodies consist of free mRNAs and RNA binding 
proteins, some of which are shared with stress granules (Ivanov, Kedersha, and 
Anderson 2019). The localisation of the Dnah5 transcript in motile ciliated mouse 
cells in large clusters suggests they are being sequestered deliberately. However, 
without further analysis of the protein composition of these clusters it is unclear 
whether these are cytoplasmic granules, polysomes (i.e. translation factories) or 
something else. The results of the SNAP-DNAH5 pulldown, Figure 4.7, do suggest 
an interaction with ALKBH5, the m6A demethylase. Recent studies have suggested 
that demethylation of certain mRNAs can result in their sequestration into stress 
granules by G3BP1 and G3BP2, which ensures their stability (Edupuganti et al. 
2017). G3BP1 has been shown to co-localise with DNAAFs and dynein subunits 
in DynAPs (Huizar et al. 2018), combined with the interaction between DNAH5 and 
ALKBH5 this suggests there could be active regulation of translation complexes. 
Furthermore isolation of P-bodies and profiling of their mRNA suggests that longer 
transcripts, such as Dnah5, are preferentially recruited here (Hubstenberger et al. 
2017). 
The methodology used by Hubstenberger et al. could be used to isolate 
cytoplasmic granules containing the axonemal dynein proteins. In this study they 
used a fluorescently tagged protein component of P-bodies and isolated all 
fluorescent granules from cells that were of a certain size. If the axonemal dyneins 
are in liquid-liquid phase separated granules such as P-bodies then this approach 
may allow for their isolation and characterisation by mass spec and RNA 
sequencing. 
In conclusion, the smRNA FISH evidence demonstrates an unusual clustering of 
few Dnah5 transcripts in mTECs and preliminary IP interaction studies suggest 
there may be translational control by ALKBH5. However, the findings of this project 
need to be validated with analysis of additional pulldowns and imaging of DNAAFs, 
DNAH5 and translational regulation proteins simultaneously with the Dnah5 
transcripts in motile ciliated cells.   
6.4 Axonemal dynein turnover and the relevance to PCD genome editing 
therapy 
The pulse-chase experiments shown in Chapter 4 demonstrate the remarkable 
stability of the SNAP conjugated dyes and of DNAH5 in the axoneme. This is the 
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first study to investigate the turnover of AD proteins in the mammalian cilia; it 
suggests that there may be low levels of turnover. The replacement of ODAs along 
the length of the mature axoneme is consistent with findings from other organisms 
(Piperno, Mead, and Henderson 1996; Stephens 1997; Viswanadha et al. 2014; 
Dai et al. 2018). However, as discussed in Chapter 4 the incubation times need to 
be increased to assess whether there really is replacement of DNAH5 on the 
axoneme. It is expected that the DNAH5 proteins stained with the initial dye would 
eventually be completely replaced by the newly synthesised protein if there is 
turnover of these complexes. In a scenario where this is the case it would be 
interesting to see whether this is due to continual transcription of the AD subunits 
or if it comes from translation of existing transcripts, which would lend weight to the 
sequestration model proposed in the previous section.  
The pulse-chase assessment of turnover indicates that any therapeutic rescue of 
ODA assembly in mature ciliated mTECs would not result in their large scale 
docking onto the axoneme for at least 32 days but probably much longer. However, 
as previously discussed in Section 4.5, the situation may be different in an 
axoneme devoid of ODAs to begin with. Therefore to assess the feasibility of 
genome editing directed at mature ciliated cells in PCD patients the cells could be 
treated with DM-CHX to prevent assembly of ADs for varying periods of time. The 
DM-CHX inhibits AD formation but allows the cilia to form without them. This would 
better reflect the mixed population of mature and maturing cells within the 
respiratory epithelium. While it would be good to be able to correct mutations in the 
mature ciliated epithelial population, which makes up ~50% of the airways, these 
cells do not have an indefinite lifespan, with the respiratory epithelium being 
replaced every 30 to 50 days (Bowden 1983; Rawlins et al. 2007). The rate of 
replacement may be even faster in PCD patients where cycles of chronic infection 
and inflammation lead to areas of the epithelial layer being damaged (Look et al. 
2001). For a lasting cure, the optimal target cell type for genome editing is the basal 
(stem cell) population in the airway epithelium which replenishes the ciliated cells 
(Boers, Ambergen, and Thunnissen 1998). Gene correction in these cycling cells 
would help to ensure that rescue would be permanent, as long as the pool of 
corrected cells remained actively cycling. In addition to the reduced usefulness of 
a strategy that targets the mature ciliated cells it would also be more difficult to 
achieve because they are differentiated and have very low levels of HDR.  
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Measuring the effectiveness of any genome editing in the restoration of the ODAs 
could be done by assessing the restoration of axonemally localised SNAP-DNAH5 
fluorescence in treated mTECs. It could be used to optimise the best approach to 
genome editing specifically aimed at PCD mutations affecting ODAs in the same 
way as the existing fluorescent reporter systems discussed in Chapter 5, reducing 
the variability and cost associated with immunofluorescence for dynein antibodies. 
However, this would be more effective if the fluorescence was seen in live cells 
because rescue could be assessed more immediately than in fixed cells.  
6.5 Engineering Cas proteins for better genome editing 
As was explained in Chapter 5, the CRISPR/Cas system has been altered in many 
ways to improve its ability to make specific changes in mammalian genomes. One 
approach has been to rationally design Cas9 fusions which perform in more 
desirable ways, for example to improve HDR (Rees, Yeh, and Liu 2019; Savic et 
al. 2018; Gu, Posfai, and Rossant 2018; Aird et al. 2018) or to convert single bases 
through chemical modification (Komor et al. 2016). The Cas9-Rep78 fusion protein 
designed in this project would be another example of these rationally designed 
molecules. The advantage of this Cas9 fusion being that it is designed to work in 
conjunction with a commonly used gene therapy vector and therefore has 
immediate applicability to therapeutic genome editing. However, further 
optimisation is required to increase the efficiency of HDR in this system. Despite 
the number of rationally designed Cas9 nucleases constantly increasing they are 
still reliant on the use of Cas9 as an intact unit to recognise the guide RNAs and 
target them to the correct place in the genome, even if the nuclease domains are 
not required (Komor et al. 2016). This represents an area which could be further 
optimised to reduce the size of vectors and make any protein targetable to a 
specific position in the genome via fusion of the minimal RNA targeting domain. 
While researchers have been attempting to rationally design a Cas nuclease which 
is able to mediate efficient and targeted gene therapy it has been discovered that 
a similar system may already exist (Klompe et al. 2019). In this study they found 
that a bacterial transposon, Tn6677, can use the CRISPR/Cas system of E. coli to 
insert itself into the genome. Furthermore this system can be altered to insert other 
sequences at different locations and does so with high levels of efficiency, ~52%. 
Therefore it may be useful for future gene therapy applications such as gene 
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replacement or HITI. However, it will also need to be simplified to reduce the 
number of factors involved and optimised for use in mammals.  
The potential for the CRISPR/Cas systems to revolutionise the treatment of genetic 
disorders such as PCD is huge and it is clear that there is still a lot to discover and 
much optimisation to be done.  
6.6 Concluding remarks 
This project has uncovered some hitherto unknown aspects of the dynein heavy 
chain DNAH5, such as where its transcripts localise in the cytoplasm, the rate at 
which it docks onto the axoneme and how long it stays there. This work has also 
helped to establish the use of a universal tagging strategy that will be useful to this 
lab for future studies. Furthermore the creation of the SNAP-Dnah5 mouse line will 
provide useful information about motile cilia biology and adds to the list of 
endogenously tagged dynein genes available. The repertoire of attempted Cas9 
fusion proteins also has a new addition with the creation of Cas9-Rep78, which will 
hopefully prove to be useful in the development of genome editing therapy for PCD. 
While many more experiments are required to validate these preliminary results, 
this project has laid the groundwork for these investigations, which ask broader 
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No. Name Nucleotide sequence (5’ to 3’) 
9 GFP forward AGAACTCTTGCTTGCTTTGCT 
10 GFP reverse TCCTTGAAGTCGATGCCCTT 
11 SDM EGFP_G67A_+XhoI_f GACCACCCTGACCTACgccGTGCAGTG
CTTCtcgaggTACCCCGACCA 
12 SDM EGFP_G67A_+XhoI_r GTAGGTCAGGGTGGTCACGAGGGTGG
GCCAGGGCACGGG 
























19 SNAP sequencing forward  CTGAATGGCGAATGGGAGC 
20 SNAP sequencing reverse  CTCTCCAGGGCTGCCAAG 
21 pMA-tia1L + GGSGSNAP no 
stop or start 240-261 
undefined 
Ccaacttaatcgccttgcagca 
22 pMA-tia1L + GGSGSNAP no 
stop or start 357-377 
undefined 
AGACGGTTTTTCGCCCTTTGAC 
23 pMA-tia1L + GGSGSNAP no 
stop or start 720-741 
undefined 
TGACCTCTCCGAACTTCACCAC 
24 pMA-tia1L + GGSGSNAP no 











35 N-1F cg6971 ACAAACCTGCTGAATTCCTGA 
36 N-1R cg6971 CCGTTTGGGGCCTTTTCAT 
37 SNAPNR cg6971 GAAGATGATACGGTGCAGGC 
38 C-1F cg6971 GGCGCATGAGGAAAAGGAAA 
39 C-1R cg6971 AACGCATAGACCACACTCCA 
40 SNAPCR cg6971 CGCTTCATTTCGCAGTCTTTG 
41 CEL1 eGFP forward Ataaccatggtgagcaaggg 
42 CEL1 eGFP reverse Tctgcttgtcggccatgata 
43 PCM1 ex2_f Agtgcttcaaagattgtattgct 
44 PCM1-ex3_f GTGCCCAACAGAAGAAAGCA 
45 PCM1 ex38_f tcattccaaagGCAGATCTAAGA 
46 PCM1 ex39_f Tgaatcagaaacgcctcacc 
47 Primer SNAP_r CTCAGGCTGGTGAAAGTAGG 
48 PCM1 del_f2 Ttcaagcatgcagactggtg 
49 PCM1 del_r39 GGGGAGAAATGACCACACCT 
50 PCM1 del_f3 Tcctggtttgatacaggcca 
51 PCM1 del_r38 Gtctccatctcctgacctcg 
52 PCM1 notdel_f Ccagttgacttggttgcctc 
53 PCM1 notdel_r Gagtctcgttctgtcaccca 
54 C-2F cg6971 GCTCAACGCCTACTTTCACC 
55 SNAPCR2 cg6971 AACGCATAGACCACACTCCA 
13 PCM1-ex3_r TAATTCTGCCTGCTCTGGGA 
54 DNAH5nterm F AGTCACCCACATGCATGAGA 
55 DNAH5nterm R Tgcagcacgtcagagactta 
56 DNAH5cterm F Acctggcttgtgttctgaga 
57 DNAH5cterm R CCAGCACTGACAGAGAAACG 
60 Pma-tia1l seq F Gctgcaaggcgattaagttg 
61 Pma-tia1l seq R Gaaggaatcatgggaaataggcc 
64 EcoRI Rep78 R GAATTCctggatccactgcttctccg 
65 Linker Rep78 F GCGCGCCGGGATCCGCTGGCTCCGC
TGCTGGTTCTGGCatgccggggttttacgagat 
66 FseI Rep78 F AAAGGCCGGCCAGGCAAAAAAGAAAA
AGGCGCCGGGATCCGCTGGCTC 
67 Stop Rep78 R AAAAGAATTCTTActggatccactg 
80 Cas9-Rep F CTTTGACACCACCATCGACC 
81 Cas9-Rep R AGGAAAGGACAGTGGGAGTG 
82 MCS F BamHI GATCCgctagcgcggccgcgtcgacgaattca 
83 MCS R HindIII agcttgaattcgtcgacgcggccgcgctagcG 
98 Mouse DNAH5_N_F GCTCAACGCCTACTTTCACC 
99 Mouse DNAH5_N_R Ttgtcttgtggccccatttg 
100 Mouse DNAH5_N_F 1 GAAATCCCGTGCCCATTCTG 
101 Mouse DNAH5_N_R 1 Cccatttccctgctctacca 
102 Mouse DNAH5_N_F 2 CGGAGAGGTCATCAGCTACA 
103 Mouse DNAH5_N_R 2 Gtgtcatctggcttgttccc 
 
Table A1 Primer sequences 
 





Table A2.1 Peptide number and sequence coverage of enriched proteins 
The table above lists the gene names, number of peptides used to identify and the 
percentage of the sequence covered by the peptides of the proteins enriched in 








Gene names Peptides Sequence coverage [%] 
Dnah5 29 7.7 
Eif2s3y 17 42.8 
Tcea1 12 39.9 
Hsp90aa1 8 12.3 
Spag1 7 9.4 
Eno1 5 17.1 
Alkbh5 4 14.4 
Sftpa1 3 14.9 
Cdh1 2 3.6 
Lox 2 8.8 
Epb41l4a 2 4.4 
Trmt112 2 20 
Myl1;Myl3 1 8.5 













































































































Table A2.2 Amino acid sequences of enriched peptides 
The table shows the gene names of the proteins enriched by pulling down SNAP-
DNAH5 with the SNAP antibody and the amino acid sequences of the 
corresponding used to identify them. 
 
 
 
 
 
